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SUMMARY 
 
Endogenous nitric oxide (NO) produced by the enzyme NO synthase (NOS) 
has an important role in a variety of physiological processes. However, NO 
becomes noxious to cells if produced in excess. Therefore, the production of NO 
is tightly regulated. A particularly exciting and novel aspect of the regulation of 
NO signalling is the possibility that the expression of NOS genes is controlled 
by unconventional mechanisms that depend on the presence of natural 
antisense transcripts (NATs). 
In this thesis I investigate the important properties of two distinct NOS-
related NATs: Lym-antiNOS2 and Mm-antiNOS1. I show that Lym-antiNOS2 
RNA is widely expressed in the CNS of the pond snail Lymnaea stagnalis. 
Furthermore, I demonstrate that the expression of Lym-antiNOS2 is 
differentially regulated by training leading to long-term memory formation. 
Moreover, my results indicate that Lym-antiNOS2 RNA is subjected to 
peripheral trafficking in neurons. As for Mm-antiNOS1, I find that its expression 
is restricted to embryonic brain tissue and is almost undetectable in the adult 
brain of Mus musculus.  
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Chapter 1: Introduction 
1.1. Discovery of Endogenous Nitric Oxide (NO) as a Signalling 
Molecule 
Nitric Oxide (NO) is a short-lived, non-polar diatomic gas that acts as a 
signalling molecule in the body. Signal transmission by a gas is an entirely new 
principle for signalling in the human organism. NO is a simple, highly reactive 
molecule that has a lifetime of only a few seconds at low concentrations in 
tissue. NO has the ability to diffuse across lipidic membranes.  
By 1948 nitroglycerin and sodium nitroprusside had already been reported to 
be used clinically as a vasodilator (Hallberg et al., 1948; Krasno and Ivy, 1950). 
After many years of investigation, researchers realised that the vasodilatation 
was produced by the generation of NO in aqueous solution, and that NO itself 
could cause vasodilatation.  In 1977 researchers found that nitroglycerin and 
related vasodilators activated cytoplasmic guanylate cyclase and thereby the 
formation of cyclic guanosine 3‟,5‟-monophosphate (cGMP) in the vascular 
smooth muscle (Arnold et al., 1977; Gruetter et al., 1979; Ignarro et al., 1991; Jacq 
et al., 1977; Katsuki et al., 1977; Murad et al., 1978). NO was then found to have 
similar biologic effects on isolated strips of bovine coronary artery where it was 
shown that NO was a potent, transient vascular smooth muscle relaxant 
(Gruetter et al., 1979). Further studies suggested that chemical reactions 
between certain nitrovasodilators and free thiols, such as cysteine and 
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glutathione, facilitated the decomposition of the parent drug accompanied by 
the generation of NO from intermediate unstable S-nitrosothiols. In the closed 
chest of anesthetized cats, S-nitrosothiols were found to elicit hemodynamic 
responses that were indistinguishable from those elicited by nitroglycerin. 
Based on earlier views expressed by Needleman and co-workers, the proposal 
was forwarded that tolerance to nitroglycerin develops as a result of the 
depletion of smooth muscle free thiols, so that S-nitrosothiols and therefore NO 
cannot be generated (Ignarro et al., 1981). Tolerance to nitroglycerin in patients 
can be abolished, or partially reversed, by the intravenous infusion of N-
acetylcysteine, which serves to restore the intracellular thiol concentration. 
The physiologic significance of the finding that NO causes vascular smooth 
muscle relaxation and inhibition of platelet function remained elusive until 
recently, when nitric oxide was shown to occur naturally in mammalian 
vascular endothelial cells and to account for the vasodilator action of 
endothelium-derived relaxing factor (EDRF). Endothelium-derived relaxing 
factor was first discovered in 1980 to account for the vascular smooth muscle 
relaxant action of acetylcholine (Furchgott and Zawadzki, 1980), and was 
subsequently shown to activate cytoplasmic guanylate cyclase, elevate vascular 
smooth muscle levels of cGMP, and inhibit platelet aggregation (Ignarro et al., 
1987; Ignarro et al., 1991). 
This body of work led to Robert F Furchgott, Louis J Ignarro and Ferid 
Murad being awarded the Nobel Prize in Physiology or Medicine for their 
discoveries concerning “nitric oxide as a signalling molecule in the 
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cardiovascular system” (Nobelprize.org, 1998). It also made NO grow in 
importance, so much that in 1992 it was proclaimed by researchers “Molecule of 
the Year” (Koshland, 1992).  
NO is a simple, diatomic molecule. NO is a gas at room temperature and 
pressure. It is also soluble in water and has the capability of fast diffusion 
through the lipidic membrane. NO has one unpaired electron and thus it is 
formally a free radical species. The radical nature of NO confers it the ability to 
react with other species. Its half-life is only around 7 seconds (Fukoto J.M., 
2000). 
NO is potentially toxic and yet has the ideal conformation to be both a 
transient intra- and extra-cellular signalling molecule. NO has evolved into a 
transducer signal for fundamental physiological processes such as long term 
memory (LTM) formation, cardiovascular function, immune response and 
neurogenesis. The discovery of NO as a vasodilator introduced the concept that 
living systems are able to produce and utilize gaseous molecules as a type of 
paracrine and autocrine signalling molecule. 
NO-related regulatory systems may be as old as cellular organization itself. 
N2 is an essential element for life and it is suggested that NO was a crucial 
intermediate in its utilization. Most of the organisms are not able to use N2 
directly because of the high activation energy required to dissociate nitrogen 
triple bonds (N≡N); in order to be used, it must be in either reduced or oxidized 
form (Moroz and Kohn, 2007). 
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Low levels of NO production are important in signalling cascades, however 
constantly increased levels of NO could result in tissue damage. Moreover, 
different types of cancers, diabetes, degenerative diseases (multiple sclerosis, 
arthritis and ulcerative chronic colitis) have been associated with chronic 
elevated expression of NO. 
1.2. Discovery of NO Signalling in the Brain 
1.2.1. Discovery of NO Synthases 
In 1989 the enzymatic formation of NO was identified in dialyzed bovine 
brain cytosol (Schmidt et al., 1989), making bovine brain the second vertebrate 
tissue –after murine macrophages– where enzymatic formation of nitrogen 
oxides from L-arginine had been demonstrated. The findings indicate that L-
arginine is a substrate for NO-forming enzymes. These NO-forming enzymes 
discovered in mammalian tissues were named NO synthases (NOS). These 
enzymes were remarkably rapidly characterized, purified and cloned: first 
described in 1989, purified in 1990 and cloned in 1991 (Bredt and Snyder, 1990; 
Stuehr et al., 1991). 
NOS was shown from the first studies to require Ca2+/calmodulin 
(Ca2+/CaM) to elicit the conversion of L-arginine to L-citrulline and produce 
NO. Immediately thereafter, Snyder and colleagues determined that neuronal 
NOS (nNOS) contains both flavin adenine dinucleotide (FAD) and flavin 
mononucleotide (FMN) in 1:1 stoichiometry, and reported that the amino acid 
sequence of its 641-residue C-terminal was highly homologous to NADPH–
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cytochrome P-450 reductase (Bredt and Snyder, 1990; Stuehr et al., 1991). They 
also reported the flavoprotein nature of inducible NOS (iNOS), having already 
demonstrated that iNOS from mouse macrophages requires 
tetrahydrobiopterin (BH4) for activity. 
Three groups of NOS isoforms that catalyze NO synthesis in mammalian 
tissues have been identified. Each of the NOS families is encoded by separate 
genes. A summary of the properties of the three isoforms of NOS is shown in 
Table 1.1. 
 
Table 1.1 Properties of mammalian NOS isoforms (Masters, 2000). 
 Endothelial NOS (eNOS or NOS3) and neuronal NOS (nNOS or NOS1) are 
constitutive and Ca2+-dependent. Inducible NOS (iNOS or NOS2) is 
Ca2+-independent and stress-induced. All of them have been characterized 
biochemically, and cloned from several mammalian species with numerous 
splicing variants. Ca2+ influxes associated with either ligand-gated or voltage-
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activated Ca2+ channels up-regulate NOS activity and result in transient 
activation of NO synthesis, release of NO and action on neighbouring cells and 
neuronal terminals (Masters, 2000; Moroz and Kohn, 2007). 
NOS in animals is a multi-domain protein consisting of two main subunits: 
N-terminal oxygenase domain (N-terminal part of NOS, with L-arginine, BH4 
and heme binding sites), which belongs to the class of heme-thiolate proteins, 
and a C-terminal reductase domain (P-450-type enzymes). The interdomain 
linker between the oxygenase and reductase domains contains a calmodulin-
binding sequence (Liu and Gross, 1996). In contrast, all prokaryotic NOSs are 
truncated and consist of the oxygenase domain alone. The most likely scenario 
for the origin of eukaryotic NOSs is the fusion of two previously independent 
genes, one representing the oxygenase domain (as bacterial NOS) and the P-450 
reductase (Alderton et al., 2001). This fusion of oxygenase and P-450 reductase 
domains may have occurred as a response to the rise of oxygen concentration in 
Proterozoic time, suggesting the possibility that NOS first appeared in basal 
animal ancestor groups (Moroz and Kohn, 2007). 
All NOS isoforms are flavo-hemoproteins that utilize NADPH as a substrate 
for reducing equivalents. Illustrated in Figure 1.1 are the binding sites for the 
cofactors, including NADPH, FAD, FMN, and Ca2+/calmodulin. Calmodulin is 
constitutively bound to the iNOS isoform and no Ca2+ is required for binding. 
The oxygenase domain of NO synthase contains a conserved cysteine residue 
that acts as an axial ligand for the heme iron (Ignarro, 2000). 
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Figure 1.1. Primary sequence map of the three isoforms of human NO synthase (Ignarro, 2000). 
In all animal tissues the enzymatic synthesis of NO proceeds according to the 
following reaction: L-arginine + O2 → NO + L-citrulline in the presence of 
NADPH and other co-factors (Figure 1.2). NOS enzymes are known to 
simultaneously require five bound cofactors, the enzyme with more co-factors 
known. Animal NOS isozymes are catalytically self-sufficient. They contain 
relatively tightly-bound cofactors (6R)-5,6,7,8-BH4, FAD, FMN and iron 
protoporphyrin IX (heme) and catalyse a reaction of L-arginine, NADPH, and 
oxygen to the free radical NO, citrulline and NADP (Alderton et al., 2001). The 
electron flow in the NO synthase reaction is: NADPH → FAD → FMN → heme 
→ O2 (Knowles and Moncada, 1994).  
All the three NOS isoforms require dimerization of two NOS units in their 
active form. The NOS enzymes are usually referred to as dimeric in their active 
form, ignoring the required calmodulin (Figure 1.3). 
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Figure 1.2 Overall reaction catalysed and cofactors of NOS. Electrons (e-) are donated by 
NADPH to the reductase domain of the enzyme and proceed via FAD and FMN redox carriers 
to the oxygenase domain. There they interact with the heme iron and BH4 at the active site to 
catalyse the reaction of oxygen with L-arginine, generating citrulline and NO as products. In 
some circumstances NO- may be a product instead of NO. Electron flow through the reductase 
domain requires the presence of bound Ca2+/CaM (Alderton et al., 2001). 
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Figure 1.3 A docking model constructed manually showing possible interactions between CaM 
complexed with a helical peptide from human eNOS and the rat nNOS reductase domain. The 
autoinhibitory control element (ACE, residues 831–872) of nNOS is partially disordered with 
two unstructured regions (831–835 and 850–870). The C-terminal helix is hidden behind the 
FMN binding domain. Cofactors FMN, FAD, and NADPH are shown as ball-and-sticks, while 
Ca2+ ions in CaM are represented as gold spheres (Li and Poulos, 2005). 
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1.2.2. Expression of NOS Enzymes in the Brain 
nNOS activity was first identified in the cerebellum, in a crude supernatant 
fraction of human cerebellum (Schmidt and Murad, 1991). It is documented that 
nNOS is the major component of NOS in the hippocampus of mice (Murashima 
et al., 2005). nNOS is located in the peripheral vagal nerves (Choate et al., 2001), 
sympathetic nerves (Wang et al., 2006) and in the autonomic control region of 
the central nervous system (Andrew and Mayer, 1999). nNOS is expressed in 
neurons, cardiac myocytes and blood vessels. 
In Lymnaea, Lym-nNOS has been localized in the serotonergic cerebral giant 
cells (CGCs), which modulate synaptic transmission within a neural network 
that generates feeding behaviour, where the CGCs employ both NO and 
serotonin in the modulation (Korneev et al., 1998). In zebrafish nNOS was 
identified to be expressed throughout the adult brain. nNOS may participate in 
neurotransmission and in mechanisms related to the continuous 
neurodevelopment and neuronal plasticity. nNOS mRNA was localized within 
central nuclei of all brain regions and in the proliferation zones, distributed 
along the ventricular regions from the telencephalon through the entire 
hypothalamus, optic tectum and rhombencephalon (Holmqvist et al., 2000). 
1.2.3. Canonical Mechanisms of the Regulation of NO  
Each member of the NOS family is known to regulate different functions. 
nNOS-derived NO performs a variety of physiological and patho-physiological 
roles. NO has been shown to be involved in the regulation of long term 
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potentiation (Schuman and Madison, 1991), in neurodevelopment (Kalb and 
Agostini, 1993) and in several neurodegenerative disorders such as stroke 
(Love, 1999), Parkinson‟s disease, Alzheimer‟s disease, and amyotrophic lateral 
sclerosis (Calabrese et al., 2007). Excessive production of NO may exert 
neurotoxicity, particularly in the presence of oxidative stress, since NO may 
react with superoxide to form peroxynitrite (Szabo et al., 2007). Because of NO‟s 
toxicity and its contribution to the pathogenesis of neurodegenerative 
disorders, nNOS is under tight regulation through different mechanisms. nNOS 
is regulated by alternative splicing, protein-protein interaction, covalent 
modifications and via CaM/Ca2+ binding domain. 
Active nNOS is dimeric with an extensive interface between the two 
oxygenase domains creating high-affinity binding sites for BH4 and L-arginine. 
The nNOS monomer has two cysteine residues which can form a disulphide 
bridge or ligate a zinc ion between the monomers, covalently linking the two 
oxygenase domains. Moreover, there is an N-terminal hook domain which can 
also stabilize the dimer. Additionally, interactions across the dimer between the 
reductase domains and between the reductase and oxygenase domains also 
exist. BH4 as well as heme and L-arginine all make nNOS a stable dimer. The 
nNOS inhibitor 7-nitroindazole reduces the affinity of BH4 and L-arginine. 
Dimerization increases nNOS activity by creating binding sites for L-arginine 
and BH4, thus facilitating electron flow. Interestingly, the electrons appears to 
flow from one monomer to another, which may be a major reason why the 
nNOS monomer is inactive (Zhou and Zhu, 2009).  
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CaM was the first protein shown to interact with NOS, and is necessary for 
the enzymatic activity of all three NOS isoforms. The Ca2+ dependence of NO 
synthesis distinguishes the NOS isoforms, with nNOS and eNOS having a 
much higher Ca2+ requirement than iNOS. CaM binding increases the rate of 
electron transfer from NADPH to the reductase domain flavins and artificial 
electron acceptors such as ferricyanide and cytochrome C. It also triggers 
electron transfer from the reductase domain to the heme centre. nNOS and 
eNOS differ in their primary structure from iNOS in the former having 40-50 
amino acid inserts in the middle of the FMN-binding subdomain, which has 
been described as an autoinhibitory loop. Analysis of mutants of eNOS and 
nNOS with this loop deleted has shown that the insert acts by destabilizing 
CaM binding at low Ca2+ and by inhibiting electron transfer from FMN to the 
heme in the absence of Ca2+/CaM (Abu-Soud et al., 1994; Alderton et al., 2001; 
Daff et al., 1999; Gachhui et al., 1998; Gachhui et al., 1996). 
Phosphorylation of the nNOS and eNOS isoforms has an effect on NOS 
activity. Fluid shear stress elicits phosphorylation of eNOS and an increase in 
calcium-independent NOS activity. Mutational studies were carried where 
Ser1179 in eNOS was replaced by alanine. Immunoprecipitation and western 
blotting of eNOS and protein kinase Akt (co-immunoprecipitation) show that 
Ser1179 of eNOS is phosphorylated by protein kinase Akt, which results in an 
increase in electron flux through the reductase domain and an increase in NO 
production. In contrast, the phosphorylation of nNOS at Ser847 by CaM-
dependent kinases leads to a decrease in NOS activity (Alderton et al., 2001; 
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Corson et al., 1996; Hayashi et al., 1999; Komeima et al., 2000; Nakane et al., 
1991). 
The N-terminal extension of nNOS contains a binding site for the 89-amino-
acid protein inhibitor of NOS (PIN). Spectroscopy has been used to map the 
PIN-binding region of rat nNOS to Met228-His244 and to determine that PIN 
binds nNOS with a 1:2 PIN:nNOS stoichiometry. Initial reports suggested that 
only nNOS associated with PIN and that PIN was inhibitory by destabilization 
of the nNOS. However, recent reports claim that PIN neither inhibits nNOS nor 
promotes monomerization, or that PIN has no effect on nNOS dimerization but 
does inhibit both NOS and NADPH oxidase activity of nNOS, eNOS and iNOS 
in a time-dependent manner. The identification of PIN as a light chain of 
myosin and dynein has led to the suggestion of an alternative role for PIN as an 
axonal transport protein for nNOS rather than a regulator of nNOS (Hemmens 
et al., 1998; Jaffrey and Snyder, 1996; Rodriguez-Crespo et al., 1998; Xia et al., 
2006).  
 The molecular chaperone Heat-shock protein 90 (Hsp90) has also been 
identified as a regulator of eNOS activity, possibly as an allosteric modulator. 
Activation by vascular endothelial growth factor, histamine or fluid shear stress 
in human endothelial cells increases the interaction between eNOS and Hsp90 
and increases eNOS activity. The activity of purified eNOS was also increased 
by purified Hsp90, suggesting a direct interaction, the details of which are not 
yet clear. nNOS was not directly activated by hsp90 in vitro, but a role for Hsp90 
in incorporation of the heme into nNOS in in vivo situations where heme is 
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limited is suggested (Bender et al., 1999). Increased NO production has been 
inhibited by caveolin. Caveolin by inhibiting Ca-CaM binding suppresses NO 
synthesis in skeletal muscle, and consequently this inhibition is reversed by Ca-
CaM (Venema et al., 1997; Zhou and Zhu, 2009) . 
Post-transcriptional regulation of the nNOS gene occurs in the form of 
alternative mRNA splicing. Figure 1.4 presents a schematic representation of 
the predicted peptides of the four nNOS splice variants detected so far (nNOSβ, 
nNOSγ, nNOSµ and nNOS-2). 
 
Figure 1.4 Splice variants of rat nNOS. nNOSα: amino acids 1-1433; nNOSβ: amino acids 236-
1433 of nNOSα; nNOSγ: amino acids 336-1433 of nNOSα; nNOSµ: amino acids 1-1433 of nNOSα 
with a 34-amino-acid insert in the FMN-binding domain. nNOS-2 (detected in mouse): amino 
acids 1-1433 of nNOSα with 504-608 amino acids deleted (Luo and Zhu, 2011). 
The human iNOS mRNA is subject to alternative splicing, including deletion 
of exons 8 and 9 that encode amino acids 242–335 of the oxygenase domain 
(iNOS8-9). The region encoded by exons 8 and 9 is critical for iNOS dimer 
formation and NO production but not for reductase activity. Heterodimers 
between full length iNOS and iNOS8-9 were not detected after co-expression, 
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suggesting that iNOS8-9 may not exert the suggested dominant negative effect 
on iNOS activity (Alderton et al., 2001; Eissa et al., 1998). A replication-deficient 
recombinant adenoviral vector that directs the expression of a truncated form of 
eNOS was shown to act as a dominant negative inhibitor of wild-type eNOS 
activity through heterodimerisation with the native protein (Paton et al., 2001). 
nNOS is mostly located in the brain, where the synthase is highly enriched in 
specific neuronal populations (Bredt and Snyder, 1990). Protein interactions 
involving the nNOS PDZ domain in neurons regulate coupling to upstream 
calcium stores and specify downstream targets of NO. Most NO synthesis in 
brain is coupled to calcium influx through the N-methyl-D-aspartate (NMDA) 
type glutamate receptor, which was first shown to increase cGMP levels via 
neuron-derived NO (Garthwaite and Boulton, 1995). Physical association of 
nNOS with the NMDA receptor determines this specificity (Figure 1.5). nNOS 
does not directly bind to the NMDA receptor. However, both nNOS and 
NMDAR interact with the postsynaptic density protein 95 (PSD-95). PSD-95 is 
known to contain three PDZ domains. These PDZ domains mediate the 
interaction of the PSD-95 with the C-terminal end of the NMDA receptor 
subunit, and also with the PDZ domain from the nNOS. This leads to the 
formation of a ternary signalling complex. This complex is essential for the 
efficient activation of nNOS by calcium and determines downstream signalling 
specificity. (Bredt, 2003) 
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Figure 1.5 Protein interactions regulating NO signalling at neuronal synapses. PDZ domain 
interactions (pink) function to bring nNOS to the NMDA receptor, allowing speciﬁc activation 
of nNOS in response to glutamate-induced calcium influx. Binding of nNOS to PSD-95 leaves 
the nNOS PDZ domain peptide binding pocket free to interact with other proteins such as 
Capon. The NO produced in association with NMDA receptor activity diffuses to presynaptic 
nerve terminals and nitrosylates Dexras associated with Capon. Abbreviations: Arg, arginine; 
CaM, calmodulin; GK, guanylate kinase domain. (Bredt, 2003) 
1.3. The NO-cGMP Signalling Pathway  
Soluble guanylate cyclase (sGC) is the only proven receptor for NO. sGC 
catalyzes the conversion of guanosine 5P-triphosphate (GTP) to cyclic 
guanosine 3‟,5‟-monophosphate (cGMP). Because it is one of two enzymes that 
produce cGMP, and because it is the only definitive receptor for NO, sGC is 
intimately involved in many signal transduction pathways of many processes. 
Soluble guanylate cyclase is a heterodimeric protein composed of α and β 
subunits; in addition, it is a hemoprotein. NO binds to the sGC heme and this 
binding event activates the enzyme (Figure 1.6). The activation of sGC and the 
subsequent rise in cGMP concentration are what allow sGC to transmit a NO 
signal to the downstream elements of the signalling cascade. Importantly, the 
free-radical electronic structure of NO makes it an excellent ligand for heme, 
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allowing it to bind to the sGC heme at a low, non-toxic concentrations 
(Denninger and Marletta, 1999). 
 
Figure 1.6 The guanylate cyclase reaction and NO signal transduction. Adaptation from 
(Denninger and Marletta, 1999) 
The NO–cGMP signal transduction pathway is employed by NO to carry out 
many of its biological effects (Figure 1.7). NO as an endogenous activator of 
soluble guanylate cyclase led to the appreciation of cGMP as a second 
messenger of immense biological significance and potential. cGMP acts on three 
main classes of effector proteins: cGMP-dependent protein kinases, cGMP-
gated ion channels, and cGMP-regulated phosphodiesterases. These effector 
proteins mediate protein phosphorylation, cation influx, and cyclic nucleotide 
metabolism, respectively. The biological actions of cGMP are terminated by its 
breakdown by phosphodiesterases. cGMP, through its effector proteins, 
mediates several of the physiological functions of NO including regulation of 
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smooth muscle tone, inhibition of platelet aggregation, regulation of 
neurotransmission, and chloride and water secretion in the intestines (Ignarro, 
2000). 
The cGMP can be degraded by phosphodiesterase or can bind to other 
proteins including ion channels, protein kinases, and phosphodiesterases as 
illustrated in Figure 1.7. cGMP can either activate or inhibit specific 
phosphodiesterase isoforms. Binding of cGMP to protein kinases causes their 
activation and subsequent phosphorylation of proteins. The phosphorylated 
proteins can cause or lead to a biological effect and are generally inactivated by 
dephosphorylation caused by protein phosphatases. Many biological actions of 
NO are mediated by cGMP via this signal transduction pathway (Ignarro, 2000). 
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Figure 1.7 Signal transduction pathway for the NO–cGMP system in mammalian cells. NO 
generated from L-arginine by NOS isoforms activates sGC, thereby increasing production of 
cGMP (Ignarro, 2000). 
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1.4. Unconventional Mechanisms in Regulation of Gene 
Expression 
1.4.1. Regulation by Natural Antisense Transcripts (NATs) 
Natural antisense transcripts (NATs) are endogenous RNAs that have 
complementary sequences to transcripts of an already known function. NATs 
can be divided into two major groups. So-called cis-encoded are issued from the 
same locus as sense transcripts. Transcribed from opposite strands of DNA, cis-
encoded NAT display perfect complementarity to their sense products. In 
contrast, trans-encoded NATs originate from a different locus and may display 
only partial complementarity with the sense transcript (Vanhee-Brossollet and 
Vaquero, 1998).  
In 1977 Jacq and co-workers (Jacq et al., 1977) reported for the first time the 
isolation and sequencing of a 5S-rRNA related gene from Xenopus laevis which 
was truncated at the 5' end (by 16 base pairs) and had 14 base pair mismatches 
when compared to the productive 5S rRNA gene. As this particular gene could 
not possibly code for a functional 5S rRNA, Jacq used the term pseudogene to 
describe this truncated 5S rDNA homologue. Since then many different 
pseudogenes have been reported. Vanin in 1985 redefined the term pseudogene 
(Vanin, 1985) to describe sequences which have been shown to be related to a 
functional gene, but are defective. 
In the past scientists believed that the gene transcription in eukaryotic 
genomes was simple. We now know a broad spectrum of RNA molecules that 
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are transcribed, ranging from long protein-coding mRNAs to short noncoding 
microRNAs (miRNAs), which frequently overlap or are inserted on either 
strand (Ponting et al., 2009). Today the term pseudogene is starting to have a 
different meaning. Pseudogene formation may act as an evolutionary 
mechanism that generates trans-NATs to the parental gene. For example, this 
could occur if the parental gene is regulated by a cis-NAT that is copied as a 
trans-NAT in the pseudogene (Muro and Andrade-Navarro, 2010).  
Trans-NATs are transcribed from a sequence that is not located in the same 
genomic locus of their target and can then evolve separately, constrained only 
by keeping a complementary region to the target gene. It is still unclear how 
relatively large and specific complementary regions can arise to form such 
antisense transcripts. A possibility that was raised is that given a parental gene 
regulated by a cis-NAT, the duplication of the genomic fragment including the 
cis-NAT may result in a pseudogene holding an active copy of the cis-NAT, 
which is naturally a trans-NAT of the parental gene (Figure 1.8). Evolution can 
then eliminate any of the NATs or tune their expression differently. More 
generally, the formation of any pseudogene results in complementary regions 
to the parental gene. If combined with elements of transcriptional control 
antisense to the pseudogene, these can conceivably lead to the generation of a 
trans-NAT antisense to the pseudogene that is a potential regulator of the 
parental gene (Muro and Andrade-Navarro, 2010). 
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Figure 1.8 Long non-coding RNAs (A) cis-encoded natural antisense transcripts (NATs), (B) 
trans-encoded NATs 
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The vast majority of NATs belong to non-coding RNAs that may regulate the 
activity of sense transcripts to which they bind because of complementarity. 
NATs that are not located in the gene they regulate (trans-NATs) have better 
chances to evolve than cis-NATs (Figure 1.9), since the sense strand of the 
cis-NAT is part of a protein-coding gene. However, the generation of a 
trans-NAT requires the formation of a relatively large region of 
complementarity to the gene it regulates (Muro and Andrade-Navarro, 2010). 
 
Figure 1.9 Analysis of the patterns of evolution of certain trans-NATs that are fully aligned to 
the parental gene. (A) Selection of transcripts with PAS and other evidence for transcription 
(trans-NAT, dark green box) in antisense of pseudogenes (hatched box). (B) Next, the 
corresponding region in the antisense of the parental gene (light green box) is obtained (Muro 
and Andrade-Navarro, 2010). 
Non-coding RNA transcripts have emerged as an important type of 
regulatory molecules. It was proposed that NATs that can bind to sense RNA 
transcripts can modulate the level of RNA. Their generation and mechanism of 
action are different to those of microRNAs, which are processed into shorter 
21nt products and have possibly less specific effects (Muro and Andrade-
Navarro, 2010). 
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Three models have been proposed to explain the regulatory effects that 
cis-NATs have on gene expression. The first model proposes that base pairing 
between the cis-NATs and their complementary sense partner results in 
cleavage and finally degradation of the mRNA (Borsani et al., 2005). This model 
asserts that cis-NATs form a double strand RNA through their complementary 
sequences, which leads to the inhibition of the function of mRNAs, leading to 
the inhibition of protein synthesis. Many of the cis-NATs are head-to-head or 
tail-to-tail complementary to their sense-related gene (Figure 1.10); for these it is 
expected that the overlap region is at least 6 to 8bp to form stable double 
strands of RNA. 
 
Figure 1.10 Classification of cis-NATs and nearby transcripts on the basis of their relative 
positions in the genome. (a) cis-NATs orientated in a head-to-head manner (5‟-end to 5‟-end), 
(b) those in a tail-to-tail manner (3‟-end to 3‟-end), and (c) those in a full-overlap manner. Full 
overlap describes the cis-NATs where a transcript on a strand of the genome is overlapped by 
the entire length of the other transcript on the opposite strand of the genome. (d) Nearby 
transcripts in a head-to-head manner where the 5‟-end of a transcript is near the 5‟-end of 
another transcript in the genome. (e) Nearby transcripts in a tail-to-tail manner where the 3‟-end 
of a transcript is near the 3‟-end of another transcript in the genome (Osato et al., 2007). 
The second model involves epigenetic regulation, where NAT mediates 
silencing and methylation of the associated gene. Common molecular 
mechanisms underlie the set up of the epigenetic modifications associated with 
gene silencing. Of particular interest is the evidence that in some instances 
25 
 
transcriptional silencing is mediated by an RNA component that gives the 
sequence specificity to precisely target particular DNA regions. Double 
stranded RNA (dsRNA) molecules are required to direct histone methylation 
and silencing. In mammals, RNAs have been associated with chromatin 
silencing in the processes of imprinting (Verona et al., 2003) and X-inactivation, 
and more recently they have been involved in the methylation and silencing of 
CpG islands at autosomal and non-imprinted locations (Boumil and Lee, 2001; 
Tufarelli, 2006; Tufarelli et al., 2003). Another example of epigenetic regulation 
is the small nucleolar RNA (snoRNA). snoRNAs are a highly evolutionarily 
conserved class of RNAs that function as ribonucleoprotein complexes to guide 
the enzymatic modification of target RNAs at sites determined by RNA:RNA 
antisense interactions. snoRNAs are 70–120 nucleotides in length and guide the 
methylation of target RNAs (Figure 1.11). These RNAs were initially discovered 
in the nucleolus and thought to exclusively target ribosomal RNAs, but are now 
recognized to be a much broader class of RNAs with different functions, 
targets, and subcellular locations (Matera et al., 2007; Taft et al., 2009)  
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Figure 1.11 Small nucleolar RNAs (snoRNAs) guide site-specific modifications of nucleotides in 
target RNAs (Cao et al., 2006). 
The third model is shows in Figure 1.12, which has gained favour due to 
recent experimental evidence, is the transcriptional collision model. When cis-
NATs are transcribed by RNA polymerases, RNA polymerases bind to the 
upstream region of a gene encoding a sense mRNA and synthesize the 
complementary mRNA, moving to the 3'-end of the gene. Similarly, RNA 
polymerases that are bound to the upstream region of a gene encoding an 
antisense mRNA move to the 3'-end of the gene. Then, RNA polymerases 
collide with each other in the overlapping region of the genes, thereby 
inhibiting the transcription. Transcription is inhibited because RNA 
polymerases prematurely stop and their incomplete transcripts get degraded 
(Carmichael, 2003; Osato et al., 2007; Rosok and Sioud, 2005). 
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Figure 1.12 Transcriptional collision model When cis-NATs are transcribed by RNA 
polymerases, RNA polymerases bind to the upstream region of a gene encoding a sense mRNA 
and synthesize the complementary mRNA, moving to the 3′-end of the gene. Similarly, RNA 
polymerases that are bound to the upstream region of a gene encoding an antisense mRNA 
move to the 3′-end of the gene. Then, RNA polymerases collide with each other in the 
overlapping region of the genes, thereby inhibiting the transcription (Osato et al., 2007).  
Studies of trans-NAT have mainly focused on small RNAs such as small 
interfering RNAs (siRNAs) and miRNAs, which function in a trans base-pairing 
mechanism with their targets and play important regulatory roles such as in 
mRNA degradation and translational repression (Kim and Nam, 2006). 
miRNAs are small, highly conserved, noncoding molecules of 18 to 24 
nucleotides that regulate gene expression in a wide variety of tissues and cell 
types (Ambros, 2004). Silencing of the related gene occurs via mRNA 
degradation or interference in the translation of the mRNA (Chitwood and 
Timmermans, 2011). It has been found that as much as 20–30% of mammalian 
transcripts are targets of miRNAs, which bind to complementary mRNAs. This 
highlights the importance of NATs as regulators across a wide number of genes 
(Chen et al., 2004; Lehner et al., 2002; Osato et al., 2007). 
Regulation of gene expression through RNA interference is less costly and 
quicker than protein synthesis. This could have given early eukaryotes an 
advantage during the evolution. For NATs to have a regulatory function, sense-
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antisense transcript pairs should at least be co-expressed and inversely 
expressed. In practice, some individual sense-antisense pairs exhibit more 
complex and irregular patterns of expression (Ponting et al., 2009). 
1.4.2. Unconventional Mechanisms Involved in the Regulation of NO 
Production 
Dr Korneev in 1999 made a particularly important discovery of an unusual 
non-coding NOS-related polyadenylated RNA of 2,345 nucleotides transcribed 
from a NOS pseudogene (Korneev et al., 1999). The major part of the transcript 
exhibits >80% sequence identity to Lym-nNOS1 mRNA but cannot be translated 
into a protein due the presence of multiple stop codons in all the three reading 
frames. Unexpectedly, the transcript presents a region of approximately 150nt 
witch shows 80% complementarity to a region close to the middle of the 
Lym-nNOS1 mRNA. For this, the NOS-related RNA was then named 
Lym-antiNOS1, and was shown via  stablishing RNA–RNA duplexes form in 
vivo (Korneev et al., 1999; Korneev et al., 2005). 
The neuron-specific co-expression of the NOS1-encoding and Lym-antiNOS1 
transcripts is strongly supportive of a role for the pseudo-NOS gene in the 
translational regulation of nNOS expression.  However, this could only occur if 
the NOS1 and Lym-antiNOS1 transcripts form stable RNA–RNA duplex 
molecules. A method commonly used to detect such duplexes involves the 
treatment of purified cellular RNA with RNase A, an enzyme that specifically 
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cleaves single-stranded RNA(Korneev et al., 1999).  The results of the 
experiment are shown in Figure 1.13 
A   
Figure 1.13 A schematic diagram showing the major steps of the ribonuclease protection 
procedure used to detect RNA–RNA duplexes in vivo. To preserve possible RNA–RNA 
hybrids, cytoplasmic RNA was purified from the CNS under nondenaturing conditions. To 
identify our hypothesized RNA–RNA duplex, the RNA has to be treated with RNase A, an 
enzyme that cleaves single-stranded but not double-stranded RNA molecules.After RNase A 
treatment, reverse transcription reactions in the presence of either P2 primer (located within the 
protected area) or P1 primer (located outside the protected area) are performed. After adding 
the P3 primer, a cDNA generated in the first reaction could be amplified using PCR and then 
will be revealed as a single band of the expected size by electrophoresis. In contrast, no cDNA 
could be produced in the second reverse transcription reaction, and subsequently, no PCR 
product is expected. In the lef t column, the predicted results of the control experiments (no 
RNase A treatment) are summarized. Two RT-PCR products should be detected in the reverse 
transcription reaction: one generated by P2 and P3 and the other by P1 and P3.(Korneev et al., 
1999) 
Furthermore, during the investigation of the function of the NO-signalling 
pathway in Lymnaea another NOS-related transcript was cloned. It has a 
polyadenylated signal and a polyA tail, characteristic features of messenger 
RNAs. The novel transcript of about 3,000nt in length was named 
Lym-antiNOS2 NAT (Korneev and O'Shea, 2002).  
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 A PCR was performed on genomic DNA, which revealed that 
Lym-antiNOS2 and Lym-antiNOS1 were part of a separate locus from the related 
gene. A detailed sequence comparison between the anti-NOS locus and the 
nNOS gene (Korneev and O'Shea, 2002) indicates that an ancestral gene 
underwent duplication and that subsequently an inversion occurred in one of 
the copies; the other copy became nNOS gene. This comparison has revealed a 
clear continuous antisense homology between the central region of anti-NOS 
locus and a corresponding region in the nNOS gene. Outside of that region the 
similarity between the anti-NOS locus and nNOS gene reverts to the normal 
sense homology. Figure 1.14 shows the structural organization of the anti-NOS 
locus and the nNOS gene. The inverted part of the anti-NOS locus contains the 
last intron and exon of the Lym-antiNOS2 gene, an intergenic region, and a part 
of the first exon of the Lym-antiNOS1 gene. The corresponding region in the 
nNOS gene is composed of eight exons and eight introns as indicated. Below 
the upper bar the positions and sequences of inverted repeats which flank the 
inverted segment are shown.  
As a result of the inversion, the exon-intron organization of the locus has 
been dramatically altered. Lym-antiNOS2 RNA has acquired some sequences 
which are not present in the Lym-nNOS mRNA. Specifically the last exon in the 
Lym-antiNOS2 gene is actually composed of three exons and two introns from 
the ancestral gene. 
The DNA inversion has drastically changed the organization of one duplicate 
of the ancestral nNOS gene. The sequence analysis suggested a new stop codon, 
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not present in Lym-nNOS mRNA, introduced by the DNA inversion. As a 
consequence of this an interruption of the original open reading frame is used 
as a signal for the termination of translation in the Lym-antiNOS2 RNA 
(Korneev and O'Shea, 2002). 
 
Figure 1.14 Structural organization of the anti-NOS locus and the nNOS gene. The upper bar 
represents a segment of the anti-NOS locus, and the lower bar shows an internal region of the 
nNOS gene. Introns are labelled by „„i‟‟ and shown by black boxes. Exons are marked by „„e‟‟ 
and indicated by gray boxes. Dashed lines indicate the limits of the inverted region in the 
anti-NOS locus and the corresponding region in the nNOS gene. The hatched boxes labelled 
antiα and antiβ in the anti-NOS locus and a and b in the nNOS gene correspond to the similarly 
labelled regions in their associated RNA molecules (Korneev and O'Shea, 2002). 
1.5. Role of NO in Memory Formation 
Animal behaviour is the result of interactions between organisms with its 
environment. Those behaviours are combinations of inborn genetically coded 
instructions and experience-dependent information. The ability to retain 
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information and modify the behaviour according to previous experience 
presents great advantages in adapting to new environments. Learning is 
defined as a process that enables an animal to generate long-lasting internal 
representations based on the experience. The retention of this internal 
representation is called memory (Dudai, 1989). 
Memory is divided into two categories, declarative and non-declarative. 
Declarative memory is the ability to recollect events or facts by conscious 
decision. Non-declarative memory is a change in behaviour as an adaptive 
response to a previous experience; it underlies the ability to perform a learnt 
task or to recognise objects without conscious thought (Milner et al., 1998). 
Non-declarative memory, unlike the declarative one, can be studied in animal 
models under controlled conditions.  
Simple forms of non-declarative memory can be divided in two main 
categories: associative and non-associative. Non-associative learning requires only 
one type of stimulus and it is considered the simplest form of learning, and is 
further classified into habituation (the progressive decrease of response to a non-
noxious stimulus presented several times in a regular temporal sequence) and 
sensitisation (the strengthening of a response to a stimulus when it is tested after 
a separate non-neutral as noxious or rewarding).  
Associative learning requires the explicit temporal pairing of 2 stimuli in 
order to associate an Unconditioned Stimulus (US), able to trigger an 
Unconditioned Response (UR), with a Conditioned Stimulus (CS), generally 
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neutral. Within the general category of associative learning there are two kinds 
of conditioning: classical and operant. Classical conditioning, usually referred 
to as Pavlov‟s experiment, consists of the pairing of a US with a CS, with a 
precise time interval between the two types of stimuli. Following conditioning 
the CS is able to trigger a Conditioned Response (CR) similar to the UR (Kandel, 
2000). Operant conditioning is the response to learning by reinforcement of the 
consequences of a behaviour. 
Ever since Ivan Pavlov in 1928 first described classical conditioning, 
researchers all over the world have been using animals where associative 
learning can be triggered on a single stimulus (Pavlov, 1927; Pavlov, 1951).  
1.5.1. The Role of the NO-cGMP Pathway in Synaptic Plasticity and 
Memory 
Although the first analyses of learning have been made on vertebrates, more 
recent studies on invertebrates have given us a more complete understanding 
of the cellular and molecular basis of learning and memory. Invertebrate neural 
networks are smaller and less complex in invertebrates than those in 
vertebrates. Moreover, single neurons can be identified through their 
morphology and electrophysiological features. Studies at the level of a single 
synapse have allowed to identify the molecules involved in the process of 
learning and memory. The first results in the identification of changes 
underlying learning at the level of a single synapse were achieved in the sea 
slug, Aplysia californica (Kandel, 2000). 
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In Aplysia, habituation of the withdrawal reflex correlates with, and is in part 
due to, depression of transmission at the monosynaptic connection between 
mechanoreceptive sensory neurons and motor neurons within the abdominal 
ganglion. Habituation-related short-term depression of the sensorimotor 
synapse appears to be due exclusively to pre-synaptic changes. However, 
changes within the sensory neuron, by themselves, do not account for more 
persistent depression of the sensorimotor synapse. Recent behavioural work 
suggests that long-term habituation in Aplysia critically involves postsynaptic 
processes, specifically, activation of AMPA- and NMDA-type receptors. In 
addition, long-term habituation requires activity of protein phosphatases as 
well as activity of voltage-dependent Ca2+ channels (Glanzman, 2009). 
Molluscs, in particular Hermissenda, Limax, Aplysia and Lymnaea, have been 
extensively used for the study of associative learning. In Lymnaea, the feeding 
system has been used extensively to investigate reward-based classical 
conditioning. Feeding in Lymnaea is a rhythmic motor behaviour where 
repeated rasping movements of a toothed tongue or radula scrape at the surface 
of floating pond-weed or other food substrates leading to the ingestion of food. 
Sucrose acts a convenient food stimulus in the laboratory and is used as a 
rewarding stimulus in conditioning experiments. Lymnaea is a generalist in its 
feeding habits and it is advantageous for it to learn about potentially useful 
foods using a variety of sensory modalities. In chemical conditioning 
experiments, snails successfully learn even with only a single trial (Alexander et 
al., 1984). In this thesis, amyl acetate is the CS and sucrose the rewarding US 
35 
 
and pairing these two chemical stimuli results in a feeding response to the CS 
when applied in the post-training test elicited more rasping movements. One-
trial conditioning only works in snails starved for 4 or 5 days. A single pairing 
of amylacetate and sucrose in starved snails results in a long-term memory 
(LTM) trace that lasts for at least 19 days, a remarkable example of associative 
learning (Benjamin, 2010). In Lymnaea it was observed that PKA (protein kinase 
A enzyme), CREB (cAMP response element-binding protein) and NOS/NO are 
selectively activated/upregulated by the associative training protocol, so 
potentially each of these factors could be sufficient for memory consolidation. 
Also, the prevention of MAPK phosphorylation after training blocks LTM and 
shows that MAPK is necessary for the consolidation of associative LTM after 
single-trial reward conditioning. It is likely that these and other signalling 
molecules make a synergistic contribution to the memory consolidation process, 
with each molecule and pathway playing an important role in LTM but neither 
of them alone being sufficient for its consolidation (Kemenes, 2008). 
Interestingly, early inhibition of protein synthesis (inhibition of PKA catalytic 
subunit activity) does not block the expression of memory at 6 hours post-
training (Kemenes et al., 2006a), indicating the involvement of a different 
signalling molecule, possibly CaMKII, in the protein synthesis dependent 
consolidation of this earlier memory trace (Wan et al., 2010). 
In isolated cerebral ganglia, stimulation with the adenylate cyclase activator 
forskolin resulted in massively increased CREB phosphorylation in neuronal 
nuclei, indicating a potential link between training-induced PKA activation in 
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the cerebral ganglia and CREB phosphorylation in conditioned animals (Ribeiro 
et al., 2003). Additional support for the role of NO as a neurotransmitter was 
provided by evidence that NO activates the soluble form of sGC in the brain, 
resulting in the synthesis of a second messenger, cGMP (Ribeiro et al., 2010). 
Figure 1.15 provides a summary of published data on the known molecular 
requirements for the early and late phase of the consolidation of long-term 
memory after single-trial classical conditioning in Lymnaea. It is interesting to 
note that the requirement for PKA and NO outlast the requirement for protein 
synthesis indicating that these molecules are required for some as yet 
unidentified transcription and translation independent processes underlying 
memory consolidation in the 1h to 6hr post-training time window (Benjamin, 
2010).  
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Figure 1.15 Time windows of known molecular requirements for LTM after single-trial food-
reward classical conditioning in Lymnaea. The large curved arrows indicate the requirement for 
the activation or synthesis of molecules in the 0h to 6h (acquisition/early consolidation) and 
24hr time window (late consolidation) for memory expressed at 24 hr and 42 hr, respectively 
(Benjamin, 2010) 
A review of molecular mechanisms of memory storage in Aplysia (Hawkins 
et al., 2006) shows a simplified model of long term memory formation (Figure 
1.16). This model describes how neurotransmitters release and activate AC 
(adenylyl cyclase), which in turn leads to the elevation of cAMP levels in the 
neuron terminals. The cAMP-activated PKA phosphorylates a K+ channel, 
causing it to close, and this leads to an action potential and consequently to an 
increase in Ca2+ influx. The increase of Ca2+ increases in turn transmitter release. 
5-HT causes an elevation of cAMP levels, resulting in the translocation of PKA 
and MAPK into the nucleus. In the nucleus MAPK will activate transcriptional 
factor CREB protein, activating several genes, and this leads to long term 
changes in the neuron underlying long-term memory formation. It has been 
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shown that learning-induced a decrease in  chloride conductance result in  
depolarization that increases  baseline levels of intracellular calcium in the CGC 
(Kemenes et al., 2006b). But further experiments will need to be performed to 
establish if this also happens in the CGCs after classical conditioning. This 
supports synaptic growth and the formation of new synapses for the activation 
of pre-existing silent synapses, and self-perpetuating mechanisms and the 
molecular basis of memory persistence (Benjamin et al., 2005). 
 
Figure 1.16 Mechanisms of long-term memory formation. Long-term synaptic plasticity 
contributing to learning involves a sequence of cellular and molecular mechanisms. (1) 
neurotransmitter release and short-term strengthening of synaptic connections, (2) equilibrium 
between kinase and phosphatase activities at the synapse, (3) retrograde transport from the 
synapse to the nucleus, (4) activation of nuclear transcription factors, (5) activity-dependent 
induction of gene expression, (6) chromatin alteration and epigenetic changes in gene 
expression, (7) synaptic capture of newly synthesized gene products, (8) local protein synthesis 
at active synapses, (9) synaptic growth and the formation of new synapses, (10) activation of 
pre-existing silent synapses, and (11) self-perpetuating mechanisms and the molecular basis of 
memory persistence. The location of these events, which may act in part to stabilize some of the 
changes that occur during short- and intermediate term plasticity, moves from the synapse (1–2) 
to the nucleus (3–6) and then back to the synapse (7–11). (Hawkins et al., 2006).  
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Many studies have demonstrated that the NO-cGMP-PKG signalling 
pathway is critical for memory formation. It is thought that the increase of Ca2+-
activated calmodulin causes the activation of nNOS, leading to the production 
of NO (Halvey et al., 2009; Roy and Garthwaite, 2006). In Lymnaea, 
consolidation of the 24-hour memory trace following one-trial chemical 
conditioning was shown to be dependent on the NO-cGMP-PKG signalling 
pathway (Korneev et al., 1999). There is a critical period of sensitivity up to 5 
hours after conditioning when blocking this pathway by drug injection 
prevents behavioural LTM formation (Kemenes et al., 2002).  
Further evidence for a role of NO in LTM comes from experiments on the 
CGCs. These neurons express mRNA transcripts from the two related nNOS 
genes (Lym-nNOS1 and Lym-nNOS2). Six hours after chemical conditioning, 
Lym-nNOS1 is up-regulated compared with controls. This up-regulation of the 
NOS coding transcript may be due to an earlier down-regulation of 
Lym-antiNOS1 at 4 hours, which is known to be inhibitory of NOS transcript 
production. As with many other aspects of NO signalling, in memory formation 
it can be traced from the beavioural to the network and single neuron level 
(Kemenes, 2008; Korneev and O'Shea, 2007). NO is known to modulate the 
strength of serotonergic transmission between the CGCs and motoneurons in 
the feeding system and this could be involved in conditioning (Kemenes et al., 
2011). 
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1.6. Role of nNOS During Embryonic Development and 
Neurogenesis 
In the mouse, both an excess and a depletion of NO have been shown to 
arrest embryo development (Tranguch et al., 2003). Similarly, recent studies 
show that artificially decreased NO levels in the brains of developing tadpoles 
lead to an increase in size and a proliferation of brain cells, leading to larger 
than normal brains. Conversely, when NO levels were artificially increased, 
brain cell proliferation decreased, and the resulting brains were smaller than 
normal (Peunova et al., 2007). 
NO has also been demonstrated to be a physiological inhibitor of 
neurogenesis in adult subventricular zone and the olfactory bulb. Mice treated 
with an inhibitor of nNOS exhibit an increase in the number of mitotic cells in 
the subventricular zone, the rostral migratory stream and the olfactory bulb, but 
not in the dentate gyrus. However, recently inhibition of nNOS has been shown 
to be capable of enhancing progenitor cell proliferation in the dentate gyrus in 
normal and in ischemic brain, and NO administration has been reported to 
promote neurogenesis (Corsani et al., 2008; Zhou et al., 2007).  
NO levels must be tightly regulated for normal embryo development to 
occur and thus the mRNA of multiple NOS isoforms must be expressed in 
embryos to support adequate levels of NO production. 
Evidence from foetal learning paradigms of classical conditioning, 
habituation and exposure learning reveal that the foetus can form memories. 
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Possible functions discussed are: practice, recognition of and attachment to the 
mother, promotion of breastfeeding, and language acquisition (Hepper, 1996). 
Researchers from the Netherlands reported that human foetuses were observed 
to form memories from at least 30 weeks old (Dirix et al., 2009). 
Expression of nNOS was first seen in rodent embryos by (Santacana et al., 
1998) The expression of nNOS during the development of the rat cerebral cortex 
from embryonic day E13 (gestation period 21 days) to postnatal day P0 was 
analyzed by immunocytochemical procedures using a specific antibody against 
rat brain nNOS. Expression of nNOS was first seen on E14 located in the 
marginal zone. Neuronal NOS immunoreactivity persisted in this layer 
throughout the embryonic period and only began to decrease on E20 and 
disappear with neuronal migration. From E17 onwards, migrating neurons 
expressing nNOS were observed in the intermediate zone with their leading 
processes directed towards the cortical plate. At the same time, efferent nNOS-
immunoreactive axons originating from cortical plate cells entered the 
intermediate zone. From E19 onwards, cells expressing nNOS and with the 
morphological characteristics of migrating cells were observed in and near the 
subventricular zone (nNOS-positive cells leaving the subventricular zone were 
not glial cells). Commissural, callosal and fimbrial fibres were seen to express 
nNOS on E18 and E19. A very interesting result was the decreased of nNOS 
expression from E20 leading to a very weak signal on E21 and P0. The 
observations suggest that NO is synthesized during embryonic life in relation to 
maturational processes such as the organization of cerebral lamination, and is 
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involved in controlling migrational processes and fibre ingrowth (Santacana et 
al., 1998). 
Further research was conducted on the expression of nNOS during the 
development of the rat optic vesicles from embryonic day E13 (gestation period 
21 days) to postnatal day P0. It was shown that nNOS is first seen at the E14 
stage, and it begins to decrease on E20. Therefore NO synthesis was directly 
linked to embryonic life, in relation to maturational processes in optic vesicles 
(Nobakht et al., 2007). Other results show that NOS1 (nNOS) is first expressed 
in mice in extrinsic nerve fibres reaching areas of vascular development at E16, 
and in the vomeronasal nerve at E15 (Zancanaro et al., 2002). 
In human embryos, nNOS-immunoreactive cells appear as early as 18 
gestational weeks (GW) in the subcortical plate and then increase 
predominantly in the subcortical white matter during the fetal period, while 
weakly immunoreactive neurons were found in the cortical II–IV layers after 
26GW. In the basal ganglia, immunoreactive neurons could be detected in the 
striatum as early as 13GW, and then showed a transient increase with peaks at 
23–24GW and 33–36GW in the putamen and caudate nucleus, respectively. In 
the cerebellum, immunoreactivity was detected in the Purkinje and basket cells 
after 23GW and 31GW, respectively. The immunoreactivity of internal granule 
cells was constantly weak. In the brain stem, constant and intense 
immunoreactive neurons were found in the central gray, pedunculopontine 
tegmental nucleus, solitary tract nucleus, and lateral reticular nucleus. The 
immunoreactivity in the neurons of the pontine nucleus and inferior olivary 
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nucleus was transiently increased, with peaks at 38–40GW and 23–24GW, 
respectively. This characteristic nNOS development of expression suggests that 
transient nNOS hyperproduction may contribute to neuron maturation as well 
as vulnerability in each period and region, and NO may play an important role 
in the basic development of human brain functions (Ohyu and Takashima, 
1998). 
1.7. Thesis outline 
This thesis addresses the following major questions: What are the 
physiological functions of the NOS-related antisense RNAs in Lymnaea? What 
are the characteristics and possible functional roles of NOS-related antisense 
RNAs in mammals? 
To answer these questions a multidisciplinary approach was employed. This 
comprises: 
 A detailed sequence analysis of Lym-antiNOS2 RNA. 
 A study of the localization of Lym-antiNOS2 RNA in Lymnaea CNS. 
 An investigation into whether memory formation causes changes in the 
expression of Lym-antiNOS2 RNA. 
 A detailed sequence analysis of a novel NOS-related mouse cis-NAT 
(Mm-antiNOS1 RNA). 
 A study of the expression of Mm-antiNOS1 RNA during mouse 
development. 
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Chapter 2: Materials and Methods 
2.1. Animal Maintenance  
Laboratory-bred stocks of Lymnaea stagnalis were raised in the Sussex 
University animal house. Snails were kept in holding tanks containing copper-
free tap water at 19-21°C on a 12-hour light-dark cycle. Snails were fed lettuce 
three times a week and vegetable-based fish food twice a week.  
2.2. Behavioural Experiments 
Before behavioural conditioning experiments, snails of similar weight and 
age (3-6 months) were selected from home tanks and placed in smaller 
laboratory tanks containing copper-free tap water (10 snails per tank). 
Behavioural experiments were performed to train the animals with a classical 
conditioning protocol. The experiment used three groups of animals starved for 
3 days: paired (P), unpaired (UP) and naïve (N) groups.  
The animals of the P group were left in a Petri dish with 90ml of Cu-free 
water for at least 10 minutes to acclimatise, before adding 5ml of Cu-free water 
to the dish, using a 10ml syringe. After 15 seconds, 5ml of copper-free water 
were added; this served to balance the temporal pattern of disturbance between 
the trained and control groups. The animals were moved to a tank with Cu-free 
water after 2 minutes. They were kept for 50 minutes in the tank and moved to 
a Petri dish containing 90ml of Cu-free water, where they were left for at least 
10 minutes. 5ml of amyl acetate 21.6mM in Cu-free water were then added to 
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the dish. 15 seconds later, 5ml of sucrose (S) 0.4 M were added. The animals 
were moved out from the Petri dish and left in a tank for 10 minutes, 1 hour, 4 
hours or 6 hours, in accordance with the protocol described in Section 4.4. 
The animals in the UP group were treated in the same way, but the two 
chemical stimuli were not paired. Snails from this group were placed in dishes 
containing 90ml of water and allowed to acclimatise for 15 minutes. 5ml of amyl 
acetate were added, followed 15 minutes later by 5ml of water. After being left 
in the dish for a further 2 minutes, snails were returned to a laboratory tank for 
the next part of the control trial for 50 minutes. The snails were placed in new 
dishes containing 90ml of water and left to acclimatise. The snails were 
presented with 5ml water followed 2 minutes later by 5ml of sucrose solution. 
The snails were left in tanks before dissection. 
The animals in the naïve (N) group were kept under the same conditions and 
had the same feeding regimen as those in the P and UP groups, but were not 
exposed to either trial. 
A randomly chosen subset of 18 animals from each group (N, UP, P) was 
retained and tested for LTM formation at 24 hours after the paired (P) and 
unpaired (UP) trial (Kemenes et al., 2002).  
2.3. General Dissection 
Using large forceps the shell was removed to free the foot. Holding the snail 
from the remaining shell and using large scissors the foot was cut off from the 
remaining shell which contains the majority of the organs. The foot was placed 
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into a large Sylgard Petri dish with normal saline and pinned out using two 
large pins. 
A vertical incision through the head was made so that the buccal mass was 
exposed, and the flaps remained pinned out with smaller pins. After inserting 
the bent pin through the buccal mass and pushing it forward into the Sylgard, 
the brain was exposed. 
The oesophagus and the two feeding ducts were cut and the penis pinned 
out for better view. The brain was finally isolated by holding it from the main 
nerves and cutting off all nerves (maintaining the buccal ganglia intact) as 
shown in Figure 2.1. In Lymnaea stagnalis the shell length ranges from 2 to 6cm, 
and although the dimensions of central nervous system are small, the cells are 
highly pigmented and clearly visible (Chase, 2002). 
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Figure 2.1 Lymnaea stagnalis isolated intact brain pinned out in a Sylgard Petri dish. 
2.4. RNA Isolation and Purification from Lymnaea stagnalis Brain 
Tissue 
After dissection the brains were placed in a sterile Eppendorf tube in ice. 
Different Absolutely RNA kits (Stratagene) were used to extract RNA 
depending on the amount of material: 
 Total RNA from relatively large amounts of material (calibrator cDNA from 
5 Lymnaea stagnalis brains) was extracted using Absolutely RNA Miniprep 
Kit reagents and manufacturer‟s protocol. 
 Total RNA for small amounts of material (quantitative PCR) was extracted 
from a single Lymnaea stagnalis brain, and single ganglia of Lymnaea stagnalis 
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brain using Absolutely RNA Microprep Kit reagents and manufacturer‟s 
protocol.  
For the two cases above, the following protocol was conducted. 100µl lysis 
buffer–β-ME mixture was added to the brain sample and blended. The sample 
was disrupted by adding 600µl of homogenisation buffer (containing guanidine 
thiocyanate and 1% -mercaptoethanol). 700µl of ethanol 70% was added to 
provide appropriate binding conditions and the sample was then applied to a 
silica-gel based column, spun 30 seconds at 11,000g and the flow-through 
discarded. To avoid genomic DNA contamination a DNA digestion step was 
performed by adding a 95µl DNase reaction mixture containing 10% of RNase-
free rDNase in rDNase reaction buffer to the column. The reaction was 
incubated at room temperature for 15 minutes. 
The column was washed several times with ethanol-based buffers to 
eliminate the contaminants and the flow-through discarded. The column was 
transferred into a clean tube and incubated for 2 minutes at room temperature, 
after which it was eluted by centrifugation for 2 minutes at 11,000g with a 
volume of 30µl nuclease-free water. The procedure was repeated once more 
with another volume of RNase-free water. The samples were stored at –80°C 
until further processing. 
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2.5. RNA Extraction from Single Identified Neuron  
Total cellular RNA from single identified CGC was extracted using the 
Absolutely RNA Nanoprep Kit (Stratagene) according to the manufacturer's 
instruction manual. RNA was dissolved in 10μl of RNase-free water. 
2.6. DNase Treatment 
One widely appreciated property of some gastropod neurons is their large 
size – they are usually referred to as giant neurons. CGCs in Lymnaea belong to 
this category. The size of the soma can be attributed to the summed metabolic 
demand of the axonal and dendritic tree associated with synaptic function. To 
satisfy these metabolic requirements, the nuclei of the giant neurons can contain 
more than 0.2µg of DNA. This is more than 200,000 times as much DNA as the 
haploid amount found in sperm (Lasek and Dower, 1971). 
To avoid genomic DNA contamination from the multiple copies of DNA 
existent in the CGC, an extra DNA digestion step was performed using TURBO 
DNA-free™ Kit (Ambion) reagents and manufacturer‟s protocol. 
1µl 10x TURBO DNase Buffer and 1μl TURBO DNase were added to the 
RNA extracted (Section 2.5) and mixed gently. The mixture was incubated at 
37°C for 45 minutes. After the incubation, 1µl of resuspended DNase 
Inactivation Reagent was added and mixed well, left for 5 minutes at room 
temperature and centrifuged at 10,000g for 1.5 minutes, finally transferring the 
RNA to a fresh tube. 
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2.7. RNA Precipitations 
The total DNA-free RNA (Section 2.6) was precipitated to eliminate any 
impurity (as DNase Inactivation Reagent) that could inhibit PCR enzymes. 
Sodium acetate was added to the RNA samples (0.2M final concentration) along 
with an equal volume of isopropanol, and 1µl of Pellet Paint. The mix was 
incubated for 1 hour at -20°C followed by 10 minutes centrifuge at 13,000g. The 
soluble was discarded and 100µl cold 80% ethanol was added to the remaining 
pellet, followed by centrifugation for 5 minutes at 13,000g. The solution was 
discarded and the pellet dried for 5 minutes at room temperature. The pure 
pellet was dissolved in 10µl of nuclease-free water. 
2.8. Quantification of Total RNA 
The concentration of RNA in a sample was checked by the use of UV 
spectrophotometry. Both RNA and DNA absorb UV light very efficiently 
making it possible to detect and quantify either at concentrations as low as 
2.5ng/µl. The nitrogenous bases in nucleotides have an absorption maximum at 
about 260nm. For a given RNA or DNA solution, the ratio [A260/A280] of 
absorbency readings at 260nm and 280nm provides an estimate of purity of the 
nucleic acid. Pure preparations of DNA and RNA have ratios of 1.8–2.0. 
For quantifying DNA or RNA, readings were taken at wavelengths of 260nm 
and 280nm. The reading at 260nm allows calculation of the concentration of 
nucleic acid in the sample. An optical density (OD) of 1 corresponds to a 
concentration of 50ng/µl of dsDNA, 33ng/µl of ssDNA or 40ng/µl of RNA. 
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Samples were typically diluted 1µl in 100µl (a dilution factor of 100) and put 
in a 100µl spectrophotometer cuvette. The RNA concentration will then be 
calculated as: 
         
            
                    
 
where OD260 is the absorbance of oligonucleotide solution at 260nm. 
2.9. First Strand Synthesis of cDNA 
The iScript cDNA Synthesis Kit (Bio-Rad) was used to synthesize first-strand 
cDNA from total RNA. 4l of 5x concentrated Reaction Buffer, 1l of iScript 
Reverse Transcriptase and up to 1g total RNA were added into a PCR 
Eppendorf tube. Water was added to take the final volume of the reaction to 
20l. The reaction was mixed gently and the sample was incubated for 5 
minutes at 25°C and then incubated 30 min at 42C, followed for 5 minutes at 
85C, and held at 4°C until storage at -20°C. Reactions were carried out in a G-
STOM GS1 Thermal Cycler equipped with a heated lid. 
2.10. Oligonucleotide Primer Design 
Previous results on single isolated CGC RT-PCR RNA expression (Korneev 
and O'Shea, 2002) show that Lym-antiNOS2 is not expressed in the CGCs. These 
results were obtained using the primers complementary to the sequences 
shown in Figure 2.2 in yellow background (forward) and light-blue background 
(reverse). The PCR product expected for those primers is an amplicon of 652bp. 
Since these studies, the availability of more efficient enzymes and kits, and a re-
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design of the primers to generate smaller amplicon length product, allows for 
more efficient reactions.  
The oligonucleotide primers used in this study were designed using aligned 
fragments of Lym-antiNOS2, Lym-nNOS1 and Lym-NOS2 genes taken from 
GenBank. The fragments were aligned using the computer program ClustalW2 
from the European Bioinformatics Institute and are predicted to amplify a 
119bp fragment (Figure 2.2). 
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   1 GGGGTGACCA GCTACCTGTA GGGGTGACCA GCTACCTGTA GGGCCATAGA AACAATTTTC 
  61 CGGTTTAGGG TGAGTNTTAC TGCTTTCTGA TAATCTTTCA GAGCCTAACG TGACGGAAAT 
 121 CGGCAGTGTT CAGGCAGTTC AATCATGGNT TGCCCGTACC GGTCGGCCAA GCTGAAAAAT 
 181 GTGCTGAATG ATAAGACTTA TGTGGACACG NTTACACCAG AGATCATTTT CGCCAGTTAC 
 241 CTTGCAACAC CCAGCGATGC ATGGGCTCAC TTATGTCCCA ACAGGCAAAT AGGCCCCCTG 
 301 GGGTCCCTAG ATCACAGGAG GAACTTTTGG TTCACGCCAC AGGCTTCATT GACCAATATT 
 361 TAAACTCATG TGAAATGACA TTCCTGTCCA GGAGCAACAC ACCGGCCCAT TTGAATAGAC 
 421 TTAGCGAGAT CCAAGATTAT GTGACAAAGT CCGGTACCTA TGACCTGACA ATGGCTGAAC 
 481 TGACATTTGG TGCTAAGCAA GCTTGGAGAT ATGCGTCCAG ATGCACTGGC AGAATGCAGT 
 541 GGTCAAAACT TCAGGTTGTT GATGCCAGAT GCATCATGAC ACCCCGAGGG ATGTATACAG 
 601 CTTTGTGCGA TCACATCAAA TATGGGACAA ACAAAGAGAA TATTAGGTTT GCCATCACCA 
 661 TATTTCCACA ACGAATAGAA GGGCCCCCNG ATTTCCGTGT ATGGAATAGT CAGTTGATAG 
 721 GCTACGCTGG CTACAGTATG GATGATGGGA AGATTATTGG GGACCCAGCC AATGTGGAAT 
 781 TTACTGATCA ATGTGTAAGG ATGGGTTGGA AACCAAAGTA TGGTATGTTT GACCCATTTC 
 841 CACTGGTTCT GTCTGCTGCT GGATTTGATC CTGAAGTTTT CGACCTCCCA CCTGAGCTAG 
 901 TGTTAAAGGT CAAGTTGGTG CATCCCGAGA ATCCCTCGTT TTCTGATATT GGTCTAAAAT 
 961 GGTACGCCCT ACCAGCTGTA TCTGGAATGC TGTTGGACTG TGGGAGCCTG GAGTTCCCCT 
1021 CGTGTCTTTT CAATGGATGG TACATGGGGA CAGAGATTGG TTCCAGGGAT TTGTGCGATT 
1081 CTCATAGGTA CAACATGCTG GAGACCATTG CCTTAAAGAT GGGGCTAAAC ACCAGAAATG 
1141 CTTCATCCTT GTGGAAAGAT CGTGCACTAT TGGACGCTAA TCCTGCTGTT CTCCACAGTT  
1201 TTCAGTCAGC CAATGTTACA ATTGTCAATC ATCACGATGC CAGTGAGTCT TTAATGTTGC  
1261 ACTTGGATAC TGAGCAACAT TTAAGAGGTG GCTGCCCAGG TGATTGGGTG TGGGTGGTGC  
1321 CACCCATAAG TAGTTCAGCT CTGGACATTT TTCACCAAGA ACTTTTGCTT TATAAGCTCA  
 
1381 AGCCTTCCTT TGAATATCAG GCCTGTAGCT GGGATCTTTC ACTCAAAATG AAGGGCTNTA  
1441 CTTTCTTCCC ATGAATTTCG GATAATACTG AAGTAAAAAT TGATTGAGCT ATATGGAAAA  
1501 CACATTTTAT TGATGTAAAT AAATATTTGT ATTTCTCAAT TGATATAAGA GACAGATATT  
1561 GAATACAAAT TTTAAAAATG ATTTGAGTAA CTTTGCAATT AACAATGTTT TAAGCAATTT  
1621 TCCAAATTTT AATGAGGACA CAAAATAAAT ATCCTTACAT TATTTAGACA ATATGCTATC  
1681 AGGCAATTTA AGCTAAATAC CATGGCTTAA ATCTTGTTTT TTGCCATTGT CCAATAGCAC  
1741 AATCCTAACT TTGTCAAGTG ACCAGCTATG ATCACCCATT TTCGGGGTCC TGTTGCCTCC  
1801 TTTATATCAA TATTTTCGAG GCAGNAAGCA TCACATGCAG CCTATGGCNA AAAATTGGAA  
1861 ATTTTTTTNA ATAAAGGTAA TAATAGAGNA ATTTTTACAG TTTTGGATAG NTAGTTAAAA  
1921 NTTAAATGTA CAAATGNAAG NTTACTTACA AAGTATTGGA CAAGGTAAAN GACATTGTCA  
1981 AGTTCATGAA ATTAGCATAA AGTGTGGGTG TTTAATTGTG GGGCTTGTGA GTGAATGTGA  
2041 ACTATCAAGT CACAATGTTG GACAATGTTG AGTGATCGAG GTGTGCAATC GATTGACGAG  
2101 GATCGAGAGG GATATAGAGA GGATCTGGGT GATAGCTACG TAGAGTCTTG AGTTCACATG  
2161 AGTCAGTCTT ACGTTCACTG AGTATTATGT CACTGAGATC CAGGCAACTT GGATCTTGGA  
2221 GTTGCAGAGT GAGATAGATG TGTGGTGATA TGTTTTGCTG ATTGGAATAT TGCCCATACA  
2281 TTTGGATACA TGTTGCAATT TAACTGAAAC GGATTGCTGT TGTAATACTG CCATAAATAA  
2341 ATGACAAATG TACCTTGAAG ATTATTGTTG ATTGAATTAA ACTAGCCTGT TGTGTGGCAA  
2401 GTATTTCACG CCAACTCAAC AGTCGCGATA ATCATACACC CTTGACAACG CCCAAATATT  
2461 CACTACCAGA ATATTAGACA TATTGAAATT CATTTGAAAA TTATTGAATA TGAAAATTCT  
2521 GTAAAGATAT AATATGAAAA CAAGCATGGC ACTTACTCTA TATACTCCCT CAGACCAGGT 
2581 CCTAAATCTC TGCTCCTGGC CATATAAAGC ATCGCCTGTG CAATATTCAA CCAACATTTC 
2641 TGCTCCCAGT TCTTTGAATG TTTTATCTAT GTACTTTCCA AAGATAGCAA AGTTGGGGTA 
2701 AGCATTAGAT CCCAGTGAAA AAACTGCAAA CCTGTATAAA AATTGGATTA AAATAAATTC 
2761 TACCATT 
 
Figure 2.2 Lym-antiNOS2 RNA sequence. PCR amplification fragment is shown in red letters. Scorp 1 and 2 positions in the cDNA sequence are shown 
in orange and green background. Scorp 3 and 4 (used in previous papers) are shown in yellow and light blue. The open reading frame is surrounded by 
dotted lines; full-line boxes show start and stop codons. The antisense homology sequence between Lym-antiNOS2 RNA and Lym-nNOS mRNA is 
shown in bold. The sense homology between Lym-antiNOS2 RNA and Lym-nNOS mRNA is indicated in grey background.  
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2.11. Reverse Transcription PCR  
All the reactions were carefully prepared using autoclaved tubes and 
autoclaved disposable pipette tips in order to avoid contamination of the 
samples. The reagents used were aliquoted to prevent degradation by repetitive 
thawing/freezing cycles. Oligonucleotide primers employed in the reaction 
were synthesized by Eurofins MWG Operon and supplied in lyophilised form. 
In the laboratory, the primers were resuspended in molecular grade DEPC-
treated deionised water to a concentration of 100μM. 
The PCRs performed in order to isolate the antiNOS2 gene in Lymnaea 
stagnalis were carried out in a volume of 25l consisting of 0.5µl 200M dNTP, 
2.5µl 10x PCR Buffer HotStarTaq (10x concentrated; contains Tris-Cl, KCl, 
(NH4)2SO4, 15mM MgCl2; pH 8.7), 5µM of each pair of primers and HotStarTaq 
DNA Polymerase 0.125μl 0.625 units/reaction (QIAGEN), 4µl cDNA and 
nuclease-free water. Amplifications were carried out in a G-STOM GS1 Thermal 
Cycler equipped with a heated lid. 
All reactions were initially denatured for 15 minutes at 95°C (HotStarTaq 
DNA Polymerase is activated by this heating step) then 1 minute at 94C 
denaturation, 1 minute at 53-57C annealing and 1 minute at 72C elongation. 
The last three steps were repeated 35 times in total, followed by a final 
extension step of 1 minute at 72 C. 
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RT- negative controls were set up alongside each set of PCR reactions to 
ensure that there was no contamination. Negative controls consisted of all 
components of the PCR reaction excluding the reverse transcriptase. 
Each reaction was optimised in order to create the right conditions for the 
amplification of the targeted fragment. This included varying the 
oligonucleotide primers used and the amount of cDNA, as well as the cycling 
strategy of annealing and extension temperatures.  
2.12. Agarose Gel Electrophoresis of DNA 
Agarose gel electrophoresis was performed using a BRL model H5 horizontal 
system for submerged gel electrophoresis. 0.3g of agarose (Promega) analytical 
grade was melted in 30ml TBE electrophoresis buffer (45mM Tris-borate, 1mM 
EDTA) 1% agarose gel by boiling in a microwave oven. The solution was cooled 
to approximately 60°C and ethidium bromide was added to a final 
concentration of 0.8µg/ml and mixed thoroughly. The agarose was then poured 
into the holding tray ensuring that the teeth of the Teflon comb were immersed, 
and allowed to set for approximate 30 minutes at room temperature prior to 
removal of the comb and submerging into the electrophoresis buffer in the tank. 
The samples to be loaded were first mixed with Bromophenol Blue Loading 
Solution (Promega) to a final concentration of 10% and then loaded into the 
wells of the gel. A 100bp molecular weight ladder (Invitrogen) was also loaded 
into the gel in order to size the DNA fragments. A current of 90 volts was then 
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applied to the gel and stopped when the dye had migrated two thirds of the 
distance through the gel. 
Gels were examined on a GeneFlash UV transilluminator (Syngene) and 
photographed using a UP-895 video graphic printer (Sony). 
2.13. Isolation of Cerebral Giant Cells 
All dissection instruments were carefully cleaned with 70% ethanol and 
wiped with RNaseZAP (Sigma-Aldrich). Snail saline (NaCl 50mM, MKCl 
1.6mM, MgCl2.6H2O 2mM, CaCl2.6H2O 3.5mM, HEPES 10mM) was prepared 
using autoclaved tubes, autoclaved disposable pipette tips and autoclave 
distilled water in order to avoid contamination. Snail saline was filtered using a 
pressure-driven filtration device (syringe-driven filter Millex-GP, 0.22µm).  
Animals were dissected under a microscope in a Sylgard-coated Petri dish 
containing snail saline (Section 2.3). The CNS was exposed by a dorsal body 
incision and isolated by severing all peripheral nerves. Where the brain was cut 
away from the buccal mass, a short-length of oesophagus was retained which 
serves as a useful anchor-point for pinning the preparation. The isolated CNS 
was placed in a small Sylgard-coated dish containing snail saline. The CNS 
commissure was cut and the brain pinned down flat to the Sylgard. The brain 
was incubated for 15 minutes in protease type V111 (1mg/ml in snail saline) 
and then washed three times in snail saline. The brain was incubated for 30 
minutes in propylene glycol (50% in snail saline) at 20ºC (room temperature). 
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While the brain was being incubated, a dissection dish and a suction pipette 
were filled with high osmolarity saline (30mM glucose in snail saline). 
The CGCs were identified by position, colour and size. Once a CGC is 
identified, the CGCs were bored with glass microelectrodes constructed with a 
tip diameter of about 10µm, which were fire-melted until round and capped. 
The glass microelectrode was advanced into the CGC with the state-of-the-art 
micromanipulators under a stereoscopic microscope, without damaging the 
soma.  The glass microelectrode pipette was connected to a suction system 
(micrometer syringe 0.2ml, Gilmont) and carefully placed on top of the neuron 
to slowly suck out the neurons and place them into a microtitre plate. 
After placing the neurons on the plate, as much liquid was sucked off the 
microtitre plate as possible, and the plate was immediately placed in a freezer at 
–80ºC. 
2.14. In situ Hybridisation 
Each brain was pinned out onto Sylgard squares using fine dissection 
needles (A1) and cut across the cerebral ganglia to flatten the brain out, and 
fixed immediately following dissection. 
The Sylgard squares were immediately placed in 4% paraformaldehyde in 
0.2M phosphate buffer (pH 7.2) for 1 hour. After 1 hour the squares were 
transferred (without wash) into a solution of 30% sucrose in phosphate buffered 
saline and left overnight at 4°C. This step causes the tissue to swell and 
prevents it from fracturing out during the freezing process. 
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The brains were removed from the Sylgard blocks, carefully soaked in a 
small amount of OCT embedding medium (Raymond Lamb), placed on a metal 
plate (making sure that the brain is absolutely flat) and surrounded with metal 
bars to form a square container. The container was filled up with OCT 
embedding medium. This preparation was lowered gently using a holder onto 
liquid nitrogen until the brain was frozen completely. The contents of the 
container were carefully removed from the bars and plate and positioned onto a 
microtome chuck so that it was level with the chuck, and transferred for storage 
at -22°C. 
After making sure that the crystal blade was cooled down to the correct 
temperature, the brains were cut into14μm-thick frozen sections. 
Sections were mounted on SuperFrost Plus slides (VWR); these slides are 
suitable for in situ hybridisation and have good binding properties with the 
tissue. The slides were air-dried for at least 30 minutes, and used straight away 
or stored at -70°C until hybridisation. 
GreenStar DIG-hyperlabelled 48-mer oligonucleotide antisense and sense 
(control) probes were produced by GeneDetect (Auckland, New Zealand). The 
antisense probe contains three oligonucleotides. The first oligonucleotide was 
designed to bind at the 5‟ end of the sequence (nucleotides 104-183, a short 
section within the sense homology region showing no homology with the other 
sequences), closely before the open reading frame for Lym-antiNOS2. The other 
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two oligonucleotides were placed after the open reading frame on the region 
without homology with the other three sequences (nucleotides 1554 - 2557). 
Oligonucleotides mix for Lym-antiNOS2 RNA probe: 
Complementary to nucleotides 101-148: 
5’CCATGATTGAACTGCCTGAACACTGCCGATTTCCGTCACGTTAGGCTC3’ 
Complementary to nucleotides 2044-2091: 
5’CGATTGCACACCTCGATCACTCAACATTGTCCAACATTGTGACTTGAT3’ 
Complementary to nucleotides 2410-2457: 
5’ATTTGGGCGTTGTCAAGGGTGTATGATTATCGCGACTGTTGAGTTGGC3’ 
The localization of these oligonucleotides within the sequence is shown in 
orange in Figure 2.3. 
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   1 GGGGTGACCA GCTACCTGTA GGGGTGACCA GCTACCTGTA GGGCCATAGA AACAATTTTC 
  61 CGGTTTAGGG TGAGTNTTAC TGCTTTCTGA TAATCTTTCA GAGCCTAACG TGACGGAAAT 
 121 CGGCAGTGTT CAGGCAGTTC AATCATGGNT TGCCCGTACC GGTCGGCCAA GCTGAAAAAT 
 181 GTGCTGAATG ATAAGACTTA TGTGGACACG NTTACACCAG AGATCATTTT CGCCAGTTAC 
 241 CTTGCAACAC CCAGCGATGC ATGGGCTCAC TTATGTCCCA ACAGGCAAAT AGGCCCCCTG 
 301 GGGTCCCTAG ATCACAGGAG GAACTTTTGG TTCACGCCAC AGGCTTCATT GACCAATATT 
 361 TAAACTCATG TGAAATGACA TTCCTGTCCA GGAGCAACAC ACCGGCCCAT TTGAATAGAC 
 421 TTAGCGAGAT CCAAGATTAT GTGACAAAGT CCGGTACCTA TGACCTGACA ATGGCTGAAC 
 481 TGACATTTGG TGCTAAGCAA GCTTGGAGAT ATGCGTCCAG ATGCACTGGC AGAATGCAGT 
 541 GGTCAAAACT TCAGGTTGTT GATGCCAGAT GCATCATGAC ACCCCGAGGG ATGTATACAG 
 601 CTTTGTGCGA TCACATCAAA TATGGGACAA ACAAAGAGAA TATTAGGTTT GCCATCACCA 
 661 TATTTCCACA ACGAATAGAA GGGCCCCCNG ATTTCCGTGT ATGGAATAGT CAGTTGATAG 
 721 GCTACGCTGG CTACAGTATG GATGATGGGA AGATTATTGG GGACCCAGCC AATGTGGAAT 
 781 TTACTGATCA ATGTGTAAGG ATGGGTTGGA AACCAAAGTA TGGTATGTTT GACCCATTTC 
 841 CACTGGTTCT GTCTGCTGCT GGATTTGATC CTGAAGTTTT CGACCTCCCA CCTGAGCTAG 
 901 TGTTAAAGGT CAAGTTGGTG CATCCCGAGA ATCCCTCGTT TTCTGATATT GGTCTAAAAT 
 961 GGTACGCCCT ACCAGCTGTA TCTGGAATGC TGTTGGACTG TGGGAGCCTG GAGTTCCCCT 
1021 CGTGTCTTTT CAATGGATGG TACATGGGGA CAGAGATTGG TTCCAGGGAT TTGTGCGATT 
1081 CTCATAGGTA CAACATGCTG GAGACCATTG CCTTAAAGAT GGGGCTAAAC ACCAGAAATG 
1141 CTTCATCCTT GTGGAAAGAT CGTGCACTAT TGGACGCTAA TCCTGCTGTT CTCCACAGTT 
1201 TTCAGTCAGC CAATGTTACA ATTGTCAATC ATCACGATGC CAGTGAGTCT TTAATGTTGC 
1261 ACTTGGATAC TGAGCAACAT TTAAGAGGTG GCTGCCCAGG TGATTGGGTG TGGGTGGTGC 
1321 CACCCATAAG TAGTTCAGCT CTGGACATTT TTCACCAAGA ACTTTTGCTT TATAAGCTCA 
1381 AGCCTTCCTT TGAATATCAG GCCTGTAGCT GGGATCTTTC ACTCAAAATG AAGGGCTNTA 
1441 CTTTCTTCCC ATGAATTTCG GATAATACTG AAGTAAAAAT TGATTGAGCT ATATGGAAAA 
1501 CACATTTTAT TGATGTAAAT AAATATTTGT ATTTCTCAAT TGATATAAGA GACAGATATT 
1561 GAATACAAAT TTTAAAAATG ATTTGAGTAA CTTTGCAATT AACAATGTTT TAAGCAATTT 
1621 TCCAAATTTT AATGAGGACA CAAAATAAAT ATCCTTACAT TATTTAGACA ATATGCTATC 
1681 AGGCAATTTA AGCTAAATAC CATGGCTTAA ATCTTGTTTT TTGCCATTGT CCAATAGCAC 
1741 AATCCTAACT TTGTCAAGTG ACCAGCTATG ATCACCCATT TTCGGGGTCC TGTTGCCTCC 
1801 TTTATATCAA TATTTTCGAG GCAGNAAGCA TCACATGCAG CCTATGGCNA AAAATTGGAA 
1861 ATTTTTTTNA ATAAAGGTAA TAATAGAGNA ATTTTTACAG TTTTGGATAG NTAGTTAAAA 
1921 NTTAAATGTA CAAATGNAAG NTTACTTACA AAGTATTGGA CAAGGTAAAN GACATTGTCA 
1981 AGTTCATGAA ATTAGCATAA AGTGTGGGTG TTTAATTGTG GGGCTTGTGA GTGAATGTGA 
2041 ACTATCAAGT CACAATGTTG GACAATGTTG AGTGATCGAG GTGTGCAATC GATTGACGAG 
2101 GATCGAGAGG GATATAGAGA GGATCTGGGT GATAGCTACG TAGAGTCTTG AGTTCACATG 
2161 AGTCAGTCTT ACGTTCACTG AGTATTATGT CACTGAGATC CAGGCAACTT GGATCTTGGA 
2221 GTTGCAGAGT GAGATAGATG TGTGGTGATA TGTTTTGCTG ATTGGAATAT TGCCCATACA 
2281 TTTGGATACA TGTTGCAATT TAACTGAAAC GGATTGCTGT TGTAATACTG CCATAAATAA 
2341 ATGACAAATG TACCTTGAAG ATTATTGTTG ATTGAATTAA ACTAGCCTGT TGTGTGGCAA 
2401 GTATTTCACG CCAACTCAAC AGTCGCGATA ATCATACACC CTTGACAACG CCCAAATATT 
2461 CACTACCAGA ATATTAGACA TATTGAAATT CATTTGAAAA TTATTGAATA TGAAAATTCT 
2521 GTAAAGATAT AATATGAAAA CAAGCATGGC ACTTACTCTA TATACTCCCT CAGACCAGGT 
2581 CCTAAATCTC TGCTCCTGGC CATATAAAGC ATCGCCTGTG CAATATTCAA CCAACATTTC 
2641 TGCTCCCAGT TCTTTGAATG TTTTATCTAT GTACTTTCCA AAGATAGCAA AGTTGGGGTA 
2701 AGCATTAGAT CCCAGTGAAA AAACTGCAAA CCTGTATAAA AATTGGATTA AAATAAATTC 
2761 TACCATT 
Figure 2.3 Full cDNA sequence of Lym-antiNOS2. In situ hybridisation probes are shown in orange background. The open reading frame is surrounded by dotted 
lines; full-line boxes show start and stop codons. The antisense homology sequence between Lym-antiNOS2 RNA and Lym-nNOS mRNA is shown in bold. The sense 
homology between Lym-antiNOS2 RNA and Lym-nNOS mRNA is indicated in grey. 
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In situ hybridisation on frozen sections was performed following the protocol 
suggested by the probes‟ manufacturer. The in situ hybridisation protocol was 
performed on three successive days. All the glass was autoclaved and all the 
solutions were freshly prepared in sterilised and RNA-free conditions and used 
only once.  
The protocol was divided into five stages: a) tissue preparation and post-
fixation; b) in situ hybridisation; c) post-hybridisation washes; d) detection, and 
e) colour reaction. 
The following two solutions were used throughout this protocol, and were 
prepared freshly on day 1: 
 1l 0.1M PB: 4.867g NaH2PO4, 10.188g Na2HPO4, up to 1l nuclease-free H2O. 
 20ml hybridisation buffer: in a 50ml Falcon tube with screw cap, 4ml 20x 
SSC, 4g dextran sulphate, 10ml formamide (deionised). The solution was 
sonicated for about 4 hours and added 0.5ml PolyA (10mg/ml), 0.5ml 
ssDNA (10mg/ml), 0.5ml tRNA (10mg/ml), 2ml DTT (1M solution), 0.2ml 
50x Denhardt‟s solution. The solution was mixed very well and stored at 
-20°C. 
All the instruments were carefully cleaned with 70% ethanol (in nuclease-free 
water) and wiped with RNaseZAP (Sigma-Aldrich). 
The slides containing the tissue sections were removed from freezer and 
placed in cold (4°C) 4% PFA in 0.1M PB (freshly made the night before and 
stored at 4°C) for 15 minutes in a large container.  
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The slides were washed three times for 5 minutes in 0.1M PB (fresh). 
Dehydration of the tissue: slides were incubated with 100% ETOH for 5 
minutes in a large container and air-dried. At this point the RNA in the tissue is 
sufficiently safe from RNases, and GeneDetect oligonucleotide probes are 
resistant to degradation by RNases so working on ice and utilization of 
nuclease-free water are not necessary anymore (RO water was used on the 
following reactions). 
The optimal amount of probe to use was determined on a trial-and-error 
basis, within the recommended concentration range of 100-1000ng probe per ml 
of hybridisation buffer. Concentrations of 1:100, 1:50 and 1:25mg/ml buffer and 
a sense control were tested on brains obtained simultaneously, with 1:50mg/ml 
buffer chosen as the optimal concentration. 
Once the optimal probe concentration was determined, different 
hybridisation temperatures were experimented to minimise background 
staining: 33°C, 35°C, and 37°C. The optimal staining was obtained at 37°C. 
Each in situ hybridisation was conducted on a) three brains for the antisense 
probe; b) two brain slices for hybridisation buffer control (i.e. without probe), 
and c) one brain for the sense probe control. 
The hybridisation buffer was preheated at 37°C. This causes the buffer to lose 
some of its viscosity and to become more spreadable, allowing for easier 
pipetting and more homogenous mixes of probe with hybridisation buffer. 
100µl of hybridisation buffer were added to each slide, which was then covered 
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(HybriSlip Hybridization Covers, Sigma-Aldrich) and checked to make sure no 
air bubbles were trapped between the sections and the cover. 
 The slides were left overnight for 20 hours at 37°C in a Boekel InSlide Out 
oven for hybridisation. To keep the humidity of the chamber and the sections 
from drying out, tissue paper filled with dH2O was placed in between the lines 
containing the slides. 
Following hybridization, excess probe was removed by SSC washes. For 
these washes, 0.5 and 1x SSC (Saline-Sodium Citrate) solutions from 20x SSC 
and DTT (Dithiothreitol) were prepared on the day. Two big glass containers 
(400ml) were placed on a water bath at 55°C, allowing enough time for the 
solutions to reach the correct temperature. SSC is a widely used, weak buffer 
which is used to control stringency of nucleic acid hybrids during in situ 
hybridisation. DTT is used to reduce disulfide bonds in RNases, which are 
needed by RNases for stability, thereby inhibiting RNase activity and providing 
RNAs with stability, helping preserve mRNA integrity. 
A quick wash of the slices was performed at room temperature using a 
shaker in 1x SSC (10mM DDT). After this wash the cover slips were carefully 
removed from the slides using forceps. This was followed by a 1x SSC (10mM 
DTT) wash for 30 minutes at 55°C, a 0.5x SSC (10mM DTT) wash for 30 minutes 
at 55°C and a 0.5x SSC (10mM DTT) wash for 10 minutes at room temperature. 
The detection procedure was carried out using an anti-DIG antibody 
conjugated to alkaline phosphatase (Roche). After 3 washes for 5 minutes on 
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TBS (Trizma buffer solution), the slides were first incubated for 30 minutes at 
room temperature with 500μl blocking solution, containing 1% sheep serum 
and 0.1% Triton X-100 in TBS. The blocking reagent was then tipped off, and 
500μl of primary antibody solution were added to each slide – anti-DIG 
antibody conjugated to the enzyme alkaline phosphatase (Roche), diluted 1:250 
in blocking reagent. The slides were then left overnight at 4°C. 
The colour reaction was conducted in alkaline substrate buffer containing 
10mm MgCl2, 0.2m Tris (pH 9.5), 0.4% Triton-X, 50mg ⁄ml 5-bromo-4-chloro-3-
indolyl-phosphate (Roche) and 100mg⁄ml nitro blue tetrazolium chloride 
(Roche).  
The slides were washed three times with PBS and left in PBS while substrate 
solution was being prepared.  
Alkaline phosphatase solution ((200mM Tris base, pH 9.5) + 10mM 
Magnesium Chloride)) was prepared. 6.6μl BCIP and NBT solutions were 
added per ml of substrate buffer. 500μl of this solution were allowed for 
covering each slide; 4μl of 3% Triton X solution per ml were added to make the 
solution more spreadable. 
Slides were placed onto a developing rack. 500μl of substrate solution was 
added to each slide, using the pipette tip to ensure that slides were fully 
covered. A lid was placed on the rack, and it was covered with foil as this is a 
dark-activated reaction. The reaction was left for about 1 hour and kept under 
watch to look for purple colour development.  
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When colour had developed, slides were washed off with PBS and mounted 
in Immu-Mount. Once the mountant had dried, slide edges were sealed with 
Histo-Clear to prevent them from drying out. 
2.15. Quantitative Real-Time PCR 
2.15.1. Relative Quantification Method 
A relative quantification method was used to analyse changes in gene 
expression of the target gene in the treatment group compared to a control 
sample. The amount of target is normalized to an endogenous reference and is 
related to the calibrator by 2-∆∆Ct, where 
∆∆Ct = ∆Ct sample - ∆Ct calibrator and ∆Ct sample = Ct target - ∆Ct reference 
The Ct value is calculated using a threshold level of fluorescence set above 
the background but within the linear phase of amplification. The cycle number 
at which an amplification plot crosses this threshold fluorescence level is called 
the Ct or threshold. 
To apply this method, the efficiencies of the target and reference genes, 
established via a standard curve, must be approximately equal (in the 5% 
range) and close to 100%. A method for assessing if the two amplicons have the 
same efficiency is to look at how ΔCt varies with the template dilution. To do 
that, the average Ct for both the target and reference and the 
ΔCt (Cttarget - Ctreference) was determined. The data were fit using least-squares 
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linear regression analysis (n=3). The absolute value of the slope of the plot 
cDNA dilution versus ΔCt should be lower than 0.1. 
2.15.2. cDNA Synthesis and Gene-Specific Primer Design 
The cDNA concentrations of all the calibrators (control and experimental) 
were determined according to the efficiency of each reaction. The primer pairs 
designed to investigate Lym-antiNOS2 and β-tubulin expression were 20-21 
nucleotide long with G-C content between 40-60%, with an annealing 
temperature close to 54°C (Table 2.1). The length of the amplicons was 119bp 
and 103bp for Lym-antiNOS2 and β-tubulin respectively. 
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Primer name Primer sequence 
β-tubulin primers  
Forward LTUBaRT  5‟AAGGGACATTACACAGAGG‟3 
Reverse LTUBbRT 5‟GTGTCAGTTGGAATCCTTG‟3 
Lym-antiNOS2 primers 
Forward Scorp 1RT 5‟GTGAACTATCAAGTCACAATG‟3 
Reverse Scorp 2RT 5‟GAACTCAAGACTCTACGTAG‟3 
Table 2.1 Oligonucleotide sequences used as primers for the amplification of Anti-NOS2 and 
β-tubulin. 
2.15.3. Primer Optimization 
Optimal design of the PCR primers is essential for accurate and specific 
quantification using real-time PCR. The optimisation of annealing temperature 
and the primer concentration is essential. The theoretical annealing temperature 
for the set of primers was validated on PCR at four different temperatures 
(52°C, 53°C, 54°C and 57°C), and a 1% agarose gel was run (Section 2.12) to 
determine at which temperature the primers are used more efficiently. The 
amount of template and primers added was the same in all the samples in the 
optimization exercise. 
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Figure 2.4 Ethidium bromide stained 1% agarose gel displaying PCR amplification products 
obtained using Lymnaea S cDNA as templates and the primer pair Scorp 1RT and Scorp 2RT. 
Lanes: 1, molecular size ladder; 2, 4, 6 and 8: RT+ at each annealing temperature; 3, 5, 7, 9: RT- 
as a negative control at each annealing temperature.  
To ensure the efficient and accurate quantification of the target template, 
real-time PCR assays should be optimized. Assays are first optimized by 
evaluating primer concentrations. To do that, four concentrations with 
equimolar amounts of each primer pair were tested: 16nM, 20nM, 40nM and 
60nM. The amount of template added was the same in all the samples in the 
optimization exercise. All the samples were run in duplicates.  
The ideal primer pair should yield the lowest average Ct value as well as 
presenting a dissociation curve that shows a single product.  
2.15.4. Assay Performance 
Following primer optimization and in order to test the efficiency, precision 
and sensitivity of the real-time PCR reaction (set up a detaled in Table 2.2 and 
Table 2.3), a standard curve was performed using a serial dilution of calibrator 
cDNA. A five-point, two-fold dilution series starting with 1:50-diluted cDNA 
was generated in triplicates. To obtain the standard curve, the Ct values of the 
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serial dilution of the calibrator cDNA were plotted against the cDNA dilution 
value. 
2.15.5. Amplification  
The real-time PCR experiments were carried out in a total volume of 25µl 
consisting of 12.5µl of FastStart SYBR Green 2x real-time PCR Master Mix 
(Roche), 2µl of the cDNA template, 11µl  of forward and reverse primers 
mixture (at different concentrations as detailed in each experiment) and 0.5µl of 
PCR-grade water. The FastStart SYBR Green 2x real-time PCR Master Mix 
contained 2x reaction buffer, 0.025U/µl Taq polymerase, 5mM MgCl2, dNTP 
mix (200µM of each dNTP), ROX (passive reference dye) and SYBR Green. 
RNA sample (~100ng/µl) 2.5μl + Water 2.5μl 
 
+RT cDNA reaction 
  
 -RT cDNA reaction 
  iScrip mix 4 μl  iScrip mix 1 μl 
iScrip reverse transcriptase 1 μl  RNA 0.25 μl 
RNA 1 μl  water 3.75 μl 
water 14 μl  Total 5 μl 
Total 20 μl  
   
  Table 2.2 Synthesis of first strand cDNA for real-time PCR. 
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  Sybr Green +RT cDNA sample H2O 
14μl +  
11μl 
oligos   
12.5μl 2μl 0.5μl 
x6 75μl 12μl 3μl 
 
  Sybr Green -RT cDNA sample H2O 
14μl + 
11μl 
oligos  
12.5μl 1μl 1.5μl 
x2 25μl 2μl 3μl 
 
 
Sybr Green 
Calibrator cDNA 
sample H2O 
14μl + 
11μl 
oligos  
12.5μl 1μl 1.5μl 
x4 50μl 4μl 6μl 
 
Primers mix 
β-tubulin β-tuba 
11μl 
 
Lym-antiNOS2  Scor1 
11μl 
(3pM) β-tubb 
 
(3pM) Scor2 
 
H2O 
  
H2O 
440μl 440μl 
Table 2.3 Protocol sample for real-time PCR reaction. Each tube was filled with 14μl Sybr Green 
mix plus 11μl primers mix. Each sample was pipetted by triplicate and duplicates of RT-. Each 
experiment was performed with a duplicate set of calibrators.    
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Amplifications were carried out in a Mx3000P real-time PCR system 
(Stratagene) which includes a built-in thermal cycler equipped with a heated 
lid, a quartz-tungsten halogen lamp to excite fluorescence, photomultiplier 
tubes for high-sensitive detection and the Mx3000P real-time quantitative 
detection software. 
All samples were analysed in duplicate. All reactions were initially 
denatured at 95°C for 15 minutes followed by a three-step protocol of 40 cycles 
of denaturation at 94°C for 30 seconds, annealing 54°C 1 minute and extension 
at 72°C for 30 seconds. In order to test the specificity of the primers the products 
were slowly melted, starting with 1 minute at 95°C followed by 30 seconds at 
60°C and 30 seconds at 95°C, and the products analysed in the melting or 
dissociation curve (plotting fluorescence versus temperature). The temperature 
at which a DNA molecule melts depends on its length and sequence; therefore 
if the PCR product consists of molecules of the same sequence a single peak will 
be detected. 
A negative control was set up alongside each set of PCR reactions consisting 
of all components of the PCR reaction including the template RT- DNA sample, 
and a calibrator in each of the PCR runs.  
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Chapter 3: Analysis of the Sequence of 
Lym-antiNOS2 NAT and its  
Expression in Lymnaea CNS 
3.1. Introduction 
Many studies have been made on understanding the molecular mechanisms 
underlying neuronal and behavioural plasticity. These studies have implicated 
several signalling pathways in consolidation of neuronal changes. In molluscs, 
Lym-NOS1 (nNOS) activity has been implicated in associative conditioning 
learning. 
In this thesis it was hypothesised that Lym-antiNOS2 plays a role in the 
regulation of NOS, and a correlation is expected in the patterns of expression of 
Lym-antiNOS2 NAT and Lym-NOS1 mRNA. In this chapter the characteristics of 
Lym-antiNOS2 sequence are analysed, and it is shown that Lymnaea CNS 
expresses the NOS-related Lym-antiNOS2 transcript. 
3.1.1. Lym-antiNOS2 RNA Structure 
Lym-antiNOS2 RNA was fully sequenced by Dr Sergei Korneev in 2002 and is 
available at GenBank (access number for Lym-antiNOS2 cDNA is AF373019, 
AF373020 for the inverted anti-NOS locus) (Korneev and O'Shea, 2002). 
Lym-antiNOS2 RNA is a polyadenylated transcript of about 3,000nt in length 
and contains a polyA tail; both of these features aid messenger RNA stability. It 
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contains an open reading frame (positions 261-1454nt) encoding a truncated 
NOS-homologous protein of 397 amino acids (Figure 3.2). The protein-encoding 
function of Lym-antiNOS2 RNA was confirmed by in vitro translation 
experiments where a single band of 45kDa was detected (Korneev and O'Shea, 
2002). Lym-antiNOS2 protein shares about 70% identity with the oxygenase 
domain of nNOS, which includes the region required for the formation of the 
functional homodimer. It does not possess the reductase domain (which 
includes calmodulin-binding sites and cofactor and cosubstrate binding sites), 
which is essential for enzymatic activity of NOS. 
 
Figure 3.1 Schematic representation of Lymnaea nNOS and Lym-antiNOS2 proteins. The upper 
bar represents the nNOS protein, which is composed of two major functional domains 
(oxygenase domain and reductase domain), connected by the calmodulin-binding site 
(hatched). Importantly, it was shown that the oxygenase domain contains regions essential for 
NOS dimerization. Note that the antiNOS-2 protein (lower bar) contains the oxygenase domain 
only. Oxygenase domains in the nNOS and antiNOS-2 proteins share 70% identity (Korneev 
and O'Shea, 2002). 
The two nNOS-related transcripts found in Lymnaea (Lym-antiNOS-1 and 
Lym-antiNOS2) are homologous to Lym-NOS1 mRNA and they do not show 
sequence similarity to each other. In Figure 3.2 it is possible to appreciate that 
the regions of similarity with nNOS are localized in different parts of the 
Lym-NOS1 mRNA and do not overlap. The NOS-related RNA molecules also 
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contain regions of significant antisense homology to Lym-NOS1 mRNA 
(Korneev and O'Shea, 2002). 
 
Figure 3.2 Schematic organization of Lym-NOS1 mRNA and nNOS-related transcripts. Dark 
gray boxes indicate regions of similarity (76%) shared by Lym-NOS1 mRNA and Lym-antiNOS2 
RNA. Light gray boxes show regions of similarity (80%) shared by Lym-NOS1 mRNA and 
Lym-antiNOS1 RNA. Antisense regions in the anti-NOS transcripts (antiα and antiβ) and their 
complementary counterparts in the Lym-NOS1 mRNA (α and β) are hatched. The antisense 
similarity of antiα to α and of antiβ to β is approximately 80% (Korneev and O‟Shea 2002). 
The full sequence of Lym-antiNOS2 RNA in Figure 3.3 shows in a grey 
background the position of the sense homology between Lym-antiNOS2 RNA 
and Lym-NOS1 mRNA. The full-line boxes show the (ATG) start site for 
translation and the presence of a new termination (TAG) signal indicating the 
end of the translation. The dotted line box delimits the open reading frame 
encoding a truncated NOS-homologous protein. 
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   1 GGGGTGACCA GCTACCTGTA GGGGTGACCA GCTACCTGTA GGGCCATAGA AACAATTTTC 
  61 CGGTTTAGGG TGAGTNTTAC TGCTTTCTGA TAATCTTTCA GAGCCTAACG TGACGGAAAT 
 121 CGGCAGTGTT CAGGCAGTTC AATCATGGNT TGCCCGTACC GGTCGGCCAA GCTGAAAAAT 
 181 GTGCTGAATG ATAAGACTTA TGTGGACACG NTTACACCAG AGATCATTTT CGCCAGTTAC 
 241 CTTGCAACAC CCAGCGATGC ATGGGCTCAC TTATGTCCCA ACAGGCAAAT AGGCCCCCTG 
 301 GGGTCCCTAG ATCACAGGAG GAACTTTTGG TTCACGCCAC AGGCTTCATT GACCAATATT 
 361 TAAACTCATG TGAAATGACA TTCCTGTCCA GGAGCAACAC ACCGGCCCAT TTGAATAGAC 
 421 TTAGCGAGAT CCAAGATTAT GTGACAAAGT CCGGTACCTA TGACCTGACA ATGGCTGAAC 
 481 TGACATTTGG TGCTAAGCAA GCTTGGAGAT ATGCGTCCAG ATGCACTGGC AGAATGCAGT 
 541 GGTCAAAACT TCAGGTTGTT GATGCCAGAT GCATCATGAC ACCCCGAGGG ATGTATACAG 
 601 CTTTGTGCGA TCACATCAAA TATGGGACAA ACAAAGAGAA TATTAGGTTT GCCATCACCA 
 661 TATTTCCACA ACGAATAGAA GGGCCCCCNG ATTTCCGTGT ATGGAATAGT CAGTTGATAG 
 721 GCTACGCTGG CTACAGTATG GATGATGGGA AGATTATTGG GGACCCAGCC AATGTGGAAT 
 781 TTACTGATCA ATGTGTAAGG ATGGGTTGGA AACCAAAGTA TGGTATGTTT GACCCATTTC 
 841 CACTGGTTCT GTCTGCTGCT GGATTTGATC CTGAAGTTTT CGACCTCCCA CCTGAGCTAG 
 901 TGTTAAAGGT CAAGTTGGTG CATCCCGAGA ATCCCTCGTT TTCTGATATT GGTCTAAAAT 
 961 GGTACGCCCT ACCAGCTGTA TCTGGAATGC TGTTGGACTG TGGGAGCCTG GAGTTCCCCT 
1021 CGTGTCTTTT CAATGGATGG TACATGGGGA CAGAGATTGG TTCCAGGGAT TTGTGCGATT 
1081 CTCATAGGTA CAACATGCTG GAGACCATTG CCTTAAAGAT GGGGCTAAAC ACCAGAAATG 
1141 CTTCATCCTT GTGGAAAGAT CGTGCACTAT TGGACGCTAA TCCTGCTGTT CTCCACAGTT  
1201 TTCAGTCAGC CAATGTTACA ATTGTCAATC ATCACGATGC CAGTGAGTCT TTAATGTTGC  
1261 ACTTGGATAC TGAGCAACAT TTAAGAGGTG GCTGCCCAGG TGATTGGGTG TGGGTGGTGC  
1321 CACCCATAAG TAGTTCAGCT CTGGACATTT TTCACCAAGA ACTTTTGCTT TATAAGCTCA  
1381 AGCCTTCCTT TGAATATCAG GCCTGTAGCT GGGATCTTTC ACTCAAAATG AAGGGCTNTA  
1441 CTTTCTTCCC ATGAATTTCG GATAATACTG AAGTAAAAAT TGATTGAGCT ATATGGAAAA  
1501 CACATTTTAT TGATGTAAAT AAATATTTGT ATTTCTCAAT TGATATAAGA GACAGATATT  
1561 GAATACAAAT TTTAAAAATG ATTTGAGTAA CTTTGCAATT AACAATGTTT TAAGCAATTT  
1621 TCCAAATTTT AATGAGGACA CAAAATAAAT ATCCTTACAT TATTTAGACA ATATGCTATC  
1681 AGGCAATTTA AGCTAAATAC CATGGCTTAA ATCTTGTTTT TTGCCATTGT CCAATAGCAC  
1741 AATCCTAACT TTGTCAAGTG ACCAGCTATG ATCACCCATT TTCGGGGTCC TGTTGCCTCC  
1801 TTTATATCAA TATTTTCGAG GCAGNAAGCA TCACATGCAG CCTATGGCNA AAAATTGGAA  
1861 ATTTTTTTNA ATAAAGGTAA TAATAGAGNA ATTTTTACAG TTTTGGATAG NTAGTTAAAA  
1921 NTTAAATGTA CAAATGNAAG NTTACTTACA AAGTATTGGA CAAGGTAAAN GACATTGTCA  
1981 AGTTCATGAA ATTAGCATAA AGTGTGGGTG TTTAATTGTG GGGCTTGTGA GTGAATGTGA  
2041 ACTATCAAGT CACAATGTTG GACAATGTTG AGTGATCGAG GTGTGCAATC GATTGACGAG  
2101 GATCGAGAGG GATATAGAGA GGATCTGGGT GATAGCTACG TAGAGTCTTG AGTTCACATG  
2161 AGTCAGTCTT ACGTTCACTG AGTATTATGT CACTGAGATC CAGGCAACTT GGATCTTGGA  
2221 GTTGCAGAGT GAGATAGATG TGTGGTGATA TGTTTTGCTG ATTGGAATAT TGCCCATACA  
2281 TTTGGATACA TGTTGCAATT TAACTGAAAC GGATTGCTGT TGTAATACTG CCATAAATAA  
2341 ATGACAAATG TACCTTGAAG ATTATTGTTG ATTGAATTAA ACTAGCCTGT TGTGTGGCAA  
2401 GTATTTCACG CCAACTCAAC AGTCGCGATA ATCATACACC CTTGACAACG CCCAAATATT  
2461 CACTACCAGA ATATTAGACA TATTGAAATT CATTTGAAAA TTATTGAATA TGAAAATTCT  
2521 GTAAAGATAT AATATGAAAA CAAGCATGGC ACTTACTCTA TATACTCCCT CAGACCAGGT 
2581 CCTAAATCTC TGCTCCTGGC CATATAAAGC ATCGCCTGTG CAATATTCAA CCAACATTTC 
2641 TGCTCCCAGT TCTTTGAATG TTTTATCTAT GTACTTTCCA AAGATAGCAA AGTTGGGGTA 
2701 AGCATTAGAT CCCAGTGAAA AAACTGCAAA CCTGTATAAA AATTGGATTA AAATAAATTC 
2761 TACCATT 
Figure 3.3 Molecular cloning of Lym-antiNOS2 transcript. Sequence of a full-length cDNA clone isolated from a Lymnaea CNS cDNA library. The antisense 
region from 2551 to 2735 bp is indicated in bold type. The core region of high homology (.80%) to the nNOS-encoding transcript is shaded. Polyadenylation 
signal is underlined. Stop and start codons are full-line boxes. The open reading frame is surrounded by dotted lines. 
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3.1.2. Cellular Localization of Lym-NOS1 in Lymnaea stagnalis CNS 
The cellular expression of Lym-NOS1 mRNA in Lymnaea CNS was analysed 
by in situ hybridisation (Korneev et al., 1999) and it has been localized on the 
modulatory CGCs that are known to have key roles in facilitation and plasticity 
in feeding (Figure 3.4).  
 
Figure 3.4 In situ hybridisation with the probe specifically recognizing Lym-NOS1 RNA. 
Cerebral ganglion is shown with CGC staining. Previous laboratory work by Michael Schofield 
for (Korneev and O'Shea, 2007). 
3.2. Sequence Analysis of Lym-antiNOS2 RNA 
Sequence alignment between Lym-antiNOS2 RNA and Lym-NOS mRNA reveals 
a 74% antisense homology between 179 nucleotides at the 3‟ end of Lym-
antiNOS2 RNA (Figure 3.5). The antisense homology is right at the 3‟ end of the 
sequence of Lym-antiNOS2 RNA out of the open reading frame, between the 
nucleotides 2555 and 2735. This antisense homology could trigger the 
CGC 
50µm 
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degradation of functional Lym-NOS1 RNA via a negative regulator of nNOS 
expression through the formation of an RNA–RNA duplex.  
 
Figure 3.5 Sequence alignment between antisense sequence of Lym-NOS1 mRNA and 
Lym-antiNOS2 RNA. Homology is shown between bases 2078 and 1900 for Lym-NOS1 (in 
antisense) on the top line and bases 2556 and 2734 of Lym-antiNOS2 in the third line. The 
middle line shows the bases with identity. A 74.3% of identity in the 179bp exists between the 
sequences. 
Lym-antiNOS2 RNA does not show antisense sequence similarities with other 
nNOS-related transcripts because the regions of similarity are localized in 
different parts of the Lym-NOS1 mRNA.  
Sense homology between Lym-NOS1 mRNA and Lym-antiNOS2 RNA has 
been found at the 5‟ end of the RNA molecule. Lym-antiNOS-2 shows high 
homology with Lym-NOS1 (1389nt - 1472nt and 2557nt - 2734nt) and 
Lym-NOS2 (2557nt - 2734nt). The sequence alignment is shown in Figure 3.6. 
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Lym-antiNOS2 sequence shares 70% sense homology within the open reading 
frame with Lym-NOS1 RNA. The sense homology starts at the 5‟ end right 
before the open reading frame for Lym-antiNOS2 at 230nt to 1390nt (Figure 3.6). 
This suggests that if Lym-antiNOS2 actually translates to a protein, it could 
function as a natural dominant negative regulator of Lym-NOS1 expression 
through binding to the normal nNOS monomer, forming a non-functional 
heterodimer (Figure 3.7).  
Lym-antiNOS2 NAT does not show sense sequence similarities with other 
nNOS-related transcripts because the regions of inversion are localized in 
different parts of the Lym-NOS1 mRNA (Figure 3.2). Nevertheless, at the 5‟ end 
of the molecule Lym-antiNOS2 shows high homology with Lym-NOS1 (274nt - 
1394nt). 
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Figure 3.6 Sequence alignment of Lym-antiNOS2 RNA and Lym-NOS1 RNA. Homology is 
shown between bases 220 to 1360 for Lym-NOS1 on the top line and bases 230 to 1370 of 
Lym-antiNOS2 in the third line. The middle line shows those bases with identity. An 80% 
identity exists between sequences. 
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Figure 3.6 (cont.) 
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Lym-antiNOS2 RNA does not possess similarities with nNOS or NOS-related 
transcripts on the position between the 5‟ end to the nucleotide 270, and at the 
middle of the sequence at 1500nt to 2500nt. These regions of non-homology are 
the ideal areas to find specific primers for the reverse transcription polymerase 
chain reaction, that will permit transcript levels of Lym-antiNOS2 NAT to be 
detectedand mesusure (Figure 3.7).  
 
Figure 3.7 Schematic sequence analysis of Lym,-antiNOS2 RNA. Dark gray boxes indicate 
regions of similarity (76%) shared by Lym-NOS1 mRNA and Lym-antiNOS2 RNA. Light gray 
boxes show regions of antisense similarity (80%) shared by Lym-NOS1 mRNA and 
Lym-antiNOS2 RNA. Open reading frame regions in Lym-antiNOS2 transcripts is hatched. 
 
3.3. Analysis of the Expression of Lym-antiNOS2 NAT in CNS 
by In Situ Hybridisation 
Three in situ hybridisation probes (described in Section 2.14) were designed 
to identify the localization of the expression of Lym-antiNOS2 RNA in the 
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central nervous system by in situ hybridisation. To increase the sensitivity of the 
method, the probes were designed to bind specifically to Lym-antiNOS2 and not 
to Lym-NOS-1 or Lym-NOS-2. The probes are situated in the two regions of 
specificity of Lym-antiNOS2 (Figure 2.3). 
All the animals used in this experiment were naïve animals selected 
randomly from their home tanks. All snails were of similar weight and age 
(approximately three months old).  In situ hybridisation on frozen sections was 
performed following the protocol in Section 2.14. The detection procedure was 
carried out using an anti-DIG antibody conjugated to alkaline phosphatase.  
To assess the specificity of the staining obtained with the antisense probes, an 
experiment was performed where the sense probe was incubated together with 
the brain sections. The sense probe has a sequence that is complementary to 
that of the antisense probes. The absence of staining following the incubation 
would indicate that the staining obtained from the experiment on antisense 
probes is highly specific. An additional experiment was performed using only 
hybridisation buffer (without probes) to establish that none of the staining is a 
product of the procedure itself (Figure 3.9B, Figure 3.10B, and Figure 3.11). 
As compared to the mammalian brain with 1011 neurons and Drosophila 
melanogaster ganglia comprising 200,000 neurons, Lymnaea stagnalis has a 
relatively simple central nervous system (CNS) consisting of a total of 20,000 
neurons, many of them individually identifiable, organized in a ring of 
interconnected ganglia (Figure 2.1). Most neurons of the Lymnaea stagnalis CNS 
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are large in size (up to ~100 μm in diameter), thus allowing electrophysiological 
dissection of neuronal networks that has yielded profound insights in the 
working mechanisms of neuronal networks controlling relatively simple 
behaviours such as feeding, respiration, locomotion and reproduction (Feng et 
al., 2009). A diagram of the snail CNS is shown in Section 2.3 (Figure 2.1), where 
it is possible to visualise the arrangement of the different ganglia. The pleural 
ganglia and pedal ganglia lie next to each other on the ventral side of the gut, 
and the cerebral ganglia are communicated via long connective nerves CBC to 
the buccal ganglia. 
3.3.1. General Staining 
Pedal ganglia  The pedal ganglia controls locomotion and conjoint muscle 
movements involving the shell (Benjamin et al., 2005). The pedal ganglia 
contain many motoneurons involved in locomotion, which are part of the 
feeding circuit and hence likely to have direct connections with the central 
ganglia. 
Figure 3.8 shows the results of our staining experiments in pedal ganglia. 
Fewer neurons stain in this area of the brain in comparison with buccal ganglia 
or cerebral ganglia. The high quantity of neurons of similar size that compose 
the pedal ganglia makes it difficult to clearly identify particular neurons. 
Buccal ganglia  The consummatory phase of feeding (cycle of feeding 
behaviour: protraction, retraction and swallowing) is driven by motor 
commands generated within the buccal ganglia (CPG), which consists mostly of 
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interneurons that connect via cerebrobuccal connectives (CBCs) (Figure 3.9A 
and Figure 3.8), motoneurons and modulatory neurons such as CGCs.  
Figure 3.9A depicts the results of the staining experiments on the buccal 
ganglia. It is possible to see a very widespread staining in the buccal ganglia, 
with all the neurons presenting staining although not as strongly as in the 
CGCs (Section 3.3.2). The buccal ganglia are involved in the production and 
modulation of feeding behaviour and thus these neurons might be involved in 
plasticity of the feeding behaviour.  
In the buccal ganglia all cells appear stained in each ganglion, even though 
the right ganglion always showed higher staining. This could be an artifact of 
the technique, but it was consistent along the different preparations. To our 
knowledge, no previous reports of differentiation between left and right ganglia 
exist in the literature; moreover, both ganglia are electrically equivalent.  
Visceral, pleural and parietal ganglia  The visceral ganglia are the rear and 
upper parts of the circumesophageal ring, a large, single ganglion whose 
function is to process information from the internal organs and organ systems. 
The pleural ganglia have a nerve path to the gullet retractor muscle and the 
main retractor muscle. The parietal ganglia are the starting point of the mantle 
nerves.  
No staining was found in the pleural ganglia, parietal ganglia and visceral 
ganglia. None of these ganglia are involved in feeding or learning; hence their 
lack of staining agrees with our hypothesis that Lym-antiNOS2 expression is 
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linked to learning processes, and is not expressed arbitrarily in the whole nerve 
system. 
3.3.2. The Cerebral Giant Cells Express Lym-antiNOS2 NAT 
In Lymnaea, the CGCs are a pair of very well-known serotonergic neurons 
that have two distinct roles in the feeding network. Firstly, they act as gating 
neurons, facilitating the response to food. Secondly, following single-trial 
appetitive conditioning, persistent depolarization of the CGCs facilitates the 
feeding response to the CS leading to LTM formation (Kemenes et al., 2006a). 
Importantly, the associative conditioning of the feeding response is dependent 
on the NO–cGMP signalling pathway in the early stage of memory formation – 
disruption of this pathway during the first 6 hours following conditioning 
prevents LTM formation (Kemenes et al., 2002).  
Figure 3.10 shows the results of our staining experiments on cerebral ganglia. 
Lym-antiNOS2 NAT in situ hybridisation in Lymnaea neurons indicates that the 
expression of Lym-antiNOS2 NAT is restricted to some areas but can be found 
in numerous neurons located in central ganglia (Figure 3.10A, C). In particular, 
we find that Lym-antiNOS2 RNA is present in the CGCs with extensive staining. 
This is an important result since it is already known that in central ganglia 
Lym-NOS1 mRNA is expressed in CGCs (Korneev et al., 2005) indicating that 
Lym-NOS1 and Lym-antiNOS2 are co-expressed in the CGCs. 
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Figure 3.8 The pedal ganglia contain Lym-antiNOS2 NAT. In situ hybridisation experiments on 
adjacent sections through the pedal ganglia showing the staining with Lym-antiNOS2 antisense 
probe, but not with the sense control probe (not shown). Lym-antiNOS2 antisense probe shows 
staining in the CBC. 
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50 µm 
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Figure 3.9 The buccal ganglia contain Lym-antiNOS2 NAT. (A) In situ hybridisation experiments 
on adjacent sections through the buccal ganglia showing the staining with the Lym-antiNOS2 
antisense probe. (B) No staining with the sense control probe.  
CBC 
CBC 
Buccal ganglia 
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Figure 3.9 (cont.)  
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Figure 3.10 The CGC contains Lym-antiNOS2 NAT. (A) In situ hybridisation experiments on 
adjacent sections through the cerebral ganglia showing the CGC stained with the Lym-
antiNOS2 antisense probe. 
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Figure 3.10 (B) In situ hybridisation experiments on adjacent sections through the cerebral 
ganglia showing no staining with the sense control probe.  
  
CGC 
50 µm 
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Figure 3.10 (C) In situ hybridisation experiments on adjacent sections through the cerebral 
ganglia showing the CGC stained with the Lym-antiNOS2 antisense probe. 
   
CGC 
CBC 
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Figure 3.11 In situ hybridisation experiments on adjacent sections through the Lymnaea CNS 
with Lym-antiNOS2 sense control probe, showing no staining. 
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3.4. Lym-antiNOS2 RNA is Expressed in the CGCs 
In view of the potential significance of our findings on Lym-antiNOS2 
expression on the CGC, we validated the results of in situ hybridisation by 
using the more sensitive RT-PCR technique (reverse transcription polymerase 
chain reaction). 
3.4.1. RT-PCR on Isolated Identified CGC 
One widely appreciated property of some gastropod neurons is their large 
size. The CGCs are frequently classified as giant neurons. The significance of 
why giant neurons occur is not clear, but giant neurons have 200,000 times the 
haploid amount of DNA, which represents 16 doublings of the diploid DNA 
content (Chase, 2002). The cell bodies of CGC are identified easily by size given 
that they are the largest ones on the ventral side of the anterior part of the 
cerebral ganglion (100-200μm in diameter). The CGCs are highly pigmented 
and clearly visible. 
 A Lymnaea brain was isolated from the body (Section 2.3) and the brain was 
carefully pinned out and the brain commissure was cut to be able to visualise 
the CGCs. The cell bodies of CGCs were identified by their position and size. 
CGCs were individually dissected from the CNS of Lymnaea as described in 
Section 2.13. 
When RNA extraction is conducted from whole brain or ganglion, the large 
amount of extra copies of DNA coming from the giant neurons is very small in 
comparison to the total amount of RNA extracted, and hence no signs of DNA 
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contamination can be found. But when RNA extraction is performed on a single 
(giant) cell, these extra copies of DNA could lead to contamination concealing 
the RNA pool. 
Because of the small amount of RNA material, a first attempt at RT-PCR was 
carried on a pool of ten CGCs, rather than on individual CGCs. To overcome 
the problem of DNA contamination, total RNA was extracted from the pooled 
neurons by means of the Absolutely RNA Nanoprep Kit (Section 2.5). The total 
RNA was treated with extra DNase treatment (Section 2.6). The RNA was 
copied into cDNA using iScript reverse transcriptase (Section 2.9) and the 
cDNA produced was subjected to PCRs using the following primers (Section 
2.11): 
Forward (Scorp1RT): 5‟-GTGAACTATCAAGTCACAARG-3‟  
Reverse (Scorp2RT): 5‟-GAACTCAAGACTCTACGTAG-3‟ 
If the CGCs express Lym-antiNOS2 RNA, a product of 119bp is the expected 
output following the amplification of cDNA by RT-PCR. A diagram of the 
Lym-antiNOS2 sequence showing the positions of the primers in the sequence 
and the amplification product using Scorp1RT and Scorp2RT primer on 
Lym-antiNOS2 RNA is presented in Figure 2.2. 
The product of the PCR was loaded on an agarose gel to perform an 
electrophoresis of DNA product. RT- controls were set up alongside each set of 
PCR reactions to ensure that there was no DNA contamination. Negative 
controls consisted of a cDNA from all components of the RT-PCR reaction 
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excluding the reverse transcriptase enzyme. If DNA contamination is present in 
the sample, a band will be present in the gel consisting of the amplification of 
genomic DNA instead of cDNA (cDNA is produced from fully transcribed 
mRNA found in the nucleus and therefore contains only the expressed genes). 
Figure 3.12A shows the DNA contamination of the RNA extracted from ten 
CGCs, justifying an extra DNase treatment step on top of the one specified as 
part of the Nanoprep kit RNA extraction protocol (Section 2.5). 
Following the results of the first RT-PCR attempt, an extra TURBO DNase 
treatment was conducted after the RNA extraction (Section 2.6). An extra 
precipitation step was also necessary (Section 2.7) to be able to clean the sample 
from impurities arising from the TURBO DNase buffer, which inhibit the PCR 
enzyme. This was a critical step due to the small amount of material present in 
the tube. The utilization of pellet paint was vital to give better visualization of 
the sample during the precipitation process. 
Working on a single, identified CGC, and after the RNA sample from the 
CGC was cleaned from DNA contamination, cDNA was synthesised (Section 
2.9), followed by PCR amplification with Scorp1RT and Scorp2RT primers 
(Section 2.11). The PCR product was analyzed by agarose gel electrophoresis 
(Section 2.12), stained with ethidium bromide and compared to a DNA ladder. 
A photograph of the gel was taken under ultraviolet lighting conditions 
showed in Figure 3.12B, where it is possible to visualise a band of the expected 
size and no contamination in the lane corresponding to RT-. The presence of a 
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band of the expected size (119bp) in RT+ (lane 2) in Figure 3.12B is an 
overwhelming proof of the expression of Lym-antiNOS2 NAT in single CGC 
and verifies our results from in situ hybridisation. 
 
A B 
 
Figure 3.12 RT-PCR experiments on RNA purified from identified CGCs: RT-PCR was 
performed with primers specific for Lym-antiNOS2 (RT- / lane 1 and RT+/ lane 2). (A) RT-PCR 
of 10 identified CGCs shows DNA contamination present on the sample (RT- lane 1).  
(B) The absence of any PCR products in RT- control (lane 1) proves that the RNA samples were 
free from DNA contamination; lane 2 (RT+) shows a band around the expected size (119bp), 
proof of the expression of Lym-antiNOS2 in the identified CGC. 
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3.5. Discussion  
Is was already known from previous publications (Korneev et al., 1999) that 
the NAT transcribed from the Lym-antiNOS1 gene functions as a negative 
translational regulator of Lym-NOS1 expression. The sequence analysis of 
Lym-antiNOS2 gene conducted in this chapter shows that it has an open reading 
frame encoding predicting a protein with 70% identity to the oxygenase domain 
of NOS. Moreover, it is of considerable interest that the truncated homologue 
encoded by Lym-antiNOS2 gene includes the domain required for dimerisation, 
but not the other regions essential for NO synthesis (Korneev and O'Shea, 2007).  
The CGCs are modulatory neurons that have been shown a change in the 
electrophysiological properties after training. Along with the electrical changes, 
they show transcription of new RNAs and protein synthesis after training. The 
neuronal sources of the NO required for LTM formation in Lymnaea have not 
yet been identified. One possibility is that NO is produced by chemosensory 
neurons involved in mediating the activation of feeding (Elphick et al., 1995). 
We also know that the CGCs are potentially capable of producing NO under 
certain specific conditions. Indeed, previous studies showed that although NOS 
gene expression is usually suppressed in the CGCs (Korneev et al., 1999), 
reward training leads to its rapid transient activation in these neurons (Korneev 
and O'Shea, 2005).  
It was already reported that Lym-NOS1 and anti-NOS genes are differentially 
regulated in this neuron as the result of training. Due to the CGCs being 
interconnected to many neural components of the feeding system, functioning 
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in a permissive manner to modulate the probability that feeding behaviour will 
be initiated, it was suggested that the ability of the CGC to signal broadly 
within the feeding neural network via NO is altered during a critical early stage 
of memory formation by the training-induced differential regulation of the 
Lym-NOS1 and anti-NOS genes (Korneev et al., 2005). 
The in situ hybridisation experiments conducted in this chapter show the 
presence of Lym-antiNOS2 RNA in the CGCs. Moreover, its expression is not 
indiscriminate across the whole brain. As the CGCs are known to have an 
important role in formation of the LTM circuit, this result is of crucial 
importance. An independent confirmation of the presence of Lym-antiNOS2 
RNA in the CGCs is given by performing single-cell RT-PCR in Lymnaea CGCs. 
These experiments are conducted on RNA extracted from individually 
identified CGCs. The results of this analysis confirm the in situ data and 
unambiguously demonstrate that Lym-antiNOS2 RNA is indeed co-expressed in 
the CGCs with NOS mRNA. Therefore it can be suggested that under the 
conditions that follow training, the production of NO in the CGCs may be 
regulated by Lym-antiNOS2 present in the same cells. 
The in situ hybridisation experiments also show that in neurons where Lym-
antiNOS2 RNA is present it is mainly cytoplasmatic, and absent in the nuclei. 
The location of Lym-antiNOS2 RNA in the cytoplasm agrees with the bi-
functional RNA hypothesis that Lym-antiNOS2 RNA might play a role in 
inhibiting the translation of NOS1 RNA, and might also encode a truncated 
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NOS-related protein that can form a non-functional heterodimer with normal 
NOS1 protein.  
The expression of Lym-antiNOS2 RNA was detected by in situ hybridisation 
in buccal ganglia, cerebra ganglia, pedal ganglia, cerebrobuccal connectives but 
not in the rest of the brain. An unexpected result of the in situ hybridisation 
experiments was the presence of Lym-antiNOS2 RNA in the CBCs, along with 
the CGCs. CBCs only contain axons, and are the only connection between the 
cerebral and buccal ganglia that form the feeding CPG. Further experiments on 
the CBCs are presented in Chapter 5. 
In this chapter we show unambiguously that Lym-antiNOS2 is expressed in 
Lymnaea brain. Previous research introduced the hypothesis that Lym-antiNOS2 
NAT can be considered as a putative bi-functional RNA because it can function 
as a protein-encoding mRNA that also contains a potential regulatory antisense 
region localised in the 3‟ UTR, but no proof that Lym-antiNOS2 RNA is co-
expressed with Lym-NOS1 mRNA in the CGCs had been found. Findings bring 
new light to this hypothesis. Together with the results that the NO-cGMP-PKG 
signalling pathway is critical for memory formation, this suggests that 
Lym-antiNOS2 NAT could be involved in the regulation of NO production 
during LTM formation. This suggestion is explored further in Chapter 4 by 
studying changes in the expression of Lym-antiNOS2 NAT after single-
conditioning training. 
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Chapter 4: Quantitative Analysis of 
Lym-antiNOS2 NAT Expression in 
Trained and Naïve Animals  
Three major questions will be addressed in this chapter:  
 Are there changes in the expression levels of Lym-antiNOS2 RNA in whole 
brain after a single conditioning trial? 
 What are the differences in the expression of Lym-antiNOS2 RNA on 
different ganglia, after a single conditioning trial? 
 Are there changes in the expression levels of Lym-NOS1 mRNA in Lymnaea 
brain after a single conditioning trial? 
To enable the quantification of different levels of expression at small 
concentrations, the use of real-time PCR is indispensable.   
4.1. Introduction 
It was shown in previous research in Lymnaea that one-trial chemical 
appetitive conditioning acts selectively and differentially within the NOS gene 
family (Korneev et al., 2005). Specifically, single-conditioning trial induced 
changes in the expression of Lym-NOS1 and Lym-antiNOS1, while Lym-NOS2 is 
stable. Importantly, it has been shown that the cerebral ganglia are the central 
locus of plasticity where associative LTM formation occurs. It has also been 
shown that the expression of the NOS1 RNA in these neurons is transiently up-
regulated after conditioning. The cerebral ganglia contain modulatory neurons 
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that are essential for the gating or initiation of feeding behaviour in response to 
the CS. 
Previous studies have hypothesized that the decrease in the amount of 
Lym-antiNOS1 RNA observed at 4 hours after conditioning can lead to an 
increase in the production of NO that facilitates memory formation, but no 
studies have been made on the Lym-antiNOS2 gene. 
4.2. Feeding behaviour in Lymnaea 
The feeding behaviour in Lymnaea stagnalis has been extensively studied 
and the interneurons which belong to the Central Pattern Generator (CPG) 
underling this rhythmic behaviour have been identified. The feeding consists of 
repetitive rasps, carried out with a toothed radula, each rasp includes three 
phases: protraction, retraction and swallow. During the protraction phase the 
radula is extruded over the substrate, after the radula is retracted it to the 
mouth, which is closed during the swallowing phase (Benjamin et al., 2000). 
 Each of these phases is generated by a different class of interneurons, 
respectively N1, N2 and N3. These interneurons form the CPG which drive the 
motoneurons localised in the buccal ganglia (B1-B10). Applications of sucrose 
on the lips or on the oesophagus trigger a fictive feeding response that can be 
recorded from the motoneurons and from the interneurons in the buccal 
ganglia. Interneurons located in the cerebral ganglia, like the cerebral giant cells 
(CGCs) gating interneurons and of the cerebro-buccal interneurons (CBIs) 
command –like interneurons play an important role in the modulation of the 
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feeding behaviour (Kemenes et al., 2006a). These interneurons in the cerebral 
ganglia are required for a food-driven response and have been shown to be 
involved in classical appetitive learning (Kemenes et al., 2006a). The sensory 
inputs reach the slow oscillator (SO), a single modulatory cell placed either in 
the left or in the right buccal ganglion. A strong current injection in in the SO 
can initiate fictive feeding, but the main role of this cell is to control the 
frequency and maintain the regularity of the feeding rhythm (Kemenes et al., 
2001) 
 
Figure 4.1 Lymnaea feeding network: schematic representation of the identified neurons 
involve in food-driven feeding behaviour (Benjamin P.R. 2006) 
4.3. Optimization of Quantitative RT-PCR 
The information for the synthesis of all proteins in an organism is encoded in 
the DNA in the form of genes. The process of transcription transfers the 
information of a gene into mRNA, which can be translated into proteins. 
Therefore, the quantification of mRNA can be used to assess the expression 
levels of a particular gene. Real-time PCR can quantify alterations in RNA 
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concentrations that were previously undetectable using earlier techniques such 
as RT-PCR or RNase protection assays.  
The real-time PCR technique enables the quantification of target gene 
expression by using a fluorescent reporter molecule to monitor the progress of 
the amplification reaction. In our case, the reported molecule is the dye SYBR 
Green that binds to double-stranded cDNA emitting a fluorescence signal. The 
main advantages of this detection method are that it is cost effective and easy to 
use. One of the limitations on the use of SYBR Green is that it can bind to any 
double-stranded DNA including primer dimers or unspecific products. 
Consequently, the primers should be designed and optimized to avoid any non-
specific binding.  
The levels of expressed genes can be measured by absolute quantification 
(standard curve method) or by relative quantification. Absolute quantification 
uses serially diluted standards of known concentration to generate a standard 
curve from which the absolute amount of an unknown concentration can be 
determined. The method employed in this study was a relative quantification 
method, where gene expression was normalized to a reference gene, and its 
levels relative to the gene expression of a non-treated sample used for 
comparison.  
In order to control the variability introduced by the real-time PCR technique 
and assure accurate results, a reference gene that is assumed to have equal 
levels of expression in each experimental sample should be used. The reference 
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gene chosen in this study was the β-tubulin gene. This gene encodes for the 
synthesis of β-tubulin which is a microtubule element of the tubulin family 
found almost exclusively in neurons. Due to its constant expression in many 
experimental conditions, the use of β-tubulin as a reference or housekeeping 
gene is recommended (Martinez-Fernandez et al., 2011).  
Relative quantification is used in studies where the experimental objective is 
to investigate small changes in RNA expression levels. The normalized amount 
of target is a unitless number that can be used to compare the relative amount 
of target in different samples. This comparison was designed such that one 
sample is the calibrator. Naïve whole brain sample was designated as the 
calibrator. 
A comparative Ct (cycle threshold) method was used as described in Section 
2.15.1. Before using the ∆∆Ct method for quantification, a validation experiment 
has to be performed to demonstrate that the efficiencies of target 
(Lym-antiNOS2) and reference (β-tubulin) amplification are approximately 
equal (Figure 4.2). 
An amplification plot using a semi-log scale representation (Figure 4.3A, B) 
was used to determine the fluorescence threshold. Measurements below this 
threshold were discarded to avoid the noise close to the baseline. An analysis of 
the dissociation curves (Figure 4.3C, D) shows that the melting temperature of 
the amplicon is 78.5°C for both PCR products. No contaminating products are 
present in this reaction.  Contaminating DNA or primer dimers would show up 
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as additional peaks separated from the desired amplicon peak. The no-template 
control for both genes did not record any amplification. 
 
Figure 4.2 Standard curves (a) standard curve generated from Lym-antiNOS2 amplification data, 
(b) standard curve generated from β-tubulin amplification data, (c) demonstration that the 
efficiencies of targets are equivalent 
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Figure 4.2 Standard curves (a) standard curve generated from Lym-antiNOS2 amplification 
data, (b) standard curve generated from β-tubulin amplification data, (c) demonstration that the 
efficiencies of targets are equivalent 
B 
C 
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Figure 4.3 Real-time PCR amplification plots of Lym-antiNOS2 (A) and β-tubulin (B).  
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Figure 4.3 (cont.) Dissociation curve of the real-time amplification (C) Lym-antiNOS2, (D) β-
tubulin   
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The total RNA extraction from Lymnaea CNS was carried out following the 
protocol described in Section 2.4 and stored at –20oC until further processing. 
cDNA was synthesised on DNase-treated total RNA following the protocol 
described in Section 2.9 and stored at –20oC. The gene-specific primers were 
designed by Dr Sergei Korneev using the Lym-antiNOS2, Lym-NOS1, Lym-NOS2 
and Lym-antiNOS1 sequences described in Section 3.2. 
Primer Optimization  To ensure the efficient and accurate quantification of the 
target template, real-time PCR assays should be optimized. Assays are first 
optimized by primer titration to see the efficiency of the reaction. To do that, 
four concentrations with equimolar amounts of each primer pair were tested: 
100 nM, 200 nM, 400 nM and 600 nM. The amount of template added was the 
same in all the samples in the optimization exercise. All the samples were run in 
duplicates. The ideal primer pair concentration should yield the lowest average 
Ct value as well as presenting a dissociation curve that shows a single product. 
Standard Curves for Analysis of Assay Performance  Following primer 
optimization a standard curve was performed using a serial dilution of a 
calibrator sample in order to test the efficiency, precision and sensitivity of the 
real-time PCR reaction. In this case, a two-fold dilution series starting with 1:50 
diluted cDNA and consisting of four points was generated in duplicate. To 
obtain the standard curve, the Ct values of the serial dilution of the calibrator 
sample were plotted (Figure 4.2). 
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In order to evaluate the overall performance of the real-time PCR reaction, a 
standard curve was generated for each gene. After amplification, the Ct‟s for 
each standard dilution were determined and plotted. The amplification of 
cDNA serial dilution with Scorp1RT and Scorp2RT primers generated a 
standard curve with an efficiency of amplification of 99.5% (Figure 4.2A). The 
slope of the line of best fit determines the efficiency of a reaction using the 
equation E = 10 (–1/slope) –1. The linearity of the assay, denoted by the R 
squared (RSq or R2) was 0.985. A value of E close to 1 implies a linear range and 
that the efficiency of the reaction is consistent at varying template 
concentrations (sensitivity). It also indicates agreement between replicates. 
For the cDNA amplification serial dilution with β-tubulin primers, the 
amplification was linear with RSq = 0.987 and an amplification efficiency of 
99.3% (Figure 4.2B). 
After the primer optimization and the assay performance evaluation, the 
next step was to test the primers at the concentration chosen (600nM for 
antiNOS-2 and 400nM for β-tubulin) with Lymnaea cDNA from the 
experimental samples. The amplification of the reference cDNA generated a 
single product with a melting temperature of 79°C (Figure 4.3C). Lymnaea 
cDNA amplified with primers for the detection of Lym-antiNOS2 yielded a 
single product (Figure 4.3D) with a melting temperature of 78°C. The no-
template control for both genes did not record any amplification. 
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Confirmation of the Identity of the Products Formed  All the reactions in the 
real-time PCR amplification generated products that agree with those expected. 
After cloning, the sequences obtained confirmed the identity of the fragments as 
Lym-antiNOS2 and β-tubulin. 
Long Term Memory formation After One-Trial Appetitive Conditioning  
The one-trial reward conditioning protocol was performed using the method 
described in Section 2.2. The snails were trained and CNS dissected by Dr Ildiko 
Kemenes. The snails were separated into six groups: 10 minutes, 1 hour, 4 
hours, 6 hours, UP and N. This protocol is illustrated in Figure 4.4.  
A total of 270 snails were trained (Table 4.1). After training the snails were 
separated following the groups on Table 4.1 and separated into tanks according 
to groups. The CNS‟s were dissected (Section 2.3) and stored frozen at -80°C. 
Some of the CNS‟s were separated into buccal ganglia, cerebral ganglia and 
remainder of the CNS‟s, before being frozen and stored at -80°C. 
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   whole brain ganglia Learning test 
N 32 16 18 
UP  32 16 18 
P-6hr 16 8 
18 
P-4hr 16 8 
P-2hr 16 8 
P-1hr 16 8 
P-10min 16 8 
Total 
 
270 
Table 4.1 Experimental groups for the one-trial reward conditioning protocol: separation of 
animals in naïve (N), unpaired (UP) and (P) paired (dissected after 10 minutes, 1, 2, 4 and 6 
hours). 
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RNA extraction was performed from the frozen CNS (Section 2.4). Part of the 
RNA was used in a reverse transcriptase reaction (Section 2.9). An equal 
volume of water was added to the RNA for the synthesis of cDNA and the 
reaction was set up as shown in Table 2.2. 
After the synthesis of cDNA a reaction for the quantification of the gene 
expression was set up. Nine samples were set up on each run. Each sample was 
run in triplicate along with a no-template control and a calibrator which is run 
on duplicate. Table 2.3 shows a sample of the protocol. 
18 snails from each group (UP, P and N) were retained and tested for long 
term memory formation at 24 hours after conditioning (paired and unpaired) 
trials. The CS alone elicited a conditioned response (CR) as shown by increased 
rasping frequency. An unpaired control group had the CS and US presented 1 
hour apart. Figure 4.5 shows that the snails on the unpaired group had not 
formed long term memory. A significant increase of the rasping movements in 
a 2-minute interval was observed as a response to the training protocol in 
paired animals.    
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Figure 4.5 Behavioural training. Trained animals exhibited a significantly higher rate of rasping 
in response to the 24 hours CS test than the animals from the unpaired control group (n=18, 
p<0.05) (Ildiko Kemenes). 
4.4. Long Term Memory Formation Induces Timed Changes in 
the Expression of Lym-antiNOS2 NAT 
LTM formation following reward conditioning of feeding behaviour in 
Lymnaea requires the NO-cGMP signalling pathway (Kemenes et al., 2002). 
This requirement is restricted to a window of time lasting about 5 hours 
following a single pairing of sucrose (US) with amyl acetate (CS). It was found 
that Lym-antiNOS1 is significantly down-regulated at 4 hours after 
conditioning. This is an example of a pseudogene whose expression is regulated 
by a behavioural stimulus. Interestingly, Lym-NOS1 RNA also exhibited 
training-evoked changes of expression, being transiently up-regulated at 6 
hours after training, 2 hours after the down-regulation of Lym-antiNOS1 
(Korneev and O'Shea, 2007).  
In light of the hypothetical role of Lym-antiNOS2 in the regulation of NOS 
expression in the CNS and its possible role in the formation of the 
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truncated-NOS Lym-antiNOS2 protein, it was important to investigate whether 
this NO-dependent memory formation is associated with specific changes in the 
expression of Lym-antiNOS2 NAT. 
The results of the qRT-PCR experiments on the expression of Lym-antiNOS2 
NAT show that the Lym-antiNOS2 gene was significantly down-regulated at 
four hours after training (Figure 4.6 and Table 4.3), followed by up-regulation at 
six hours after training. Within-groups analysis demonstrates that responses to 
the training on the paired group were statistically significant. T-test performed 
between paired groups versus unpaired and naïve group shows no difference 
between groups of the levels of expression of Lym-antiNOS2 at 10 minutes and 1 
hour after training. Results of the statistical analysis are summarised in Table 
4.2. 
The dynamic sensitivity of Lym-antiNOS2 expression to a very weak sensory 
cue (single pairing of US and CS) is remarkable. The analysis of the temporal 
dynamics of the post-training expression of the Lym-antiNOS2 NAT in the 
whole brain by real-time PCR shows that the Lym-antiNOS2 gene was down-
regulated at 4 hours and up-regulated at 6 hours after training. These dynamics 
for Lym-antiNOS2 gene are noteworthy, and provide another example of a 
pseudogene whose expression is regulated by a behavioural stimulus, as with 
the Lym-antiNOS1 gene, whose expression is down-regulated at 4 hours after 
training but shows no changes at 6 hours or 24 hours (Korneev et al., 2005).  
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Dr Korneev has shown that Lym-NOS1 was transiently up-regulated at 6 
hours and Lym-antiNOS1 was down-regulated at 4 hours after training 
(Korneev et al., 2005). It is possible to hypothesise that the decrease in the 
amount of Lym-antiNOS1 and Lym-antiNOS2 NAT at four hours could lead to 
the increase in the amount of Lym-NOS1 mRNA molecules available for 
translation. After its up-regulation at 6 hours, Lym-antiNOS2 NAT could be 
acting as a suppressor of NOS through the formation of a non-functional 
heterodimer, where NOS1 is not required anymore for LTM formation. It is still 
necessary to prove that translation of Lym-antiNOS2 RNA into protein does 
occur in vivo. Lym-antiNOS2 RNA was confirmed to translate into a protein via 
in vitro translation experiments (Korneev and O'Shea, 2002).    
  Paired-Unpaired Paired-Naïve 
10 minutes p=0.6 p=0.8 
1 hour p=0.5 p=0.2 
4 hours p<0.0005 p<0.03 
6 hours p<0.01 p<0.005 
Table 4.2 Statistical analysis of Lym-antiNOS2 expression in Lymnaea CNS after one-trial reward 
conditioning.   
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Figure 4.6 Training-induced regulation of Lym-antiNOS2 NAT in Lymnaea CNS. Real-time PCR 
analysis of the Lym-antiNOS2 NAT expression in CNS. Levels of Lym-antiNOS2 in 10min group 
(blue bar), 1Hr (red bar), 4Hr (green bar), 6Hr (purple bar), unpaired control (UP) (turquoise 
bar) and naïve group (orange bar) normalised to an endogenous reference (β-tubulin) and 
relative to a calibrator (CAL) was calculated as 2-∆∆Ct=∆Ct- ∆Ct(cal). ∆Ct and ∆Ct(cal) are the 
differences in threshold cycles for target (Lym-antiNOS2) and reference (β-tubulin) measured in 
the samples and in the calibrator, respectively. The bars show the mean value of eight samples ± 
standard deviation of the quotient. Results show a down-regulation of Lym-antiNOS2 at 4 hours 
after training and up-regulation at 6 hours after training. The single asterisk at the 4Hr group 
indicates a statistically significant difference from control p = 0.0005. The double asterisk in the 
6Hr conditioned group indicates a statistically significant difference from the control p =0.01.  
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10min 1Hr 4Hr 6Hr UP Naive 
antiNOS2 ∆Ct 24.79 24.88 24.96 24.42 24.08 24.22 
(+/-) 0.58 0.54 0.49 0.60 0.46 0.58 
βtub ∆Ct 18.12 18.54 17.92 18.95 17.88 17.69 
(+/-) 0.79 0.76 0.52 0.51 0.45 0.79 
∆CT antiNOS2- βtub 6.66 6.33 7.04 5.48 6.20 6.54 
(+/-) 0.98 0.93 0.71 0.79 0.64 0.98 
∆∆Ct 1.13 0.80 1.51 -0.06 0.66 1.00 
(+/-) 0.98 0.93 0.71 0.79 0.64 0.98 
Relative 0.46 0.58 0.35 1.04 0.63 0.50 
- 0.23 0.27 0.14 0.44 0.23 0.25 
+ 0.45 0.52 0.23 0.76 0.36 0.49 
Table 4.3 Relative quantification of Lym-antiNOS2 NAT using comparative (∆∆Ct ) method in its 
products by Real-Time PCR. 
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4.5. Single Conditioning Trial Induces Changes in the 
Expression of Lym-antiNOS2 RNA Differently Depending on 
the Ganglia 
From the in situ hybridisation experiment (Section 3.3) we know that 
Lym-antiNOS2 gene is expressed mainly at cerebral ganglia and buccal ganglia, 
and from the real-time PCR experiment we can see that the levels of expression 
of Lym-antiNOS2 gene change over time following reward conditioning of the 
feeding behaviour. Given that the patterns of spatial expression of 
Lym-antiNOS2 gene differ in cerebral and buccal ganglia (widely expressed in 
buccal ganglia but localized in cerebral ganglia), it is expected that the patterns 
of expression of Lym-antiNOS2 gene over time are also different across these 
two ganglia as revealed by in situ hybridisation. 
To address this question, intact animals were subjected to one-trial classical 
conditioning, as described in Section 2.3, dissecting the buccal ganglia and 
cerebral ganglia from the snails‟ CNS. 
Given the magnitude of the whole training experiment and the number of 
animals required for it, the dynamics of expression of Lym-antiNOS2 in post-
training buccal ganglia and cerebral ganglia was analysed by real-time PCR 
only at 1 hour and 6 hours after training. Results show a remarkable difference 
of the expression levels of Lym-antiNOS2 over time between buccal and cerebral 
ganglia after single trial classical conditioning. In the buccal ganglia (Figure 4.7 
and Table 4.4), within-groups analysis shows levels of Lym-antiNOS2 of the 
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buccal ganglia to the training on the paired group (1 hour and 6 hours) were 
statistically different to the unpaired group, and point to a negative transient 
regulation of the expression of Lym-antiNOS2.  The levels of Lym-antiNOS2 
NAT decrease after training and remain low (no fluctuation) over time after the 
training at those two time points (p<0.003). In cerebral ganglia (Figure 4.8 and 
Table 4.5), within-group analysis shows a statistically significant difference in 
the response of the paired group to training between 1 hours and 6 hours 
(p<0.03). The expression of Lym-antiNOS2 in cerebral ganglia would seem to 
follow the same temporal pattern as that shown in Figure 4.6 for the whole 
brain after training. 
The results of this experiment and those of the in situ hybridisation give 
strong support to the hypothesis that Lym-antiNOS2 participates in the 
regulation of nNOS expression in the CNS. 
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Figure 4.7 Training-induced regulation of Lym-antiNOS2 NAT in Lymnaea buccal ganglia. Real-
time PCR analysis of the Lym-antiNOS2 NAT expression in buccal ganglia. Level of Lym-
antiNOS2 in 1Hr (blue bar), 6Hr (red bar), unpaired control (UP) (green bar) normalised to an 
endogenous reference (β-tubulin) and relative to a calibrator (CAL) was calculated as 2-
∆∆Ct=∆Ct- ∆Ct(cal). ∆Ct and ∆Ct(cal) are the differences in threshold cycles for target 
(Lym-antiNOS2) and reference (β-tubulin) measured in the samples and in the calibrator, 
respectively. The bars show the mean value of eight samples ± standard deviation of the 
quotient. Note that there is a down-regulation of Lym-antiNOS2 at 1 hour after training and at 6 
hours after training. The single asterisk at 1 hours group (blue bar) indicates a significant 
difference from control p<0.003. The double asterisk in the 6 hours conditioned group (red bar) 
indicates a significant difference from the control p =0.003. 
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1Hr 6Hr UP 
antiNOS2 Ct 31.34 31.17 30.48 
(+/-) 0.94 1.14 0.64 
Btub Ct 24.50 24.33 24.96 
(+/-) 0.98 0.62 0.90 
∆CT antiNOS2-Btub 6.84 6.84 5.52 
(+/-) 1.35 1.30 1.10 
∆∆Ct 1.28 1.28 -0.03 
(+/-) 1.35 1.30 1.10 
Relative 0.41 0.41 1.02 
- 0.25 0.24 0.55 
+ 0.64 0.60 1.17 
 
Table 4.4 Relative quantification of Lym-antiNOS2 NAT using comparative (∆∆Ct ) method in its 
products by real-time PCR. 
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Figure 4.8 Training-induced regulation of Lym-antiNOS2 NAT in Lymnaea cerebral ganglia. 
Real-time PCR analysis of the Lym-antiNOS2 NAT expression in cerebral ganglia. Level of Lym-
antiNOS2 in 1Hr (blue bar), 6Hr (red bar), unpaired control (UP) (green bar) normalised to an 
endogenous reference (β-tubulin) and relative to a calibrator (CAL) was calculated as 2-
∆∆Ct=∆Ct- ∆Ct(cal). ∆Ct and ∆Ct(cal) are the differences in threshold cycles for target 
(Lym-antiNOS2) and reference (β-tubulin) measured in the samples and in the calibrator, 
respectively. The bars show the mean value of eight samples ± standard deviation of the 
quotient. Note that there is a down-regulation of Lym-antiNOS2 at 1 hour after training and up-
regulated at 6 hours after training. The single asterisk at 6 hours group (red bar) indicates a 
significant difference from 1hr to 6hr p<0.03.  
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  1Hr 6Hr UP 
Lym-antiNOS2 Ct 26.53 27.00 26.66 
(+/-) 0.69 0.83 0.76 
βtub Ct 19.76 20.94 20.22 
(+/-) 0.61 0.71 0.68 
∆CT Lym-antiNOS2 - βtub 6.77 6.06 6.44 
(+/-) 0.92 1.09 1.02 
∆∆Ct 1.16 0.45 0.83 
(+/-) 0.92 1.09 1.02 
Relative 0.45 0.73 0.56 
- 0.21 0.39 0.29 
+ 0.40 0.83 0.58 
Table 4.5 Relative quantification of Lym-antiNOS2 NAT using comparative (∆∆Ct) method in its 
products by real-time PCR. 
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4.6. Single Conditioning Trial Changes the Levels of Expression 
of Lym-NOS1 mRNA in Lymnaea Brain 
In order to form a better understanding of the requirements of the NO-cGMP 
signalling pathway during long-term memory formation following reward 
conditioning of feeding behaviour, and in light of the proposed role of Lym-
antiNOS2 gene in the regulation of NOS expression in the CNS, it was 
important therefore to investigate whether this NO-dependent memory 
formation is associated with specific changes in the expression of Lym-NOS1 
(NOS1).  
A late up-regulation of the expression of Lym-NOS1 at 6 hours after single 
trial feeding reward conditioning has been demonstrated (Korneev et al., 2005), 
but times earlier than 4 hours were not examined in this study. In order to 
compare the Lym-NOS1 mRNA and Lym-antiNOS2 RNA levels at this earlier 
period, Dr Natasha Pouchkina-Stantcheva performed real-time PCR at 10 
minutes, 1 hour, 4 hours and 6 hours after single training reward conditioning 
on Lymnaea CNS samples.  
I conducted an independent analysis of the raw data collected from that 
experiment. Results (Figure 4.9 and Table 4.6) show that the expression of 
Lym-NOS1 fluctuates over time after single trial classical conditioning. Within-
groups analysis demonstrated that responses to training on the paired group 
were statistically significant. T-test performed between paired groups versus 
unpaired and naïve groups show a significant increase in the expression of 
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Lym-NOS1 at 1 hour and 6 hours after training (1hour vs. UP: p < 0.002; 4 hours 
vs. UP: p < 0.003).  
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Figure 4.9 Training-induced regulation of Lym-NOS1 mRNA in Lymnaea CNS. Real-time PCR 
analysis of the Lym-NOS1 mRNA expression in CNS. Levels of Lym-NOS1 in 10min group (blue 
bar), 1Hr (red bar), 4Hr (green bar), 6Hr (purple bar), unpaired control (UP) (turquoise bar) and 
naïve group (orange bar) normalised to an endogenous reference (β-tubulin) and relative to a 
calibrator (CAL) were calculated as 2-∆∆Ct=∆Ct- ∆Ct(cal). ∆Ct and ∆Ct(cal) are the differences in 
threshold cycles for target (Lym-NOS1) and reference (β-tubulin) measured in the samples and 
in the calibrator, respectively. The bars show the mean value of eight samples ± standard 
deviation of the quotient. Results show an up-regulation of Lym-NOS1 at 1 hour and at 6 hours 
after training. The single asterisk at 1 hour group (red bar) indicates a significant difference 
from control UP p = 0.002. The double asterisk in the 6 hours conditioned group (purple bar) 
indicates a significant difference from the control p =0.003. 
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  10min 1Hr 4Hr 6Hr UP Naive 
NOS1 ∆Ct 25.76 24.43 25.48 25.83 26.17 25.40 
(+/-) 0.40 0.42 0.41 0.53 0.38 0.51 
βtub ∆Ct 17.84 17.74 17.43 18.97 18.22 17.71 
(+/-) 0.52 0.42 0.47 0.49 0.44 0.31 
∆Ct NOS1-βtub 7.92 6.68 8.05 6.86 7.95 7.69 
(+/-) 0.66 0.59 0.62 0.72 0.58 0.60 
∆∆Ct 1.23 0.00 1.36 0.17 1.26 1.00 
(+/-) 0.66 0.59 0.62 0.72 0.58 0.60 
Relative 0.42 1.00 0.39 0.89 0.42 0.50 
- 0.16 0.34 0.14 0.35 0.14 0.17 
+ 0.25 0.51 0.21 0.58 0.21 0.26 
Table 4.6 Relative quantification of Lym-NOS1 NAT using comparative (∆∆Ct) method in its 
products by real-time PCR 
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4.7. Discussion 
Significant progress has been made in our understanding of the complex 
machinery involved in the regulation of LTM formation and the role of the 
molecular pathway of NO-cGMP signalling. Moreover it is clear that the 
regulation of NO signalling is very complex and it occurs at various levels. It 
can be mediated via unconventional mechanisms. In memory formation NATs 
represent a complex addition to the molecular mechanisms controlling gene 
expression. 
This studies reveal that Lym-antiNOS2 NAT is likely to play a role in the 
regulation of NO signalling. We have found that the Lym-antiNOS2 gene is 
down-regulated at four hours and up-regulated at six hours after training. 
Moreover, these changes in expression occur in response to a very weak 
sensory cue (single pairing of US and CS), and their patterns –both spatial and 
temporal– vary across different ganglia. 
During LTM formation the concentration of Ca2+ increases with transmitter 
release. 5-HT causes a big increase in cAMP levels, resulting in the translocation 
of PKA and MAPK into the nucleus. However, it is not clear that this process is 
sufficient for LTM to be formed. Many studies have increasingly shown the 
importance of NO during LTM formation (Harooni et al., 2009; Juch et al., 2009; 
Ribeiro et al., 2008). In this chapter I focus on the possible role that Lym-NOS1, 
Lym-antiNOS1 and Lym-antiNOS2 may have during the formation of LTM.  
131 
 
It is interesting to note that the temporal patterns of regulation of Lym-NOS1, 
Lym-antiNOS1 and Lym-antiNOS2 are all different: Lym-NOS1 up-regulates at 1 
and 6 hours, and is down-regulated at 4 hours (Figure 4.9); Lym-antiNOS1 is 
down-regulated at 4 hours (Korneev et al., 2005); Lym-antiNOS2 is down-
regulated at 4 hours and up-regulated at 6 hours (Figure 4.6). This demonstrates 
that their expression is not associated with a common promoter, even if they 
belong to the same cluster. 
It is also worth noting that the second peak of Lym-NOS1 at six hours after 
training appears to be smaller than its peak at one hour. Our hypothesis is that 
this smaller six-hour peak is a manifestation of a higher Lym-NOS1 peak before 
the five-hour mark, helped by the down-regulation of Lym-antiNOS1 (Figure 
4.10) and Lym-antiNOS2 at four hours. This earlier Lym-NOS1 peak would 
generate the NO necessary at five hours for long-term memory formation. An 
analysis of the level of expression of Lym-NOS1 RNA and Lym-antiNOS2 RNA 
after single conditioning trial at five hours would help confirm or disprove this 
hypothesis. The Lym-antiNOS2 peak at six hours would have the role of down-
regulating Lym-NOS1 after long term memory has been formed, and NO is 
therefore not needed anymore (Figure 4.11). 
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Figure 4.10 Training-induced regulation of Lym-antiNOS1 RNA antiNOS down at 4h post 
training (Korneev et al., 2005) 
 
Figure 4.11 Training-induced regulation of Lym-NOS1 mRNA and Lym-antiNOS2 in Lymnaea 
CNS. Real-time PCR analysis of the LymnNOS1 mRNA and Lym-antiNOS2 expression in CNS. 
Level of Lym-nNOS1 (red bars) and  Lym-antiNOS2 (blue bars) in  10min group, 1Hr, 4Hr, 6Hr, 
unpaired control (UP) and naïve group.  
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Chapter 5: Lym-antiNOS2 NAT is 
Subjected to Peripheral Trafficking   
5.1. Introduction 
It is now generally accepted that in neural cells, certain RNAs are targeted 
towards dendrites and axons by specific RNA trafficking pathways. Recent 
studies in mammals show that a disruption in the 3‟ untranslated region (UTR) 
of CaMKIIα reduces late-phase long-term potentiation and impairs 
memory(Mikl et al., 2010). The knock-out of CaMKII maked the onset for a new 
subfield in neuroscience, in which mouse mutants are used as a tool to gain 
insight into the molecular basis of cognition and brain plasticity. To investigate 
the physiological role of αCaMKII in vivo, several mutants have now been 
generated. With the help of gene targeting, hippocampal area (CA3)-restricted 
null mutants of αCaMKII were created, which demostrated that localization of 
CaMKIIα is indispensable for the establishment of long-term hippocampal-
dependent memories (Elgersma et al., 2004). 
In Lymnaea CNS, the cerebral ganglia and the buccal ganglia are connected 
by axons across the CBCs (cerebral-buccal connective). In the cerebral ganglion, 
the serotonergic giant cells are well known to project directly into the CBCs 
(Weiss and Kupfermann, 1976). This has been identified in in vivo recordings, 
and shown to be active mainly during the appetitive phase of feeding 
(Kupfermann and Weiss, 1982).   
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Some authors have focused on the role of the connections between the 
cerebral and buccal ganglia, both in the transmission descending from the 
cerebral to the buccal ganglia–command and control functions (Xin et al., 2000) 
and ascending in the opposite direction (Chiel et al., 1988; Kuslansky et al., 
1978) showing that the transmission of information occurs in both directions. 
It has been shown with in vivo electrode recording implanted around the 
cerebrobuccal connective that most of the activity travels in the cerebral-to-
buccal direction. This reveals that the CBC impulse traffic (and therefore the 
dialogue between cerebral and buccal ganglia, see Figure 5.1) is activated 
bidirectionally even in the absence of full consummatory behaviour (which also 
involves activation of the neural circuits producing swallowing movements of 
the buccal mass) and food, provided that the cyclic motor pattern is produced 
(Fiore et al., 1992). 
In Chapter 3 the discussion about in situ hybridisation experiments 
suggested the presence of Lym-antiNOS2 RNA in the CBCs. Chapter 4 shows 
how the expression of Lym-antiNOS2 RNA varies during LTM formation. 
Confirmation of trafficking of Lym-antiNOS2 RNA in the CBCs, seen together 
with these results in mammals, would reinforce the hypothesis that 
Lym-antiNOS2 plays an important role in LTM formation in Lymnaea. 
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5.2. In Situ Hybridisation Reveals the Presence of Lym-antiNOS2 
in the Cerebrobuccal Connectives  
We inspected in more detail the slices obtained by in situ hybridisation 
staining against Lym-antiNOS2 NAT, in the experiments described in Section 3.3 
(Figure 5.2). As with Figure 3.8 and Figure 3.10, this inspection shows specific 
staining within the CBCs. The cerebrobuccal connectives show a particularly 
strong staining, and its staining resembles that of granules formed during 
peripheral trafficking of RNA. These suggest that trafficking of Lym-antiNOS2 
NAT occurs as a natural process in the brain of Lymnaea. These findings are 
important as they suggest that Lym-antiNOS2 NAT is subject to peripheral 
trafficking. Moreover, many RNAs that have been found to undergo trafficking 
have been shown to play important roles in cellular processes, trafficking is an 
energy-intensive process involving moving components of the translation 
machinery (Carson and Barbarese, 2005). 
 It has been shown that a key regulatory event in translational regulation is 
the movement of the mRNA templates into the axonal compartment (Yoo et al., 
2010). This result suggested to us that Lym-antiNOS2 RNA could be travelling 
along the CBCs from CGCs to buccal ganglia, where it would play a part in the 
regulation of NO synthesis. 
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Figure 5.1 Schematic diagram of anatomical organization of lip and tentacle sensory pathways. 
The lips and tentacles are connected to the cerebral ganglia via the median lip nerve (mln), 
superior lip nerve (sln), and tentacle nerve (tn). The cerebral-buccal connective (cbc) forms the 
only connection between the cerebral and buccal ganglia that contain the feeding CPG. Primary 
chemosensory cells in the lips and tentacles extend direct projections in the lip and tentacle 
nerves that synapse onto sensory integrating neurons (SI) in the cerebral ganglia (for simplicity, 
interactions are shown as direct connections). These neurons affect the feeding CPG in the 
buccal ganglia via the cerebral-buccal connective (Straub et al., 2004)  
 
Figure 5.2 In situ hybridisation showing CBCs with granules containing Lym-antiNOS2. In situ 
hybridisation experiments on adjacent sections through the buccal ganglia showing the stained 
of Lym-antiNOS2 NAT. 
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5.3. RT-PCR Confirms the Presence of Lym-antiNOS2 RNA in 
the CBCs  
Previous work in Aplysia has shown that many neurons that have axons in 
the CBC are part of the circuitry responsible for generating feeding. Moreover, 
it has been found that numerous neurons in the cerebral and buccal ganglia and 
many axons in the cerebrobuccal connective show neuropeptide 
immunoreactivity. This suggests that CBCs may be involved in the CPG for the 
feeding system of Aplysia (Fujisawa et al., 1999). 
To confirm the existence of Lym-antiNOS2 RNA in the cerebrobuccal 
connectives, quantitative real-time PCR was essential, since the RNA 
concentration in the axons of Lymnaea is unknown and potentially very low. 
Real-time PCR allows RNA concentrations that were previously undetectable 
using earlier techniques to be detected. 
For this experiment CNS from Lymnaea was isolated. The brain commissure 
was cut and the brain pinned down to a Sylgard-coated dish containing snail 
saline. The brain was dissected and separated in three tubes containing: a) 
buccal ganglia, b) cerebral ganglia and c) CBCs. 
RNA extraction was performed (Section 2.4) followed by synthesis of cDNA 
(Section 2.9) and quantitative real-time PCR (Section 2.15). Real-time PCR was 
performed using the primers Scorp1 and Scorp2 (Figure 2.2). The concentration 
of Lym-antiNOS2 in each part of the brain was related to the concentration of 
the same RNA in Lymnaea whole CNS. 
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Results in Table 5.1 show in the „Relative‟ column the value of the expression 
of Lym-antiNOS2 in the different parts of the brain, divided by the value of the 
expression of Lym-antiNOS2 in whole brain. These results indicate that the CBC 
samples contain 23.9 times as much Lym-antiNOS2 RNA as the whole-brain 
sample (this is a relative value of the expression of Lym-antiNOS2 to the 
concentration of β-tubulin RNA in the sample, assuming stably expressed in the 
CBCs). Expression levels in buccal ganglia and cerebral ganglia are close to 
those of Lym-antiNOS2 RNA in whole brain. This demonstrates that in a naïve 
snail Lym-antiNOS2 is not only travelling along the CBCs but it is accumulated 
in the CBCs (Figure 5.3 and Table 5.1).  
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Figure 5.3 Peripheral trafficking of Lym-antiNOS2 NAT in Lymnaea CBC. Real-time PCR analysis 
of the Lym-antiNOS2 NAT expression in cerebral ganglia, buccal ganglia and CBCs. Level of 
Lym-antiNOS2 in CBCs (blue bar), buccal ganglia (red bar), cerebra ganglia (green bar) 
normalised to an endogenous reference (β-tubulin) and relative to a calibrator (CAL) were 
calculated as 2-∆∆Ct=∆Ct- ∆Ct(cal). ∆Ct and ∆Ct(cal) are the differences in threshold cycles for target 
(Lym-antiNOS2) and reference (β-tubulin) measured in the samples and in the calibrator, 
respectively. 
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  CBC Buccal Cerebral 
Lym-antiNOS2 Ct 25.18 30.42 26.66 
(+/-) 0.11 0.69 0.76 
βTub Ct 24.20 24.96 20.22 
(+/-) 0.06 0.83 1.52 
∆Ct 0.98 5.47 6.44 
(+/-) 0.13 1.08 1.70 
∆∆Ct= ∆Ctc-∆Ct -4.58 -0.09 0.88 
(+/-) 0.13 1.08 1.70 
Relative 23.90 1.07 0.54 
- 1.99 0.56 0.38 
+ 2.17 1.18 1.22 
Table 5.1 Relative quantification of Lym-antiNOS2 NAT using comparative (∆∆Ct) method in its 
products by real-time PCR. 
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5.4. Analysis of the Sequence of Lym-antiNOS2 Reveals a 
cis-acting Transport Element within the 3‟UTR 
Trafficking in neurons has been studied in recent years. Probably more than 
20 different mammalian mRNAs have been identified including RNA encoding 
neuromodulin, MAP2, CaMKIIα, CREB, β-actin, fragile X mental retardation 
protein (FMRP), protein kinase C(γ) (Palacios and St Johnston, 2001). The nature 
of RNA localization pathways has emerged primarily from studies of Drosophila 
and Xenopus oocytes. The initial steps in the localization process are determined 
by the cis-acting elements within the RNA. This series of signals that are 
usually, but not exclusively, located within the 3‟ UTR direct the binding of 
trans-acting factors to the RNA (Kloc et al., 2002). 
It has been demonstrated that not all the different RNAs use the same 
trafficking element, but several may use closely related elements. Recent studies 
suggest that the molecular mechanisms of RNA targeting in neurons are likely 
to be the same for a wide range of localized neuronal RNAs, and most neuronal 
RNAs are probably transported along microtubules in kinesin/dynein-
containing granules (Hyun et al., 2011).  
Cis-acting elements have been found by sequence comparisons in many 
localized RNAs. Several trans-acting transport elements have also been 
identified. Table 5.2 shows a list of some of the identified cis-acting elements 
and the correspondent trans-acting factor. 
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Subsequent experiments with oligodendrocytes and fibroblasts led to the 
current model (Figure 5.4) in which RNAs that are to be localized team up with 
their transacting factor during, or immediately following, maturation of the 
mRNA in the nucleus. The RNA with its cognate protein is exported to the 
cytoplasm, where they are incorporated into large transport granules. These 
granules, which have been observed in many cell types, contain multiple 
ribosomes and probably many of the molecules needed to translate the 
transported mRNA, including t-RNA synthetases and elongation factors 
(Smith, 2004). 
 
Table 5.2 cis-acting elements and trans-acting factors (Smith, 2004). 
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Figure 5.4 Model for trafficking of A2 response element (A2RE)-containing RNAs. The A2RE, 
which is represented in a different colour from the remainder of the mRNA, binds 
heterogeneous nuclear ribonucleoprotein (hnRNP) A2 or hnRNP A3 (yellow circle), and the 
complex is recruited to transport granules that move along the microtubules (orange unlabeled 
horizontal lines). The granules contain multiple copies of the RNA-protein complex. At its 
destination, the mRNA is anchored and translated. Each of the steps in this process, including 
RNA degradation, is a potential posttranscriptional control point for gene expression (Smith, 
2004). 
After the experiments described in Section 5.2-5.3 a further analysis of the 
Lym-antiNOS2 sequence was necessary to determine which trafficking element 
Lym-antiNOS2 could be using and where it is located in its sequence. This 
analysis reveals the presence of a sequence for a CPE-like element (UUUUAU) 
in the desired direction. Figure 5.4 shows the position of the CPE element 
(inside the nucleus, red circle) at the 3‟ UTR, which is the expected localization 
for this kind of element. As the CPE-like element is recognized by the CPE-
binding protein (CPEB), the Lym-antiNOS2 RNA to which it belongs may be 
recruited to be transported in granules. 
The identification of a cis-acting element in the Lym-antiNOS2 sequence 
completes the work started in Sections 5.2-5.3. Together, the experiments in 
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Sections 5.2 and Section 5.3 establish that Lym-antiNOS2 is subjected to 
peripheral trafficking between cerebral ganglia and buccal ganglia, through the 
CBCs. Furthermore, within cerebral ganglia the expression of Lym-antiNOS2 is 
restricted to a few neurons, and particularly the CGC pair. In view of this, it is 
possible to hypothesise that trafficking of Lym-antiNOS2 actually occurs 
between the CGCs and the buccal ganglia, but more work has to be done to 
confirm this. 
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5.5. Discussion 
Early research suggested that protein synthesis may occur outside the 
neuronal cell body, since it was found that polyribosomes are localized to 
subsynaptic areas of the neuron. It is now clear that the trafficking process 
involves mRNA-binding proteins that are primarily bound to the 3‟-UTR of 
responsive mRNAs. Our data indicates that trafficking of Lym-antiNOS2 occurs 
in Lymnaea. We show that the CPE-like sequence (UUUUAU) is present in 
Lym-antiNOS2, and it is localized in the expected region corresponding to the 
3‟UTR. Moreover, the in situ hybridisation experiments in this chapter reveal 
the presence of Lym-antiNOS2 RNA granules that are typical of trafficking 
processes in the CBCs. The presence of Lym-antiNOS2 RNA in the CBCs was 
then confirmed using quantitative real-time PCR, showing that the 
concentration of Lym-antiNOS2 RNA is nearly thirty times the concentration in 
the cerebral or buccal ganglia. Multiple lines of evidence indicate that targeted 
RNA trafficking coupled with local protein synthesis occur in neurites, such as 
the example of axonal transport and local translation of CREB mRNA in axons 
that is followed by its retrograde transport to the nucleus where it activates 
transcription of pro-survival genes in response to nerve growth factor 
(Andreassi and Riccio, 2009)  
In the case of Lym-antiNOS2 RNA, this thesis has studied the spatial 
regulation of its expression, how this regulation changes and exhibits temporal 
regulation after single conditioning trial, and now how Lym-antiNOS2 RNA 
moves along the CBCs in a complex mechanism where the translation of Lym-
147 
 
antiNOS2 RNA could be regulated by its localization in subsynaptic regions of 
the neuron, possibly between the buccal ganglia and the CGCs in the cerebral 
ganglia. Targeted RNA trafficking depends on the interaction between 
cis-acting elements and trans-acting factors. The Lym-antiNOS2 sequence has a 
CPE-like motif, which suggests that Lym-antiNOS2 RNA undergoes an active 
peripheral trafficking, although little is known about cis-acting elements and 
trans-acting factors in molluscs. 
The regulation of Lym-antiNOS2 expression in neurons controls not only 
when but where they are going to be expressed, in a very complex way. RNAs 
which undergo such complex regulation are likely to play an important role in 
neuronal function. As an example, work in mammals suggests that most 
transported RNAs appear to be translationally dormant while en route (Kindler 
et al., 2005). mRNAs can be translated in response to an activation signal at their 
destination sites, as in the case of importin β and RanBP1 mRNAs, both of 
which undergo axonal trafficking. Local synthesis of RanBP1 and importin β 
contributes to the formation of a signalling complex that travels from the 
injured axon to the cell body (Yudin et al., 2008). 
This thesis presents the first report suggesting trafficking of RNA in 
molluscs. Importantly, the trafficking process identified, involving CPEB, has 
also been reported previously in mammals. This would point to a highly-
conserved process during evolution. Many molecular mechanisms are involved 
in the local control of translation. In eukaryotes, the entwined pathways of 
RNA transport and local translational regulation are key determinants in the 
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spatio-temporal articulation of gene expression. One of the main advantages of 
this mechanism over transcriptional control in the nucleus lies in the fact that it 
endows local sites with independent decision-making authority, a consideration 
that is of particular relevance in cells with complex cellular architecture such as 
neurons (Kindler et al., 2005). The complex mechanisms underlying such 
signalling are only now beginning to be addressed by scientists. 
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Chapter 6: Sequence Analysis of 
Mm-antiNOS1 RNA and 
Characterization of the Expression 
during Brain Development 
6.1. Introduction 
NO regulates synapse formation and patterning, thus playing a role in 
embryonic and adult neurogenesis and development. Research shows that NO 
is a modulator of axon outgrowth and guidance, synaptic plasticity, neuronal 
precursor proliferation, and neuronal survival. NO-cGMP signalling 
contributes to neural precursors derived from human embryonic stem cells 
(hESC) and enhances the differentiation of precursors toward functional 
neurons (Tao Li et al., 2010).  
Previous work on the molluscan model system Lymnaea stagnalis has shown 
that a transNAT complementary to the NOS-encoding mRNA plays an 
important role in the regulation of the NO signalling pathway in the CNS 
(Korneev and O'Shea, 2002). The initial work on the same model (Chapter 3) 
shows a second trans-NAT that has an open reading frame encoding a 
truncated NOS-homologous protein of 397 amino acids. 
This thesis hypothesised that the truncated homologue encoded by the 
Lym-antiNOS2 gene has a strong suppression effect on Lym-NOS1 enzymatic 
activity. The experiments carried out in Chapter 3 and Chapter 4 give strong 
150 
 
support to this hypothesis. Moreover, a similar organization of a locus in the 
human genome has been discovered, which also evolved by gene duplication 
followed by an internal DNA inversion and is reminiscent of our findings in 
Lymnaea. This human locus is transcribed into a noncoding RNA containing a 
region of significant complementary to NOS2A mRNA. These two RNAs 
exhibit concurrent reciprocal changes in undifferentiated human embryonic 
stem cells and in hESCs induced to differentiate into neurogenic precursors. 
The results suggest that anti-NOS2A is involved in the regulation of neuronal 
differentiation through the modulation of the NOS2A gene (Korneev et al., 
2008). Other cases of regulation of NOS via natural antisense transcript have 
been reported in mammals, where eNOS expression can be regulated by an 
overlapping cis-antisense transcript by a hypoxia stimulus (Robb et al., 2004).  
These results point to the regulation of NO via the regulation of the 
expression of NOS through a NOS-related NAT as a highly-conserved process. 
To explore further this hypothesis where NOS expression can be regulated by 
an overlapping NAT, Dr Korneev explored using computational analysis a 
database of all known mice cDNA sequences. A NOS-related pseudogene was 
found whose full-insert sequence exhibits significant sequence similarity to 
NOS-encoding mRNAs (GenBank accession number AK146140). This NOS-
related pseudogene was identified in the database as a previously-unclassified 
RNA. We named this RNA Mm-antiNOS1 RNA, as its sequence was shown to 
be related to that of NOS1. 
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In this chapter the Mm-antiNOS1 sequence is first analysed. Then, the 
possibility of Mm-antiNOS1 expressing in the brain on Mus musculus embryos 
and adults is studied, along with its regulation during neuronal differentiation 
in embryonic brain. 
Results discussed in Section 1.6 show that NOS1 is expressed in rat between 
E13 and E20 of the gestation period. This would suggest that NO production in 
rodents is of particular importance during late stages of gestation. If Mm-
antiNOS1 were to have a role in the regulation of NO production, it is likely that 
its expression would be confined to this late gestation period. 
The transcriptional status of Mm-antiNOS1 was investigated using RT-PCR 
analysis of RNA extracted from embryonic brains at different stages of 
development (10 days, 14 days and 18.5 days), using primers against 
Mm-antiNOS1 cis-NAT. Once confirmed that Mm-antiNOS1 is expressed in mice 
CNS, quantitative RT-PCR experiments were conducted to evaluate the level of 
expression of Mm-antiNOS1 at different stages of embryonic development, and 
in newborn and adult mice. 
6.2. Sequence Analysis of Mm-antiNOS1 RNA 
Alignment between NOS1 mRNA and Mm-antiNOS1 RNA   The homologies 
to NOS were thoroughly examined using Geneious software (Geneious Pro™ 
5.4, http://www.geneious.com/).  
Figure 6.1 shows the sequence comparison between NOS1 mRNA and 
Mm-antiNOS1 RNA. Two important observations can be made from these 
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results. First, the Mm-antiNOS1 RNA is 1308bp long, which is significantly 
shorter than NOS1 mRNA (4388bp). Second, the region of complementarity to 
the NOS-encoding transcript is restricted to exons 20 and 21. The sequence was 
found to have a polyadenylation signal and polyA tail. 
Mm-antiNOS1 is a novel NOS-related transcript containing a large region 
(~300bp) which is identical to a region within NOS1 mRNA (more than 96%of 
antisense identity). NOS-encoding cis-transcripts that affect the regulation of 
NO production have also been found in other mammals. Such is the case of 
eNOS in human, where the regions of homology between eNOS (NOS3) and its 
cis-NAT are oriented in a tail-to-tail configuration, and the mRNAs encoding 
antisense transcript and eNOS are complementary for 662bp (Robb et al., 2004). 
The trans-NAT antiNOS2A affects the regulation of NOS2A in humans(Korneev 
et al., 2008). In Lymnaea, Lym-antiNOS1 and Lym-antiNOS2 affect the regulation 
of nNOS. In both cases (NOS2A and nNOS and their transcripts), the regions of 
homology are shorter (~100bp) and with a lower homology (~70%). 
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Sequence alignment between Mm-antiNOS1 RNA and NOS1 mRNA (Figure 
6.2) reveals 97% of antisense identity between nucleotides 345-442 of 
Mm-antiNOS1 RNA and exon 21 of NOS1 mRNA, and 95% antisense identity 
between nucleotides 443-630 of Mm-antiNOS1 RNA and exon 20 of nNOS1 
mRNA. The antisense identity is located at the centre of the Mm-antiNOS1 RNA 
sequence (full-overlap, Figure 1.10). The transcription of the opposite DNA 
strand from NOS1 gene introduced new instructions for the termination and 
initiation of transcription, and changes in the splicing of the RNA. As a result, 
Mm-antiNOS1 does not contain an open reading frame.  
It has been shown that as much as 20% of human transcription clusters might 
form sense-antisense pairs (Chen et al., 2004). However, when the length of the 
overlapping region is <600bp, 24.5% of cis-NATs in a full-overlap manner show 
high expression (Osato et al., 2007). Mm-antiNOS1 as a fully-overlapping 
cis-NAT with <<600bp overlap with NOS1 mRNA, and is therefore likely to be 
highly expressed. Moreover, sense-antisense transcripts pairs have a 
significantly higher probability of involvement in the regulation of translational 
activity. In the case of Mm-antiNOS1 cis-NAT, the hypothesis is that this 
antisense homology could trigger the degradation of functional nNOS1 RNA 
via the formation of an RNA–RNA duplex, resulting in a negative regulation of 
nNOS expression that would effectively be controlling the production of NO.  
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Figure 6.2 Sequence alignment between NOS1 mRNA and Mm-antiNOS1 RNA. An identical 
sequence in opposite direction is shown between bases 345 and 622 for Mm-antiNOS1 
(AK146140) on the second line and bases 3,119 and 3,388 of NOS1 (NM_008712) in the third line. 
A 97% of identity in approximately 300bp is shown between sequences.   
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Alignment between NOS1 gene and Mm-antiNOS1 RNA  Figure 6.3 and 
Figure 6.4 show how the organization of exon/intron is affected by the fact that 
they are transcribed in opposite directions. A clear example of this is the 
presence of the NOS1 intron 19 in the Mm-antiNOS1 RNA sequence. It is 
important to have in mind that this is a comparison between an RNA sequence 
and its related gene sequence. A detailed description of the alignment between 
Mm-antiNOS1 RNA and NOS1 gene is shown in Table 6.1, indicating that 
Mm-antiNOS1 RNA has an identical sequence to that of the NOS1 gene over the 
fragments detailed in Figure 6.5. 
 
Figure 6.3 Schematic representation of Mm-antiNOS1 illustrating the deduced intron/exon 
structure. 
Figure 6.4 provides an alignment comparison between the sequences of 
Mm-antiNOS1 RNA and NOS1 gene. This analysis reveals that both sequences 
are fully homologous, as opposed to the cases of trans-NATs whose NATs are 
transcribed from areas originated from inversions within gene duplication. The 
average sequence homology between the Mm-antiNOS1 RNA and the 
corresponding region of the NOS1 gene is almost identical, at about 96%. 
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Mm-antiNOS1 RNA NOS1 gene Identity 
1bp - 55bp 72,391bp - 72,323bp 
intron 21 
96% 
55bp - 160bp 71,778bp - 71,873bp 95% 
160bp - 305bp 71,391bp - 71,546bp intron 21 98% 
305bp - 430bp 71,078bp - 71,219bp exon 21 97% 
430bp - 1301bp 68,601bp - 69,473bp intron 19/exon 20 96% 
Table 6.1 Areas of antisense homology between Mm-antiNOS1 RNA and NOS1 gene.  
Figure 6.4 and Figure 6.5 show the comparison between the NOS1 gene and 
Mm-antiNOS1 RNA. It is possible to observe that Mm-antiNOS1 has a full match 
with the NOS1 gene with full identity. Because they are almost identical, we can 
assert that Mm-antiNOS1 is produced from the opposite direction of the very 
same NOS1 genomic locus, leaving no doubt that Mm-antiNOS1 belongs to the 
family of cis-NATs. This change of the strand from which the genomic sequence 
transcribes the RNA affects the exon/intron organization significantly (Figure 
6.3). Figure 6.6 shows that NOS1 is located in mouse chromosome 5 in the 
region between 118,304,123 and 118,416,825 base pairs. 
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6.3. Mm-antiNOS1 NAT is Detected in Embryonic and Adult 
Brain of Mice 
Gene-specific primers for RT-PCR were designed by Dr Sergei Korneev using 
the Mm-antiNOS1 sequences described in Figure 6.1. The primers are 
superimposed over the Mm-antiNOS1 sequence in the figure. The sequences for 
these primers are: 
Forward Mm-antiN6: 5‟-AAAACACCCTTGTTACCACAC-3‟  
Reverse Mm-antiN7: 5‟-AGCTCTTGTCCGTACCAC-3‟ 
The expression of Mm-antiNOS1 was analysed during the development of 
the mouse brain on embryonic days E10, E14 and E18.5. Results from the RT-
PCR experiments are shown in Figure 6.7. An amplicon of 110bp was of the 
expected size from the amplification of pair primers Mm-antiN6/7. Expression 
of Mm-antiNOS1 was first seen on E14, demonstrated by a band near the 100bp 
range at lane 3. The same band is visualised at a higher intensity at E18.5 (lane 
5), suggesting that at E18.5 the expression of Mm-antiNOS1 is up-regulated.  
The absence of bands in the RT- controls (lanes 4 and 6) validate our hypothesis 
that Mm-antiNOS1 is indeed transcribed at those stages of mice embryonic 
brain development. No bands were detected at E10 embryonic development, 
and the integrity of the RNA sample was confirmed by the ability of the RNA 
sample to amplify a reference gene in later RT-PCR reactions. A control step of 
cloning and sequencing of the PCR product contained the expected Mm-
antiNOS1 sequence, confirming these results. 
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Figure 6.7 Results of the RT-PCR experiments performed on total RNA extracted from murine 
embryonic brains: 10-day embryo brain (lanes 1, 2), 14-day embryo brain (lanes 3, 4), and 18.5-
day embryo brain (lanes 5, 6). Staining with ethyl bromide reveals bands at around 100bp in 
lanes 3 and 5, and no bands at the respective controls (lanes 4 and 2). 
As discussed in the previous paragraph, Figure 6.7 reveals that the intensity 
of the bands around 100bp in the experiment varies across the different stages 
of embryonic development. If, as in some other NATs, Mm-antiNOS1 were to 
suppress the production of NO, a differential expression of Mm-antiNOS1 over 
the different stages of embryonic development would fit with the hypothesis 
that Mm-antiNOS1 is involved in the process of embryonic brain development. 
6.4. Quantitative Analysis of Mm-antiNOS1 NAT Expression in 
Embryonic CNS 
Real-time RT-PCR was conducted on RNA extracted from 10-day, 14-day 
and 18.5-day embryonic brain, and also on newborn and adult mice. cDNA 
from 14-day embryonic mouse brain was used as a calibrator. 
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Primer Optimization Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
was chosen to be used as a reference gene, because GAPDH is an enzyme that is 
often stably and constitutively expressed at high levels in most tissues and cells. 
During real-time RT-PCR we amplified GAPDH using the following primers: 
Forward MmGAPDH2: 5‟-TGTCTCCTGCGACTTCAAC-3‟ 
Reverse MmGAPDH3: 5‟-AGCCGTATTCATTGTCATACC-3‟ 
As in Section 4.3, real-time RT-PCR assays were optimised to ensure an 
efficient and accurate quantification of the target template. Assays were first 
optimised by evaluating primer concentrations. To do that, four concentrations 
with equimolar amounts of each primer pair were tested: 100nM, 200nM, 
400nM and 600nM. The amount of template added was the same in all the 
samples in the optimization exercise. All the samples were run in duplicate. The 
ideal primer pair should yield the lowest average Ct value, as well as 
presenting a dissociation curve that shows a single product. 
First-strand synthesis of cDNA (Section 2.9) was performed using total RNA 
(provided by Dr Korneev) from all the developmental stages described above. 
Real-time RT-PCR was conducted on these cDNA samples. Each sample was 
run in triplicate along with RT- control and a calibrator. 
Standard-Curve Analysis of Assay Performance Standard-curve analysis was 
performed using a serial dilution of a calibrator sample in order to test the 
efficiency, precision and sensitivity of the real-time RT-PCR reaction. Two-fold 
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dilution series starting with 1:50 diluted cDNA and consisting of four points 
were generated in duplicate. 
To obtain the standard curves, the Ct values of the serial dilution of the 
calibrator sample were plotted for each gene (Figure 6.8). After amplification, 
the Ct‟s for each standard dilution were determined and plotted. The 
amplification of cDNA serial dilution with Mm-antiNOS1 primers generated a 
standard curve with an efficiency of amplification of 99.7%, RSq = 0.985. For the 
cDNA amplification serial dilution with GAPDHs primers the efficiency was 
close to that of the Mm-antiNOS1 primers, at 97.8%, with RSq = 0.987. The 
lowest average Ct values were achieved for 600nM GAPDH and 400nM 
Mm-antiNOS1 concentrations. 
The amplification of the reference gene generated a single product with a 
melting temperature of 81°C (Figure 6.8A). Calibrator cDNA amplified with the 
Mm-antiNOS1 primer pair yielded a single product (Figure 6.8B) at a melting 
temperature of 81°C. The no-template control for both genes did not record any 
amplification. 
The reactions in the real-time RT-PCR amplification generated products that 
agree with those expected. After cloning and sequencing, the sequences 
obtained confirmed the identity of the fragments as Mm-antiNOS1. 
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Figure 6.8 Dissociation curves of the real-time amplification of Mm-antiNOS1 (a) and GAPDH 
(b). In the next page, standard curves generated from Mm-antiNOS1 amplification data (c) and 
GAPDH amplification data (d).  
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Figure 6.8 (cont.)   
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Differential Regulation of Mm-antiNOS1 During Embryonic Brain 
Development  It has been proven that NOS1 is expressed during embryonic 
brain development (see Section 1.6), and its expression decreases at the end of 
the gestation period. In the previous section the expression of Mm-antiNOS1 
was identified in embryonic brain at different stages of development. This lead 
to the hypothesis that Mm-antiNOS1 RNA expression may contribute to neuron 
maturation in each period, by regulating the production of NO through the 
regulation of NOS1 gene expression –a crucial function in the basic 
development of brain function in mammals. 
To validate this hypothesis, we investigated quantitative changes in the 
expression levels of Mm-antiNOS1 RNA by means of real-time RT-PCR in 
embryonic brain taken at different stages of development (10 days, 14 days, 18.5 
days), newborn and adult brains. 
These quantitative experiments led to the following important results. First, 
it was found that the expression level of the Mm-antiNOS1 RNA in 10-day old 
embryonic brain is extremely low, but by day 14 it increases by more that 
twelve times, and continues to increase until day 18.5 (just before birth). It is 
interesting to note that the level of expression has its peak at 18.5 days of 
gestation (full gestation of 18-20 days), at thirteen times higher than the level of 
expression at fourteen days. However, in brains from newborn mice the level of 
expression of Mm-antiNOS1 was found to be three times lower than the one 
measured just before birth, and even lower in adults where its level of 
expression decreases to half of the level of a newborn (Table 6.2 and Figure 6.9). 
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From these results we can conclude that brain development in mouse 
embryos is associated with up-regulation of Mm-antiNOS1 cis-NAT. An 
involvement of Mm-antiNOS1 RNA in neuronal differentiation is suggested. 
Because Mm-antiNOS1 is up-regulates at the time when NOS1 is down-
regulated. Also it has been suggested that NAT with homology superior to 80% 
have a high probability to form dsRNA. In this case Mm-antiNOS1 is practically 
identical to NOS1 sequence in the opposite direction. Therefore, it can be 
predicted that Mm-antiNOS1 will form dsRNA. This information suggests that 
Mm-antiNOS1 may be involved in the down-regulation of the expression of 
NOS1. This in turn leads to the hypothesis that Mm-antiNOS1 RNA expression 
may contribute to neuron maturation during brain development via the 
regulation of NOS1 gene expression in mammals. Further research needs to be 
conducted to confirm this. An important future step would be to quantify the 
expression of NOS1 in mouse at the same developmental stages than those used 
on Mm-antiNOS1 RNA, in order to better understand the interplay in their 
levels of expression.  
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Figure 6.9 Development-induced regulation of Mm-antiNOS1 RNA in mice CNS. Real-time PCR 
analysis of the Mm-antiNOS1 RNA expression in CNS of mice embryo. Level of Mm-antiNOS1 
in 10 days (blue bar), 14 days (red bar), 18.5 days (green bar), newborn (purple bar) and adult 
(turquoise bar) normalised to an endogenous reference (GAPDH) and relative to a calibrator 
(CAL) was calculated as 2 - ∆∆Ct = ∆Ct - ∆Ct(cal). ∆Ct and ∆Ct(cal) are the differences in threshold 
cycles for target (Mm-antiNOS1) and reference (GAPDH) measured in the samples and in the 
calibrator, respectively. The bars show the mean value of eight samples ± standard deviation of 
the quotient. Note that there is an up-regulation of Mm-antiNOS1 at 18.5 days and the 
expression decrease after born.  
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  10 days 14 days 18.5 days Newborn Adult 
Mm-antiNOS1 Ct 32.34 29.24 24.56 25.53 28.51 
(+/-) 0.65 0.94 1.17 0.56 0.19 
GAPDH Ct 13.62 14.12 13.20 12.63 14.60 
(+/-) 0.43 0.30 0.34 0.43 0.29 
∆Ct 18.72 15.12 11.36 12.90 13.90 
(+/-) 0.77 0.98 1.21 0.70 0.34 
∆∆Ct= ∆Ct(cal) - ∆Ct 9.96 6.35 2.60 4.14 5.14 
(+/-) 0.77 0.98 1.21 0.70 0.34 
Relative 0.0010 0.0122 0.1655 0.0569 0.0284 
- 0.0004 0.0061 0.0944 0.0220 0.0061 
+ 0.0007 0.0120 0.2200 0.0359 0.0077 
Table 6.2 Relative quantification of Mm-antiNOS1 NAT using comparative (∆∆Ct) method in its 
products by real-time PCR. 
6.5. Discussion 
This chapter reports the discovery of a novel cis-NAT Mm-antiNOS1 
transcribed from the murine genome. It is demonstrated that Mm-antiNOS1 
transcript is produced from the same locus as their sense counterpart NOS1, 
and is transcribed into a non-coding NOS-related cis-NAT which has the 
potential ability to act as a negative regulator of NOS gene expression. 
Importantly, Mm-antiNOS1 RNA exhibits high sequence identity to NOS1 
mRNA exons 20 and 21 (full identity; no isoforms containing splicing of exons 
20/21 have been found in the literature). 
Other non-coding NOS-related NATs have been shown to be involved in the 
regulation of NO through the regulation of NOS expression, such as the case of 
eNOS-related NAT regulated by hypoxia.  In NOS3 regulation it has been 
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shown that the expression of NOS3 can be regulated by an overlapping cis-
antisense transcript in a stimulus-dependent fashion. This provides evidence of 
sense/antisense interactions.  
It has also been demonstrated in Lymnaea that during LTM formation, the 
expression of anti-NOS1 and Lym-antiNOS2 trans-NAT is regulated by single-
trial appetite conditioning. Another case has been found in humans, where 
antiNOS2A trans-NAT expression is regulated during neurogenesis(Korneev et 
al., 2008) 
A higher identity of 80% should result in a higher probability of 
Mm-antiNOS1 and nNOS1 forming an RNA-RNA duplex. We show that 
Mm-antiNOS1 and nNOS1 are identical (more than 97%), which would give a 
high probability of this event to occur.  Also the length of homology region 
would bring extra stability to the RNA-RNA duplex formed, which should help 
avoid unwanted translation of the RNA-RNA duplex in those cases where this 
duplex is recruited by the translation machinery before it‟s degraded. 
Neurogenesis in the mammalian brain has been associated with the 
upregulation of NOS2 gene expression (Corsani et al., 2008; Zhu et al., 2003). It 
has also been shown that NO levels derived from NOS1 and NOS2 at an early 
age constitute a major factor of risk for sleep and/or memory impairments in 
mice (Colas et al., 2006). Importantly, it has been shown that NOS1 is expressed 
during embryonic brain development, and its expression decreases at the end of 
the gestation period (see Section 1.6). These findings are in line with the 
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discoveries in this thesis through real-time RT-PCR on murine embryonic 
brains, where an increase in the levels of expression of Mm-antiNOS1 RNA 
closely before birth is demonstrated. 
A very exciting outcome of these quantitative studies is how the level of 
expression of Mm-antiNOS1 is upregulated during development. Of particular 
interest is the extremely large and sudden change in the expression levels of 
Mm-antiNOS1 in the embryo from day 18.5 (just hours before birth) and the 
newborn (hours after being born), where the expression of Mm-antiNOS1 drops 
to about a third of its previous value. Such a change may be related to the 
mechanisms of neuronal plasticity. When seen together, the results of NOS1 
and Mm-antiNOS1 expression would imply that brain development in embryos 
is associated with up-regulation of Mm-antiNOS1 cis-NAT and the down-
regulation of NOS1 just before birth. The results suggest that the down-
regulation of NOS1 could be directly related with up-regulation of 
Mm-antiNOS1.  
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Chapter 7: General Discussion and 
Future Work 
7.1. Introduction 
It has been described that more than 20% of the genes on the human 
transcription clusters might form sense-antisense pairs. This figure is higher 
than previously thought. It has also been predicted that 15% of mouse genes 
form sense-antisense transcript pairs (Chen et al., 2004). NOS is regulated in 
different processes by natural antisense transcripts. Such is the case in 
mammals, where hypoxia induces the expression of a cis-transcript of an NOS3-
encoding antisense gene in human (Robb et al., 2004). Also, Lym-antiNOS1 has 
proven to be involved in long term memory formation in Lymnaea (Korneev et 
al., 2008; Korneev et al., 2005). AntiNOS2A is differentially regulated during 
neuronal differentiation of embryonic stem cells (Korneev, Korneeva et al. 
2008). All of this supports the hypothesis that antisense regulation may be more 
widespread than previously estimated, and that the production of NO seems to 
be regulated via the regulation of the expression of NOS through NATs. 
7.2. The Role of NOS-Related NATs in Memory Formation 
This thesis is based on the hypothesis that Lym-antiNOS2 NAT could be a 
putative bi-functional RNA because it can function as a protein-encoding 
mRNA that also contains a potential regulatory antisense region localised in the 
3‟ UTR (Korneev and O'Shea, 2007). Together with the knowledge that 
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endogenous NO produced by the enzyme NOS has an important role in the 
formation of long term memory, this could mean that Lym-antiNOS2 NAT is 
involved in the regulation of long term memory formation. 
My first target was to identify where Lym-antiNOS2 was expressed in the 
CNS of Lymnaea. In the thesis I show by in situ hybridization that Lym-antiNOS2 
expression is restricted to neurons in buccal ganglia and some neurons in the 
cerebral ganglia. The most noticeable of those neurons is the modulatory 
interneuron CGC connected to the central pattern generator interneuron of the 
feeding system (Figure 4.1 and Figure 5.1). This neuron gates the conditioned 
feeding response and is an essential part of the neural network involved in LTM 
formation. The presence of Lym-antiNOS2 trans-NAT in the CGCs was 
confirmed by identified CGC RT-PCR, co-expressed with Lym-NOS1 mRNA. 
The in situ hybridisation staining with probes specific against Lym-antiNOS2 
showed localisation to be mainly cytoplasmatic. An unexpected result was that 
the CBCs presented staining that is typical of RNA granules involved in 
peripheral trafficking. The presence of Lym-antiNOS2 in the CBCs was 
confirmed by quantitative RT-PCR, showing that the concentration of 
Lym-antiNOS2 RNA in the CBCs is much higher than the concentration in the 
cerebral or buccal ganglia. A further analysis of Lym-antiNOS2 sequence shows 
a CPE-like sequence localized in the 3‟ UTR, which agrees with its localisation 
in the axon. Further experiments using Lym-antiNOS2 CPE-less mutants, 
showing no migration to the axons, would help to support the theory of 
Lym-antiNOS2 RNA peripheral trafficking to the axon. 
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It is interesting to note that the NO-cGMP signalling pathway has been 
implicated in LTM formation. In one-trial appetitive associative conditioning it 
was shown that there is an obligatory requirement for this pathway during the 
first five hours of LTM formation (Kemenes et al., 2002). Moreover, Lym-NOS1 
gene is transiently upregulated in cerebral ganglia after conditioning. The 
activation of the gene is precisely timed and occurs at the end of a critical 
period during which NO is required for memory consolidation. It has also been 
demonstrated that the expression of Lym-antiNOS1 is down-regulated by 
training at four hours after conditioning (Korneev et al., 2005). 
Unlike most other endogenous messengers that are deposited in vesicles, 
processed on demand and/or secreted in a regulated fashion, NO is a highly 
active molecule that readily diffuses through cell membranes and thus cannot 
be stored inside the producing cell. Rather, its signalling capacity must be 
controlled at the levels of biosynthesis and local availability. The importance of 
temporal and spatial control of NO production is highlighted by the finding 
that differential localization of NOS translates into distinct effects of NO. Thus 
NOSs belong to the most tightly controlled enzymes at all levels 
(transcriptional, translational, co- and post-translational modifications, 
substrate availability and specific sorting to subcellular compartments), its close 
proximity to their target proteins being essential (Oess et al., 2006). 
The work on this thesis reveals a spatial regulation of Lym-antiNOS2 
expression. Lym-antiNOS2 RNA undergoes peripheral trafficking through the 
CBCs via a complex mechanism that regulates the localization to subsynaptic 
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regions of the neuron, increasing the likelihood of Lym-antiNOS2 RNA being 
involved in NO production and hence in NO‟s role in LTM formation. 
In this study it was found that the Lym-antiNOS2 gene is down-regulated at 
four hours, as Lym-antiNOS1 has been reported to be down-regulated (Korneev 
et al., 2005) in response to a very weak sensory cue stimulus (single 
conditioning food trial). The down-regulation at four hours coincides with the 
time at which the NO-cGMP pathway is required for the formation of LTM. I 
also show that Lym-NOS1 is up-regulated at one hour after training, which 
confirms and extends previous work (Kemenes et al., 2002) where the 
requirement for NO for the memory trace was shown to be obligatory from the 
first point tested at one hour. I also demonstrate that Lym-antiNOS2 is up-
regulated at six hours. 
Interestingly, this study found that the second peak of Lym-NOS1 mRNA at 
six hours after training appears to be smaller than its one-hour peak (Figure 
4.9). One possibility is that this smaller six-hour peak is a manifestation of a 
higher Lym-NOS1 peak before the six-hour mark. This Lym-NOS1 peak before 
the six-hour mark would generate NO necessary before six hours for LTM 
formation. The down-regulation of Lym-antiNOS1 and Lym-antiNOS2 RNA at 
four hours may be helping increase Lym-NOS1 RNA levels, attaining a peak at 
between four and six hours.  The Lym-antiNOS2 RNA peak at six hours could 
be down-regulating the production of NO after LTM has been formed and NO 
is therefore not required anymore. 
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It was also demonstrated that the regulation of the expression of 
Lym-antiNOS2 NAT is not affecting the whole brain. In particular it is 
remarkable how Lym-antiNOS2 is transiently down-regulated in the buccal 
ganglia after training, while in cerebral ganglia it seems to follow the regulation 
pattern observed for whole CNS. 
In this thesis it is demonstrated that the regulation of Lym-antiNOS2 RNA 
expression in neurons is controlled not only temporally but also where it is 
going to be expressed, in a very complex way. This regulation can be triggered 
by single-conditioning trial. We demonstrate that Lym-antiNOS2 changes its 
localization to subsynaptic regions via peripheral trafficking. To our 
knowledge, this is the first report of trafficking of RNA in molluscs, setting this 
as a unique discovery for understanding how expression of certain RNAs is 
regulated at multiple levels. Importantly, the potential trafficking process we 
have identified, which may involve CPEB, has also been reported previously in 
mammals, pointing to a highly-conserved process during evolution.  
The dynamic sensitivity to a sensory cue of Lym-antiNOS2 is shared also with 
Lym-antiNOS1 and Lym-NOS1, providing a clear illustration of a pseudogene 
whose expression is regulated by a behavioural stimulus.  
The results discussed in this section allow us to suggest that Lym-antiNOS2 is 
clearly regulating the production of NO during LTM formation through the 
regulation of expression of Lym-NOS1 mRNA. 
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7.3. The Role of NOS-Related NAT during Embryonic Brain 
Development 
This thesis also reports the discovery of a novel NOS1-related cis-NAT in 
mouse, Mm-antiNOS1, which is produced from the same sequence as NOS1 
from the opposite strand of DNA. We also demonstrate that Mm-antiNOS1 is 
transcribed in embryonic CNS from the fourteenth day of gestation. 
Because of its identical sequence with NOS1 mRNA over 300bp, but in 
opposite direction, Mm-antiNOS1 cis-NAT is very likely to act as a negative 
regulator of NOS1 mRNA expression. Other NOS-related cis-NATs have been 
proven to act as regulators of NO production, as in the case of eNOS expression 
regulation via hypoxia stimulus in humans (Fish et al., 2007). 
Levels of NOS1 mRNA in the cortex and the hippocampus decrease with age 
in mice (Colas et al., 2006). The expression NOS1 mRNA is first detected in the 
CNS at fourteen days of embryonic gestation, and its expression decreases at 
the end of the gestation period (Santacana et al., 1998). A very exciting outcome 
of this work, derived from the quantitative RT-PCR experiments examining 
expression levels of Mm-antiNOS1, is that the Mm-antiNOS1 gene is up-
regulated during the embryonic gestation until it peaks at eighteen and a half 
days, the end of the gestation period. After birth, expression of Mm-antiNOS1 
RNA drops to about a third of its previous value.  
It is important to note that the values for the levels of expression of NOS1 
RNA previously reported (Nobakht et al., 2007; Santacana et al., 1998) and the 
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values of the expression of Mm-antiNOS1 seem to follow inverted patterns of 
up- and down-regulation during brain development. Together, our results 
suggest that the down-regulation of the NOS1 gene during embryonic 
development could be driven by a reciprocal up-regulation of Mm-antiNOS1. 
Results currently available do not allow the establishment of a conclusive 
correlation, given that the results on NOS1 RNA are made on rats and are semi-
quantitative, while the studies on Mm-antiNOS1 conducted in this thesis were 
performed on mouse, using quantitative techniques. Further work is required to 
show the expression levels of NOS1 RNA in mouse embryos at 10 weeks, 14 
weeks and 18.5 weeks, newborn and adult mouse.  
7.4. Future Work 
This thesis addresses two different models of unconventional mechanisms in 
the regulation of NO production. Each of these are attractive areas for further 
research. 
Lymnaea model of LTM formation There are a number of different directions 
in which this work could be continued to further characterise the 
unconventional molecular mechanisms involved in the regulation of NO 
production through the Lym-antiNOS2 gene, which is involved in the appetitive 
conditioning of Lymnaea feeding behaviour. 
The thesis works on the hypothesis that if a dimer were formed between a 
full-length NOS protein and the truncated version encoded by Lym-antiNOS2 
gene, the resulting dimer would not possess NO-synthesising activity. 
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Therefore, it is possible that Lym-antiNOS2 protein functions as a natural 
dominant negative regulator of NOS activity through the formation of a non-
functional heterodimer with a normal NOS monomer. In vitro translation of 
Lym-antiNOS2 RNA shows that Lym-antiNOS2 RNA is translated into protein 
(Korneev and O'Shea, 2002). However future work has to be done on the in vivo 
translation of Lym-antiNOS2 RNA, and its dimerisation with a normal NOS 
monomer still needs to be proven, both in vitro and in vivo. 
There are currently no known specific antibodies against Lym-NOS1, making 
the visualization of these protein enzymes in tissue very difficult. A novel 
technique called morpholino oligomers (an antisense technology used to block 
access of other molecules to specific sequences within nucleic acid) is sometimes 
used in cases where no antibodies are available. The homology between 
Lym-NOS1 sequences and Lym-antiNOS2 sequences, starting at the beginning of 
the Lym-antiNOS2 RNA sequence and much earlier than the open reading 
frame, makes this technique impractical in this case, but there may still be a case 
for experimenting with this technique because morpholino oligomers have to be 
directed to the beginning of the ORF. 
It would also be interesting to construct a fuller picture of the expression 
patterns triggered by single-conditioning trials. In particular, it would be 
important to analyze the level of expression of Lym-NOS1 and Lym-antiNOS2 
trans-NAT in more detail a) through the CGC and CBCs; b) at the five-hour time 
point and c) after six hours. Studying the expression at the five-hour point 
would help to validate our hypothesis in relation to a possible Lym-NOS1 peak 
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before six hours. Looking at expression after six hours would address our 
hypothesis of the six-hour Lym-antiNOS2 RNA peak triggering down-
regulation of NO production.  
When investigating the expression and co-expression of Lym-antiNOS2 RNA 
and Lym-NOS1 RNA in CGC and CBCs, a further analysis of the Lym-NOS1 
RNA sequence is necessary to reveal peripheral trafficking motifs.  To prove 
that RNA peripheral trafficking is active in snails it would be necessary to show 
that the proteins attach to the RNA in the axons. A first possible step is to 
experiment using CPEB antibodies commercially available for others species. 
Morpholino oligomers could be injected in the snail against the area in 
Lym-antiNOS2 RNA containing CPE motif. Combined with in situ 
hybridization, showing if Lym-antiNOS2 RNA is still present on the CBCs or 
not, this would further our understanding of the peripheral trafficking 
processes discovered in this thesis. 
Murine model in embryonic development Previous research has studied the 
pattern of expression of nNOS in CNS during embryonic development in rats. 
This thesis reports the discovery of the NOS1-related cis-NAT Mm-antiNOS1. 
However it is still unknown whether Mm-antiNOS1 cis-NAT has a role in the 
regulation of NO production. A natural first step towards answering this 
question is to understand the temporal and spatial levels of expression of 
Mm-antiNOS1 cis-NAT in the brain of mice embryos at 18 days of gestation, 
where we have observed its highest expression peak. Specific probes against 
183 
 
Mm-antiNOS1 cis-NAT have already been generated in this thesis for in situ 
hybridization. 
At the same time, the initial studies on the expression levels of nNOS RNA 
relied on semi-quantitative methods (immunostaining, histochemistry) which 
work at the protein level. A highly recommended next step is the identification 
of the levels of NOS1 mRNA expression through quantitative RT-PCR, which 
would help confirm the reciprocal regulation of NOS1 mRNA and 
Mm-antiNOS1 cis-NAT during the embryonic development, and determine 
whether the regulation of NOS1 protein synthesis is influenced by 
Mm-antiNOS1.  
Further directions Together, the results from the studies in Lymnaea model of 
LTM formation and those in Murine model in embryonic development could 
enhance our understanding of the differences in molecular mechanisms 
between invertebrate and mammalians species. This in turn would allow us to 
gain insight into the extent to which it is possible to extrapolate between 
species. 
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